0000950170-23-055978.txt : 20231027 0000950170-23-055978.hdr.sgml : 20231027 20231027160521 ACCESSION NUMBER: 0000950170-23-055978 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 32 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20231027 DATE AS OF CHANGE: 20231027 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEI Pharma, Inc. CENTRAL INDEX KEY: 0001262104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510407811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-41827 FILM NUMBER: 231355527 BUSINESS ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-369-7100 MAIL ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MARSHALL EDWARDS INC DATE OF NAME CHANGE: 20030902 10-K/A 1 meip-20230630.htm 10-K/A 10-K/A
--06-300001262104FYtrue00012621042021-07-012022-06-300001262104meip:ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInCoveredYearMemberecd:NonPeoNeoMember2022-07-012023-06-3000012621042022-07-012023-06-300001262104ecd:NonPeoNeoMembermeip:FairValueOfOutstandingUnvestedStockAndOptionAwardsGrantedInTheCoveredYearMember2022-07-012023-06-300001262104meip:DanielGoldMember2022-07-012023-06-300001262104meip:StockAndOptionAwardValuesReportedInSctForTheCoveredYearMemberecd:NonPeoNeoMember2021-07-012022-06-300001262104meip:ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInCoveredYearMemberecd:PeoMembermeip:DavidUrsoMember2020-07-012021-06-300001262104meip:DavidUrsoMember2021-07-012022-06-300001262104meip:DanielGoldMemberecd:PeoMembermeip:StockAndOptionAwardValuesReportedInSctForTheCoveredYearMember2022-07-012023-06-3000012621042022-12-310001262104ecd:PeoMembermeip:StockAndOptionAwardValuesReportedInSctForTheCoveredYearMembermeip:DavidUrsoMember2020-07-012021-06-300001262104meip:StockAndOptionAwardValuesReportedInSctForTheCoveredYearMemberecd:NonPeoNeoMember2022-07-012023-06-300001262104ecd:NonPeoNeoMembermeip:ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYearsMember2020-07-012021-06-300001262104ecd:NonPeoNeoMembermeip:ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYearsMember2021-07-012022-06-3000012621042023-09-150001262104meip:DanielGoldMemberecd:PeoMembermeip:ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYearsMember2021-07-012022-06-300001262104meip:ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInCoveredYearMemberecd:PeoMembermeip:DavidUrsoMember2022-07-012023-06-300001262104ecd:PeoMembermeip:DavidUrsoMembermeip:FairValueOfOutstandingUnvestedStockAndOptionAwardsGrantedInTheCoveredYearMember2022-07-012023-06-300001262104ecd:NonPeoNeoMembermeip:FairValueOfOutstandingUnvestedStockAndOptionAwardsGrantedInTheCoveredYearMember2020-07-012021-06-300001262104meip:FairValueOfStockAndOptionAwardsForfeitedDuringTheCoveredYearMemberecd:NonPeoNeoMember2020-07-012021-06-300001262104meip:DanielGoldMemberecd:PeoMembermeip:FairValueOfOutstandingUnvestedStockAndOptionAwardsGrantedInTheCoveredYearMember2021-07-012022-06-300001262104meip:DanielGoldMemberecd:PeoMembermeip:ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYearsMember2020-07-012021-06-300001262104ecd:PeoMembermeip:DavidUrsoMembermeip:FairValueOfOutstandingUnvestedStockAndOptionAwardsGrantedInTheCoveredYearMember2021-07-012022-06-300001262104meip:DavidUrsoMember2020-07-012021-06-300001262104ecd:PeoMembermeip:DavidUrsoMembermeip:FairValueOfOutstandingUnvestedStockAndOptionAwardsGrantedInTheCoveredYearMember2020-07-012021-06-300001262104meip:DanielGoldMembermeip:ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInCoveredYearMemberecd:PeoMember2020-07-012021-06-300001262104ecd:NonPeoNeoMembermeip:FairValueOfOutstandingUnvestedStockAndOptionAwardsGrantedInTheCoveredYearMember2021-07-012022-06-300001262104ecd:PeoMembermeip:DavidUrsoMembermeip:ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYearsMember2021-07-012022-06-300001262104meip:DanielGoldMember2021-07-012022-06-300001262104meip:ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInCoveredYearMemberecd:NonPeoNeoMember2021-07-012022-06-300001262104meip:DavidUrsoMember2023-06-022023-06-020001262104meip:ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInCoveredYearMemberecd:NonPeoNeoMember2020-07-012021-06-300001262104meip:StockAndOptionAwardValuesReportedInSctForTheCoveredYearMemberecd:NonPeoNeoMember2020-07-012021-06-300001262104ecd:PeoMembermeip:StockAndOptionAwardValuesReportedInSctForTheCoveredYearMembermeip:DavidUrsoMember2022-07-012023-06-30000126210412022-07-012023-06-300001262104meip:DanielGoldMemberecd:PeoMembermeip:FairValueOfOutstandingUnvestedStockAndOptionAwardsGrantedInTheCoveredYearMember2020-07-012021-06-300001262104meip:DavidUrsoMember2022-07-012023-06-300001262104meip:ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInCoveredYearMemberecd:PeoMembermeip:DavidUrsoMember2021-07-012022-06-300001262104meip:DanielGoldMemberecd:PeoMembermeip:StockAndOptionAwardValuesReportedInSctForTheCoveredYearMember2021-07-012022-06-300001262104meip:DanielGoldMemberecd:PeoMembermeip:FairValueOfStockAndOptionAwardsGrantedInCoveredYearThatVestedMember2022-07-012023-06-300001262104ecd:PeoMembermeip:ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYearsMembermeip:DavidUrsoMember2022-07-012023-06-3000012621042020-07-012021-06-300001262104meip:DanielGoldMember2020-07-012021-06-300001262104meip:DanielGoldMembermeip:ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInCoveredYearMemberecd:PeoMember2022-07-012023-06-300001262104meip:DanielGoldMemberecd:PeoMembermeip:StockAndOptionAwardValuesReportedInSctForTheCoveredYearMember2020-07-012021-06-300001262104ecd:NonPeoNeoMembermeip:ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYearsMember2022-07-012023-06-300001262104meip:DanielGoldMembermeip:ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInCoveredYearMemberecd:PeoMember2021-07-012022-06-300001262104ecd:PeoMembermeip:StockAndOptionAwardValuesReportedInSctForTheCoveredYearMembermeip:DavidUrsoMember2021-07-012022-06-300001262104meip:FairValueOfStockAndOptionAwardsForfeitedDuringTheCoveredYearMembermeip:DanielGoldMemberecd:PeoMember2022-07-012023-06-300001262104ecd:PeoMembermeip:ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYearsMembermeip:DavidUrsoMember2020-07-012021-06-30xbrli:sharesiso4217:USD
Table of Contents

 

--

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K/A

(Amendment No. 1)

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended June 30, 2023

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to .

Commission File Number: 001-41827

MEI Pharma, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware

51-0407811

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

11455 El Camino Real, Suite 250, San Diego, CA 92130

(Address of principal executive offices) (Zip Code)

(858) 369-7100

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

 

 

 

 

 

Title of each class

Trading

Symbol

Name of each exchange

on which registered

Common Stock, $0.00000002 par value

MEIP

The Nasdaq Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act:

None

(Title of Class)

Indicate by a check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No

Indicate by a check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No

 


Table of Contents

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

 

 

 

 

 

 

Large accelerated filer

Accelerated filer

 

 

 

 

Non-accelerated filer

Smaller reporting company

 

 

 

 

 

 

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240,10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

The aggregate market value of the voting and non-voting common equity held by non-affiliates, based on the closing price per share of Registrant's Common Stock on the Nasdaq Capital Market was approximately $31.8 million as of December 31, 2022.

As of September 15, 2023, there were 6,662,857 shares of the registrant’s common stock, par value $0.00000002 per share, outstanding.

Auditor Name: BDO USA, P.C.

Auditor Location: San Diego, California

PCAOB ID Number: 243

 

 


Table of Contents

 

 

EXPLANATORY NOTE

Throughout this document MEI Pharma, Inc. is referred to as “MEI,” and, together with its subsidiaries, as “we,” “us,” or “our.”

On September 26, 2023, MEI filed its Annual Report on Form 10-K for the fiscal year ended June 30, 2023 (the “Original Form 10-K”). Certain Part III information was omitted from the Original Form 10-K in reliance on General Instruction G(3) to Form 10-K. General Instruction G(3) to Form 10-K provides that registrants may incorporate by reference certain information from a definitive proxy statement which involves the election of directors if such definitive proxy statement is filed with the Securities and Exchange Commission (the “SEC”) within 120 days after the end of the fiscal year. We do not anticipate that MEI's definitive proxy statement involving the election of directors in connection with its MEI's fiscal year 2024 annual meeting of stockholders will be filed by October 27, 2023 (i.e., within 120 days after the end of the 2023 fiscal year). Accordingly, this Amendment No. 1 (this “Amendment”) hereby amends and restates Part III, Items 10 through 14, of the Original Form 10-K as set forth below. The information included herein as required by Part III, Items 10 through 14, of the Original Form 10-K is more limited than what is required to be included in the definitive proxy statement to be filed in connection with our 2024 annual meeting of stockholders. Accordingly, the definitive proxy statement to be filed at a later date will include additional information related to the topics herein and additional information not required by Part III, Items 10 through 14, of Form 10-K.

This Amendment also restates Item 15 of Part IV of the Original Form 10-K. In addition, as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), new certifications by our principal executive officer and principal financial officer are filed as exhibits to this Amendment under Item 15 of Part IV hereof.

No other amendments are being made hereby to the Original Form 10-K. Except as stated herein, this Amendment does not reflect events occurring after the filing of the Original Form 10-K with the SEC on September 26, 2023, and no attempt has been made in this Amendment to modify or update other disclosures as presented in the Original Form 10-K. Terms used but not defined herein have the meanings given to them in the Original Form 10-K.

i


Table of Contents

 

MEI PHARMA, INC.

TABLE OF CONTENTS

 

 

 

 

 

 

 

Page

 

 

EXPLANATORY NOTE

 

 

i

 

 

 

 

 

 

 

 

PART III

 

 

 

 

Item 10:

Directors, Executive Officers and Corporate Governance

1

Item 11:

Executive Compensation

8

Item 12:

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

23

Item 13:

Certain Relationships and Related Transactions, and Director Independence

24

Item 14:

Principal Accountant Fees and Services

24

 

 

 

PART IV

 

 

 

 

Item 15:

Exhibits, Financial Statement Schedules

25

 

 


Table of Contents

 

PART III

Item 10. Directors, Executive Officers and Corporate Governance

Directors

Set forth below are the names, ages as of October 1, 2023, and certain biographical information regarding our directors who are not being considered for re-election at the Annual Meeting.

Name

 

Age

 

Positions Held

 

Expiration of Term

Charles V. Baltic III

 

62

 

Director

 

Fiscal 2025 Annual Meeting of Stockholders

Nicholas R. Glover, Ph.D.

 

54

 

Director

 

Fiscal 2025 Annual Meeting of Stockholders

Frederick W. Driscoll

 

72

 

Director

 

Fiscal 2025 Annual Meeting of Stockholders

David M. Urso

 

59

 

President, CEO and Director

 

Fiscal 2025 Annual Meeting of Stockholders

Thomas C. Reynolds, M.D., Ph.D.

 

64

 

Director

 

Fiscal 2026 Annual Meeting of Stockholders

Daniel P. Gold, Ph.D.

 

69

 

Director

 

Fiscal 2024 Annual Meeting of Stockholders

Tamar D. Howson

 

75

 

Director

 

Fiscal 2024 Annual Meeting of Stockholders

Sujay R. Kango

 

60

 

Director

 

Fiscal 2024 Annual Meeting of Stockholders

 

David M. Urso, age 59, J.D., President, Chief Executive Officer and Director

Mr. Urso served as Chief Operating Officer and General Counsel of MEI from July 2018 to June 2023 and as President and Chief Executive Officer since June 2023. Mr. Urso was appointed as a member of MEI’s board of directors effective June 8, 2023. Prior to July 2018, Mr. Urso had been MEI’s Senior Vice President of Corporate Development and General Counsel since April 2014. Mr. Urso joined MEI with more than two decades of experience in the life science industry, most recently as Chief Operating Officer and General Counsel at Tioga Pharmaceuticals, a privately held drug development company he co-founded in 2005 as a Principal at Forward Ventures, where he was responsible for identifying and developing life science venture capital investments. Prior to joining Forward Ventures in 2002, Mr. Urso was Director of Corporate Development and Legal Affairs at DNA Sciences, Inc. Previously, he worked as an attorney in the corporate securities and licensing groups at Wilson Sonsini Goodrich & Rosati LLP and Cooley Godward LLP, after beginning his career as a bench scientist at SmithKline Beecham and the University of Pennsylvania Medical School. Mr. Urso received a J.D. from Harvard Law School and a B.A. in Molecular Biology and Philosophy from Reed College.

Charles V. Baltic III, age 62, Chair

Mr. Baltic has served as a director of MEI Pharma since October 2011 and as Chair of the Board of directors of MEI since January 2023. He previously served as Chair of the Nominating and Governance Committee from 2012 to 2022. Mr. Baltic also serves as a director and Chairman of the Board of AssayQuant Technologies, Inc., a private company focused on kinase-based assay drug development technology licensed from the Massachusetts Institute of Technology. Mr. Baltic was previously affiliated with Needham & Company, LLC as Managing Director and Co-Head of Healthcare Banking from 2009 until 2019 and as Senior Advisor from 2019 to 2022. Mr. Baltic served as acting CEO of Amyndas Pharmaceuticals, a private development-stage biotechnology company focused on immunology and innate immunity complement therapeutics based on technology licensed from the University of Pennsylvania from March 2021 to October 2021. Mr. Baltic served as Executive Vice President and COO of SIDIS Corp. from 2019 to 2021, overseeing the sale of the Propel Labs flow cytometry business to Thermo Fisher Scientific in February 2021. Mr. Baltic was a Managing Director and head of the biotechnology practice at CRT Capital Group from 2006 to 2008. From 2001 to 2006, he served as a Managing Director in Healthcare Investment Banking at Wachovia Securities. Prior to Wachovia, he was with Healthcare Investment Banking at Cowen and Company for six years. Prior to beginning his investment banking career in 1996, Mr. Baltic practiced corporate and securities law with the firm Dewey Ballantine, representing numerous healthcare and securities clients. Mr. Baltic previously served as a director of SIDIS Corp. from 2015 to 2019. Mr. Baltic served as a director of the trade association Life Science Washington from 2013 to 2018. Mr. Baltic served as a director of MedVantage Inc., a private health informatics company acquired by IMS Health (now IQVIA Holdings) in 2011. Mr. Baltic served on the U.S. Securities and Exchange Commission’s Advisory Committee on Small and Emerging Growth Companies from 2013 to 2015. He served as a founding Trustee of Hope Funds for Cancer Research from 2007 to 2017. Mr. Baltic earned B.A. (honors) and J.D. degrees from Georgetown University and a M.B.A. degree in finance from the Wharton School of the University of Pennsylvania.

Nicholas R. Glover, Ph.D., age 54, Director

Dr. Glover has been a director of MEI Pharma since June 2013. He is currently a consultant to the biotech industry. Previously, he served as President and Chief Executive Officer of Sierra Oncology (NASDAQ: SRRA), a drug development company focused on advancing targeted therapeutics for the treatment of patients with cancer, from July 2014 through May 2020. Prior to joining Sierra, he served as President and Chief Executive Officer of YM Biosciences, an oncology drug development company, from November 2010 until its acquisition by Gilead Sciences in February 2013. Previously, Dr. Glover was President and Chief Executive Officer of Viventia Biotech, a biopharmaceutical

1


Table of Contents

 

company involved in the discovery and development of monoclonal antibody-based technologies for the treatment of cancer, which he joined after serving as an investment manager for MDS Capital, a life sciences venture capital firm. Dr. Glover holds a B.Sc. (Hons) in Chemistry from the University of East Anglia, U.K., a M.Sc. in Chemistry from the University of British Columbia, Canada, and a Ph.D. in Chemistry from Simon Fraser University, Canada.

Frederick W. Driscoll, age 72, Director

Mr. Driscoll has been a director of MEI Pharma since February 2018. He currently serves on the board of directors of Cue Biopharma, Cellectar Biosciences, Inc. and Calliditas Therapeutics. He served as interim chief financial officer at Invivyd, Inc. from September 2022 to May 2023. He served as chief financial officer of Renovacor from March to June 2022. He served as the chief financial officer of Flexion Therapeutics, Inc. from 2013 to 2017 and rejoined in June 2021 as chief financial officer. Prior to joining Flexion, he was the chief financial officer at Novavax, Inc. from 2009 to 2013. From 2008 to 2009, Mr. Driscoll served as the chief executive officer at Genelabs Technologies, Inc. and from 2007 to 2008 he served as the company's chief financial officer. He was also the chief executive officer of OXiGENE, Inc. from 2000 to 2006. Mr. Driscoll also served as the chairman of the board and audit committee chair at OXiGENE and as a member of the audit committee for Cynapsus Therapeutics, Inc. Mr. Driscoll earned a bachelor’s degree in Accounting and Finance from Bentley University.

 

Thomas C. Reynolds, M.D., Ph.D., age 64, Director

Dr. Reynolds has been a director of MEI Pharma since February 2013. He is President of Two Paddles Consulting LLC since December 2013, providing consulting services to biotechnology and pharmaceutical companies. Dr. Reynolds served as an independent director of Trillium Therapeutics Inc. (NASDAQ: TRIL; TSX: TR), an immuno-oncology company, until April 2021. Previously, he served as Chief Medical Officer of Seattle Genetics from March 2007 until his retirement in February 2013. While at Seattle Genetics, he was responsible for building and leading an integrated clinical development, regulatory and medical affairs organization, highlighted by the development and approval of ADCETRIS®. From 2002 to 2007, Dr. Reynolds served at ZymoGenetics (acquired by BMS in 2010), most recently as Vice President, Medical Affairs, where he oversaw the clinical development and regulatory filing of RECOTHROM®. Previously, he was Vice President, Clinical Affairs at Targeted Genetics, and before that was at Somatix Therapy (acquired by Cell Genesys in 1997). Dr. Reynolds received his M.D. and Ph.D. in Biophysics from Stanford University and a B.A. in Chemistry from Dartmouth College.

Daniel P. Gold, Ph.D., age 69, Director

Dr. Gold served as MEI’s President, Chief Executive Officer and a director from April 2010 until the consummation of the Merger. He joined MEI with approximately 25 years of drug discovery and development experience, most recently as President and Chief Executive Officer of Prospect Therapeutics, a mid-stage oncology company. Prior to his tenure at Prospect, Dr. Gold was founder and Chief Scientific Officer of Favrille, where he was an integral member of a team that advanced the company’s lead oncology candidate through a pivotal Phase 3 clinical trial. He currently serves on the Board of Trustees of the Hope Funds for Cancer Research. Dr. Gold’s academic qualifications include Postdoctoral Fellowships at the Dana-Farber Cancer Institute, at the Harvard School of Medicine and the Massachusetts Institute of Technology, Center for Cancer Research. He holds a Ph.D. in Pathology/Immunology from Tufts University, Boston and a bachelor’s degree in Biology from the University of California, Los Angeles.

Tamar D. Howson, age 75, Director

Ms. Howson has been a director of MEI Pharma since July 2019. She is a highly experienced business development executive and consultant with more than 30 years of service in the pharmaceutical and biotechnology industries. Ms. Howson currently serves on the board of directors of Immunic Pharma and Cue Pharma. Between 2009 to 2019 she served on the boards of various other life sciences companies including Actavis plc, Aradigm Corporation, ContraVir Pharmaceuticals, Inc., Cynapsus Therapeutics Inc., Enzymotec PLC, Idenix Pharmaceuticals Inc., Organovo Holdings Inc, OXiGENE, Inc., and Scientus Pharma, a private company. From 2009 to 2011, Ms. Howson served as a member of the transaction advisory firm JSB-Partners, providing business development support to life sciences companies. From 2007 to 2008, Ms. Howson served as Executive Vice President, Corporate Business Development at Lexicon Pharmaceuticals, a public biotech company. Prior to joining Lexicon, Ms. Howson served as Senior Vice President, Corporate and Business Development at Bristol-Myers Squibb and SmithKline Beecham plc. Ms. Howson holds an M.B.A. from Columbia University, a M.S. from City University of New York, and a B.S. in Chemical Engineering from the Technion, Israel.

Sujay R. Kango, age 60, Director

Mr. Kango has been a director of MEI Pharma since November 2021. Mr. Kango is an experienced executive with more than 25 years of experience in the pharmaceutical and biotechnology industries. Mr. Kango currently serves as the President and CEO of Tmunity Therapeutics and is a board member of Infinity Pharmaceuticals. He has held senior management positions where he has been instrumental in transforming earlier stage biotechnology companies into fully integrated global biotechnology organizations. Mr. Kango has built commercial infrastructures and teams, while leading multiple global product launches. Mr. Kango joined Acceleron Pharma in 2018, where he most recently served as the executive vice president and chief commercial officer and was responsible for establishing the company’s global presence, including its launch of Reblozyl in North America. Mr. Kango played a critical role in Acceleron’s $11.5 billion acquisition. In addition, Mr. Kango has led multiple global product launches across several therapeutic areas including oncology-hematology, rare diseases, immunology, and virology. Previously Mr. Kango was vice president of global commercial development for oncology at AbbVie, prior to which he served as the executive

2


Table of Contents

 

vice president and chief commercial officer at Infinity Pharmaceuticals. Mr. Kango also served as vice president, global marketing, and sales operations at Onyx Pharmaceuticals, an Amgen subsidiary. Prior to Onyx, he held several leadership positions including vice president sales and marketing-oncology at Merck & Co., global commercial leader- Procrit®/Eprex® at Ortho-Biotech, and various sales and marketing positions at Schering-Plough. Mr. Kango earned a B.S. in Microbiology and an M.B.A. from McNeese State University.

Information about the Board of Directors and its Committees

The Board of Directors has responsibility for the overall corporate governance of MEI Pharma. During the fiscal year ended June 30, 2023, a majority of the members of the Board of Directors were, and as of the date of this Proxy Statement are, independent within the meaning of the Nasdaq Stock Market (“Nasdaq”) rules.

The Board has established an Audit Committee to oversee MEI’s financial matters, a Compensation Committee to oversee our compensation policies, plans and programs and a Nominating and Governance Committee to assist the Board of Directors in nominating board members to be elected by the stockholders at the Annual Meeting, to fill vacancies and newly created directorships, and to evaluate and monitor all matters with respect to governance of MEI and oversee compliance by MEI with its legal and regulatory obligations.

 

Schedule of Committee Members (as of October 1, 2023)

Board Member

Audit

Committee

Compensation

Committee

Nominating &
Governance Committee

Charles V. Baltic, III

img104060336_0.jpg 

img104060336_1.jpg 

Frederick W. Driscoll

img104060336_2.jpgimg104060336_3.jpg 

Nicholas R. Glover

img104060336_4.jpg 

img104060336_5.jpg 

Tamar D. Howson

img104060336_6.jpg 

img104060336_7.jpg 

Sujay R. Kango

 

img104060336_8.jpg 

img104060336_6.jpg 

 

 

 

 

Thomas C. Reynolds

img104060336_9.jpg 

img104060336_10.jpg 

 

 

 

 

Daniel P. Gold

 

 

 

img104060336_1.jpg = Committee Member

img104060336_10.jpg = Committee Chair

img104060336_11.jpg = Financial Expert

Audit Committee

The Audit Committee of the Board of Directors has been established in accordance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Audit Committee’s responsibilities include:

overseeing financial and accounting activities;
selecting and recommending the annual appointment of independent auditors;
reviewing and approving the scope of audit and non-audit assignments and related fees;
assessing annually MEI’s major financial risks and exposures;
evaluating the independence and performance of the independent auditors:
reviewing the accounting principles used in financial reporting;
reviewing and assessing our financial reporting activities and disclosures included in our periodic reports and the accounting standards and principles followed;
reviewing the adequacy and effectiveness of our internal control over financial reporting; and
reviewing and approving related party transactions.

3


Table of Contents

 

Mr. Driscoll has served as Chairman of the Audit Committee since August 29, 2019. The other members of the Audit Committee are Mr. Baltic, and Dr. Glover. Mr. Driscoll has been determined by the Board of Directors to be an “audit committee financial expert” as defined by the SEC.

The Board of Directors has determined that each of the Audit Committee members is independent, as defined by applicable Nasdaq and SEC rules. We have adopted an Audit Committee Charter, which is posted on its website at www.meipharma.com. The Audit Committee met five times during the fiscal year ended June 30, 2023.

Compensation Committee

The Compensation Committee acts on behalf of the Board to fulfill the Board’s responsibilities to:

oversee, review, modify and approve our compensation strategy and policies;
assess the independence of compensation consultants and legal advisors prior to engagement;
exercise sole power to retain compensation consultants and advisors and to determine the scope of the associated engagements;
review and approve annual corporate performance goals;
evaluate the chief executive officer’s and executive officers’ performance;
review and determine the compensation to be paid to our executive officers, including the allocation of equity related grants;
recommend the compensation and terms of appointment of non-executive directors to the Board of Directors for review and approval;
ensure MEI meets the reporting requirements promulgated by the SEC regarding compensation and disclosure of compensation and compensation related practices;
assess potential compensation related risks; and
evaluate and ensure compliance with “Say-on-Pay” requirements.

The Compensation Committee also consults with and considers the recommendations of the chief executive officer with respect to the appropriate level and mix of the various compensation components, focused primarily on the particular goals of applicable executives and employees in a particular year. The Board of Directors has adopted a written charter for the Compensation Committee, which is available on our website at www.meipharma.com. Dr. Glover has served as the Chairman of the Compensation Committee since December 16, 2021. The other members of the Compensation Committee are Ms. Howson, Mr. Kango and Dr. Reynolds. The Board of Directors has determined that each member of the Compensation Committee is independent as defined by applicable Nasdaq rules. The Compensation Committee met three times during the fiscal year ended June 30, 2023.

Nominating and Governance Committee

The Nominating and Governance Committee is responsible for assisting the Board of Directors in:

identifying qualified individuals who possess the desired experience and skills to serve on the Board;
proposing chairpersons and members on committees to the Board;
considering all qualified director candidates identified by the Nominating and Governance Committee, or by stockholders, in the event any member of the Board of Directors does not wish to continue in service or if the Board of Directors decides not to re-nominate a member for re-election;
overseeing the Board evaluation process and evaluating the size and composition of the Board; and
evaluating any stockholder proposal and whether to recommend to the Board of Directors and whether MEI shall support or oppose the proposal.

Dr. Reynolds has served as Chairman of the Nominating and Governance Committee since January 2023. The other members of the Nominating and Governance Committee are Ms. Howson, Mr. Kango and Mr. Baltic. MEI Pharma’s Nominating and Governance Committee Charter is posted on its website at www.meipharma.com. The Board of Directors has determined that each of the Nominating and Governance Committee members is independent, as defined by applicable Nasdaq and SEC rules. The Nominating and Governance Committee met nine times during the fiscal year ended June 30, 2023.

Stockholders who would like to propose an independent director candidate for consideration for nomination by the Board of Directors at next year’s annual meeting of stockholders may do so by submitting the candidate’s name, resume and biographical information to the attention of Justin J. File, Secretary, MEI Pharma, Inc., 11455 El Camino Real, Suite 250, San Diego, California 92130. All stockholder nominations

4


Table of Contents

 

received by the Secretary, which comply with the advance notice provisions of MEI's Amended and Restated Bylaws, will be presented to the Nominating and Governance Committee for the same consideration as individuals identified by the Nominating and Governance Committee through other means.

While we has no minimum qualifications for director nominees, the Nominating and Governance Committee reviews the prospective candidate’s biographical information and assesses each candidate’s independence, diversity, skills and expertise based on a variety of factors, including the following criteria:

whether the candidate has exhibited behavior that indicates he or she is committed to the highest ethical standards;
whether the candidate has had broad business, governmental, non-profit or professional experience that indicates that the candidate will be able to make a significant and immediate contribution to the Board of Directors’ discussion and decision-making; and
whether the candidate will be able to devote sufficient time and energy to the performance of his or her duties as a director.

Application of these factors requires the exercise of judgment by members of the Nominating and Governance Committee when the Committee makes recommendations to the Board of Directors, and cannot be measured in a quantitative way. In addition, the Nominating and Governance Committee considers, as one factor among many, the diversity of Board candidates, which may include diversity of skills and experience as well as geographic, gender, age, and ethnic diversity. The Nominating and Governance Committee does not, however, have a formal policy with regard to the consideration of diversity in identifying Board candidates. The Nominating and Governance Committee and the Board of Directors generally value the broad business experience and independent business judgment in the health care, life sciences and other fields of each member. Specifically, Mr. Baltic is qualified for the Board based on his business experience in the health care investment banking industry. Mr. Driscoll is qualified for the Board based on his business experience in the pharmaceutical industry in the area of finance and his status as an “audit committee financial expert”. Dr. Glover is qualified for the Board based on his business experience and his drug development experience in the oncology field. Ms. Howson is qualified for the Board based on her business experience in the pharmaceutical industry in the area of business development. Mr. Kango is qualified for the Board based on his business and pharmaceutical industry experience in the areas of commercialization, strategic marketing, business development and drug development in oncology. Mr. Urso is qualified for the Board based on his experience in varying roles of leadership within the Company, including most recently as Chief Executive Officer and [·]. Dr. Reynolds is qualified for the Board based on his medical experience and experience in clinical development and regulatory and medical affairs. Dr. Gold is qualified for the Board based on his prior experience as the Company’s chief executive officer and other experience in clinical development and the pharmaceutical industry.

In addition, the Nominating and Governance Committee oversees compliance by MEI with its legal and regulatory obligations and periodically reviews our:

Code of Business Conduct and Ethics;
Insider Trading Policy;
Corporate Disclosure Policy;
amended and restated certificate of incorporation;
amended and restated bylaws; and
the independent status of our directors.

Director Independence

The Board of Directors has determined the independence of each director in accordance with the elements of independence set forth in the Nasdaq listing standards. Based upon information solicited from each director, the Board of Directors has determined that each of Mr. Baltic, Mr. Driscoll, Dr. Glover, Ms. Howson, Mr. Kango and Dr. Reynolds has no material relationship with MEI Pharma and is “independent” within the meaning of Nasdaq’s director independence standards as currently in effect. In making the foregoing determinations, the Board of Directors has considered both the objective tests set forth in the Nasdaq independence standards and subjective measures with respect to each director necessary to determine that no relationships exist that would interfere with the exercise of independent judgment by each such director in carrying out responsibilities of a director. Each of Dr. Gold, as former President and Chief Executive Officer, and Mr. Urso, as current President and Chief Executive Officer, are not considered independent in accordance with Nasdaq’s requirements.

Board Leadership Structure

Mr. Baltic has served as the Chair of our Board of Directors since January 2023. The Board of Directors does not have a policy addressing whether the same person should serve as both the Chief Executive Officer and Chair of the Board or if the roles should be separate. Our Board believes that it should have the flexibility to make its determination based upon what it considers to be the appropriate leadership

5


Table of Contents

 

structure for MEI at the time. The Board believes that its current leadership structure, with Mr. Urso serving as President and Chief Executive Officer and Mr. Baltic serving as Chair of the Board is appropriate for MEI at this time.

Board Role in Risk Oversight

Risk is an integral part of the Board and Committee deliberations throughout the year. While the Board has the ultimate oversight responsibility for the risk management process, various committees of the Board also have responsibility for risk management. In particular, the Audit Committee focuses on financial risk, including internal controls, and receives financial risk assessment reports from management. Risks related to the compensation programs are reviewed by the Compensation Committee. The Nominating and Governance Committee exercises oversight of governance risks, including succession planning and legal compliance. The Board is advised by these committees of significant risks and management’s response through periodic updates.

Board Diversity

The table below provides certain information with respect to the composition of our Board. Each of the categories listed in the table has the meaning ascribed to it in Nasdaq Listing Rule 5605(f).

Board Diversity Matrix (As of August 31, 2023)

Total Number of Directors

8

 

Female

Male

Non-Binary

Did Not Disclose Gender

Part I: Gender Identity

 

 

 

 

Directors

1

7

Part II: Demographic Background

 

 

 

 

African American or Black

Alaskan Native or Native American

Asian

1

Hispanic or Latinx

Native Hawaiian or Pacific Islander

White

1

6

Two or More Races or Ethnicities

LGBTQ+

Did Not Disclose Demographic Background

 

Board Diversity Matrix (As of August 31, 2022)

Total Number of Directors

9

 

Female

Male

Non-Binary

Did Not Disclose Gender

Part I: Gender Identity

 

 

 

 

Directors

3

6

Part II: Demographic Background

 

 

 

 

African American or Black

Alaskan Native or Native American

Asian

1

Hispanic or Latinx

Native Hawaiian or Pacific Islander

White

3

5

Two or More Races or Ethnicities

LGBTQ+

Did Not Disclose Demographic Background

Anti-Hedging and Pledging Policies

Under our Insider Trading Policy, all directors, officers, employees and consultants of MEI are subject to restrictions on hedging of securities of MEI. These restrictions apply to securities of MEI owned by such persons, regardless of whether such securities were granted by us to such persons as compensatory awards. Our Insider Trading Policy prohibits such persons from engaging in short sales of securities of MEI or in transactions in publicly traded options with respect to our securities. In addition, our Insider Trading Policy permits, but discourages, such persons from holding our securities in a margin account or pledging securities of MEI as collateral for a loan and from entering standing orders with respect to our securities.

Stockholder Communications with the Board of Directors

Our stockholders may communicate with the Board of Directors, including non-executive directors or officers, by sending written communications addressed to such person or persons in care of MEI Pharma, Inc., Attention: Secretary, 11455 El Camino Real, Suite 250, San Diego, California, 92130. All communications will be compiled by the Secretary and submitted to the addressee. If the Board of Directors modifies this process, the revised process will be posted on our website.

6


Table of Contents

 

Appointment of Directors

Our amended and restated certificate of incorporation and amended and restated by-laws provide that the number of directors will be set by resolution of the board, but shall be between two and nine. We currently have eight directors.

Under our amended and restated certificate of incorporation and amended and restated by-laws, directors are to be elected at each annual meeting of stockholders for a term of three years unless the director is removed, retires or the office is vacated earlier. The board is divided into three classes with respect to the term of office, with the terms of office of one class expiring each successive year. This classified board provision could discourage a third party from making a tender offer for MEI's shares or attempting to obtain control of MEI Pharma. It could also delay stockholders who do not agree with the policies of the Board of Directors from removing a majority of the Board of Directors for two years.

A director may resign at any time. The resignation is effective upon receipt of notice. Any or all directors may be removed with cause by a resolution of stockholders entitled to vote to elect directors. Vacancies from resignation or removal or expansion of the size of the board may be filled by resolution of a majority of directors then in office or by a sole remaining director, and any director so appointed shall serve for the remainder of the full term of the class of directors in which the vacancy occurred.

Attendance of Directors at Board Meetings and Stockholder Meetings

During the fiscal year ended June 30, 2023, the Board of Directors held a total of seventeen meetings, and each director attended at least 75% of the total number of meetings of the Board of Directors and of the meetings of each committee of the Board of Directors on which such director served.

All directors are expected to attend our annual meetings of stockholders. All directors then in office attended the annual meeting of stockholders held in December 2022.

Code of Ethics

We have adopted a Code of Business Conduct and Ethics that applies to our directors and employees and we have posted the text of the policy on our website at www.meipharma.com.

Executive Officers

Our executive officers are appointed by and serve at the discretion of the Board of Directors. Set forth below are the names and certain biographical information regarding MEI Pharma’s executive officers as of October 1, 2023.

David M. Urso, age 59, President and Chief Executive Officer

See “Directors” above for biographical information regarding Mr. Urso.

Justin J. File, age 53, Chief Financial Officer and Secretary

Mr. File has 30 years of experience in accounting and finance, working in both public and private companies. He has a diverse range of experience, having worked in various industries, including the life sciences industry for the past 16 years. From 2015 to 2023, Mr. File was the Chief Financial Officer and Corporate Secretary of Evofem Biosciences, Inc., a women's health company that developed and commercialized Phexxi®, a nonhormonal contraceptive for women. While at Evofem he helped bring the company public through a reverse merger and was responsible for overseeing corporate finance and accounting, information technology and investor relations. Previously, Mr. File provided executive financial and accounting oversight consulting services to biotechnology companies, and before that led accounting operations and reporting at Sequenom, Inc., a molecular diagnostic company. He additionally served as Treasurer of Sequenom’s diagnostic subsidiary. Before joining industry, Mr. File worked for approximately ten years in public accounting, primarily with Arthur Andersen LLP. Mr. File graduated from Central Washington University with a Bachelor of Science in Accounting and Business Administration. He is a Certified Public Accountant (inactive).

Richard G. Ghalie, M.D., age 66, Chief Medical Officer

Dr. Ghalie has been Chief Medical Officer since April 2021. Prior to April 2021, Dr. Ghalie had been MEI’s Senior Vice President, clinical development since March 2016. He is a hematologist and oncologist with more than 25 years of drug development experience at public and private companies. Dr. Ghalie has held several executive positions in the pharmaceutical industry and has led medical teams that successfully filed NDAs and MAAs resulting in the approval of four new indications. Dr. Ghalie holds a medical degree from the French School of Medicine in Lebanon, a master’s degree from the University Paris XI and an MBA from the University of Washington in Seattle. He has authored or co-authored more than 125 manuscripts, book chapters and scientific publications.

 

7


Table of Contents

 

Item 11. Executive Compensation

COMPENSATION DISCUSSION AND ANALYSIS

This Compensation Discussion and Analysis describes the compensation strategy, policies, programs and practices for the named executive officers identified in the Summary Compensation Table. For fiscal year 2023, the named executive officers consist of Daniel P. Gold, Ph.D., President, Chief Executive Officer and Director, Brian G. Drazba, Chief Financial Officer, David M. Urso, Chief Operating Officer and General Counsel, and Richard G. Ghalie, M.D., Chief Medical Officer, to whom we collectively refer in this Compensation Discussion and Analysis as our “named executive officers.”

Fiscal year 2023 was a year of transition and change for us. In December 2022 we announced plans to realign our clinical development efforts after jointly deciding with our development partner, Kyowa Kirin Co., Ltd. ("KKC"), to discontinue development of our lead drug candidate, zandelisib, outside of Japan. We consequently focused our development efforts on our two early-stage clinical assets, voruciclib and ME-344. The discontinuation of the partnership with KKC resulted in a reduction to our workforce by 51% during fiscal year 2023 in a staggered program that affected 28 employees in December 2022 and an additional 26 employees through June 2023. In February 2023, we entered into an agreement and plan of merger with Infinity Pharmaceuticals, subject to approval by our stockholders, which subsequently was not approved by our stockholders in July 2023. In May 2023 and in accordance with our previously announced transition plan, our board of directors appointed David M. Urso to be President and Chief Executive Officer of MEI and terminated the employment of Daniel Gold, Ph.D., our Chief Executive Officer since 2010, in each case effective as of June 2, 2023. Also, in accordance with our previously announced transition plan, we terminated the employment of our fiscal year 2023 Chief Financial Officer, Brian Drazba, in August 2023 and announced the appointment of Justin J. File, as his successor.

Compensation Philosophy and Objectives

We believe that the performance of our executive officers significantly impacts our ability to achieve our corporate goals. We, therefore, place considerable importance on the design and administration of our executive officer compensation program. This program is intended to enhance stockholder value by attracting, motivating and retaining qualified individuals to perform at the highest levels and to contribute to our growth and success. Our executive officer compensation program is designed to provide compensation opportunities that are tied to individual and corporate performance.

Our overall compensation philosophy has been to pay our executive officers an annual base salary and to provide opportunities, through cash and equity incentives, to deliver higher compensation if certain key performance goals are satisfied or exceeded. The primary principles of our fiscal year 2023 compensation strategy were:

Compensation decisions are driven by a pay-for-performance philosophy;
Compensation should reflect individual and corporate performance; and
Target annual compensation is competitively positioned against a peer group of similar companies.

The Compensation Committee’s Process

The Compensation Committee acts on behalf of the Board with respect to fulfilling the Board’s responsibilities to oversee our compensation policies, plans and programs and reviewing and determining, as appropriate, the compensation to be paid to executive officers and directors. To achieve this task, the Compensation Committee (i) reviews and approves corporate performance goals and objectives that support and reinforce our long-term strategic goals and compensation plans; (ii) reviews the individual performance of the executive officers; (iii) establishes policies with respect to equity compensation arrangements, timing and pricing of equity awards for newly hired employees, promotions and annual grants for executive and non-executive employees and directors; (iv) reviews regional and industry-wide compensation practices and trends to assess the propriety, adequacy and competitiveness of our executive compensation programs among comparable companies in our industry; (v) reviews and approves the terms of any employment agreements, severance agreements, change-of-control protections and any other compensation arrangements of the executive officers; (vi) performs and considers a compensation risk assessment; and (vii) considers stockholder feedback and Say-on-Pay voting results.

With respect to compensation of our Chief Executive Officer, the Compensation Committee evaluates the Chief Executive Officer’s performance in light of relevant performance goals and objectives, taking into account the policies of the Compensation Committee and, with respect to long-term incentive compensation, stockholder return and the results of the most recent stockholder advisory vote on executive compensation. The Compensation Committee reviews and approves (or if appropriate, recommends to the Board for final determination and approval) individual and corporate performance goals and objectives of our other executive officers. The Compensation Committee considers the recommendations of the Chief Executive Officer with respect to the compensation of our other executive officers. The Compensation Committee also makes recommendations to the Board with respect to this “Compensation Discussion and Analysis” section and recommends that such section be included in any of our annual reports on Form 10-K, registration statements, Proxy statements or information statements.

8


Table of Contents

 

The Compensation Committee meets at least once a year or more frequently as its members deem necessary or appropriate. Under its charter, the Compensation Committee has the authority, in its sole discretion, to retain or obtain the advice of a compensation consultant, legal counsel or other advisors as the Compensation Committee may determine to assist in the performance of the Compensation Committee’s duties and responsibilities, only after taking into consideration the factors prescribed by the SEC and Nasdaq that bear upon the adviser’s independence.

Setting Executive Compensation

The Compensation Committee considers peer group analysis as a component of its overall executive compensation decision process, but it does not attempt to set executive compensation to a specific benchmark level, or percentile as compared to executive compensation levels at other companies. The Compensation Committee determines the mix of compensation of each executive officer based on its review of such competitive data and an assessment of the individual’s performance. We believe our approach to compensation does not encourage excessive risk-taking by our executives as it is not a market outlier and is based on a typical mix of short- and long-term compensation tied to both internal objectives and to stockholder value.

Our peer group of companies for fiscal year 2023 consisted of 22 similar publicly-traded drug development companies, all approved by the Compensation Committee, with input from management and F. W. Cook, our compensation consultant. The peer group is composed of drug development companies with a similar market cap, (median peer market cap at the time the peer data were reviewed by the Committee in June 2022 was $157 million), generally without material revenue from commercial products, and with emphasis on oncology drug development companies, as follows:

 

Adaptimmune Therapeutics

G1 Therapeutics

Aeglea BioTherapeutics

Geron Corporation

Agenus, Inc.

IDEAYA Biosciences

AnaptysBio, Inc.

Karyopharm Therapeutics

AVEO Pharmaceuticals

Molecular Templates, Inc.

Calithera Biosciences

Pieris Pharmaceuticals

CEL-SCI Corporation

Rigel Pharmaceuticals

Clovis Oncology, Inc.

Syndax Pharmaceuticals

CTI Biopharmaceuticals

Syros Pharmaceuticals

CytomX Therapeutics

UroGen Pharma Ltd.

Epizyme Pharmaceuticals

Verastem, Inc.

The Compensation Committee believes that our base compensation, cash incentives and equity programs reward the achievement of defined corporate goals and objectives. This is critical for ensuring a competitive program that retains our existing executive officers and allows us to hire new executive officers, particularly considering the competitive nature of our industry.

The peer data were used as context for setting fiscal 2023 executive officer compensation. The Compensation Committee does not set a target benchmark, but in fiscal year 2023 the value of total direct compensation was below the median for the CEO and for all other named executive officers, and Mr. Urso’s total compensation value in fiscal year 2023 as our new CEO was approximately 17% lower than our prior CEO, Dr. Gold’s, compensation value in fiscal year 2022. Further, the fiscal year 2023 option value for Mr. Urso includes both his regular annual fiscal year 2023 award as COO and General Counsel in July 2022 and a second grant to recognize his promotion to CEO in June 2023, which was also intended to be his annual CEO equity award in fiscal year 2024.

Role of Stockholder Say-on-Pay Votes

At our annual meeting of stockholders held in January 2023, approximately 80% of the shares voted at the meeting approved, on an advisory basis, the compensation of our named executive officers. The Compensation Committee considers input from stockholders, its compensation consultant and proxy advisors, when assessing its compensation philosophy and the components of its compensation program, giving further consideration to the level of attainment of corporate goals and to the compensation data of our peer group so that compensation decisions are broadly consistent with market practice.

Elements of Compensation

Each executive officer’s compensation has three key elements: (i) base salary, (ii) performance-based cash incentives and (iii) equity-based compensation. These elements of executive compensation are intended to align the interests of our executive officers with those of our stockholders.

Base Salary

Base salaries serve to provide a fixed amount of compensation to our executive officers for successfully fulfilling their responsibilities. We establish base salaries for our executive officers when they join us or upon promotion. Base salaries for executive officers are reviewed and

9


Table of Contents

 

determined by the Compensation Committee annually during the first fiscal quarter, following consultation with our compensation consultant. The Compensation Committee determined to increase officer salaries by 3.5% at the start of fiscal year 2023, reflecting an increase below the expected industry average. Accordingly, Mr. Urso was provided a salary increase of 3.5% in July 2022, while he was COO and General Counsel, with a subsequent increase of 15% upon his promotion to CEO in June 2023. Dr. Ghalie, Dr. Gold, and Mr. Drazba were also provided a salary increase of 3.5%, respectively, at the start of fiscal year 2023.

Performance-based Cash Incentives

The Compensation Committee believes that allocating a meaningful amount of our executive officers’ total cash compensation to the achievement of corporate goals and objectives aligns their interests with those of our stockholders. The Compensation Committee establishes annual corporate incentive bonus targets for each of our executive officers, expressed as a percent of base salary. Fiscal year 2023 bonus targets as a percent of base salary were set at the start of the fiscal year at 60% for Dr. Gold, 45% for Mr. Urso, and 40% for Mr. Ghalie and Mr. Drazba. The corporate goals and objectives are generally critical path activities or strategic initiatives designed to enhance stockholder return.

The Compensation Committee determined that the fiscal year 2023 goals should be broken into a first half (1H) group and a second half (2H) group in recognition of the year’s uncertainty, though bonuses were not paid until after the entire year was complete. The goals were as objective as possible in both their definition and their scoring at the end of the period, though scoring goals included a subjective element to recognize the quality of achievements.

 

The following is a description of the primary corporate goals for fiscal year 2023, which guided the Compensation Committee in determining total compensation.

1H –

Obtain clarity from the FDA on accelerated approval pathway(s).
Coastal clinical study enrollment target by December 31, 2022.
Maintain sufficient funds for a minimum cash balance as of December 31, 2022.

2H –

ME-344 clinical trial enrollment target by June 30, 2023.
Voruciclib cohort three clinical trial enrollment target by June 30, 2023.
Zandelisib submission of abbreviated clinical study report to contract research organizations for distribution to global authorities by June 30, 2023.
Maintain sufficient funds for a minimum cash balance as of June 30, 2023.

The Compensation Committee determined we had met 77.5% of target based on weighted achievement of the goals above. The named executive officers were paid 77.5% of their target bonus for the corporate achievement without any individual adjustment.

Equity-based Compensation

The Compensation Committee believes that long-term value creation is achieved through an ownership culture that encourages performance by our executive officers through stock and stock-based awards. This potential reward for stockholder value creation is also key to our retention strategy. Under our Amended and Restated MEI Pharma, Inc. 2008 Omnibus Equity Compensation Plan (the “2008 Equity Plan”), we may award incentive and non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, and performance shares and units. Stock options expire after 10 years, have an exercise price equal to the fair market value at grant, typically vest 25% after one year and in equal monthly installments thereafter over the next 36 months and have a three-month post-termination exercise period. All equity awards to NEOs in fiscal year 2023 were stock options because they are naturally performance-based without any value delivery unless the stock price increases after grant.

The regular annual equity grant cycle occurs at the start of the fiscal year and at the start of fiscal year 2023, we granted annual options to Dr. Gold, then Chief Executive Officer, Mr. Urso, then Chief Operating Officer and General Counsel, Mr. Drazba, then Chief Financial Officer, and the Chief Medical Officer, Dr. Ghalie, to purchase 74,800, 52,500, 17,500, and 28,000 shares of our common stock, respectively. These option awards amounts had grant date fair value that was below the median of the peer companies. Grant amounts were different based on MEI's assessment of the relative importance of each executive to the future, the need to retain them, and market data for their position. All of the option awards granted at the start of fiscal year 2023 were granted with an exercise price of $10.80, which was the closing sales price on the date of grant. Mr. Urso was provided a second option award to purchase 166,571 shares of our common stock upon becoming CEO in June 2023, with an exercise price equal to the $7.50 closing price on the grant date. The combined grant date fair value of his CEO option award in the final month of fiscal year combined with his annual option award as COO and General Counsel in the first month of the fiscal year remains below the median for a CEO in the peer group. All options granted before and during 2023 are currently underwater as of September 15, 2023 and do not provide any value at our current share price.

10


Table of Contents

 

Executive Benefits and Perquisites

We offer benefit programs to our employees, including named executive officers, which include paid time off, health insurance, a company funded HSA account and a company sponsored 401(k) plan. Our executive officers generally do not receive any supplemental retirement benefits or perquisites and participate in the above listed benefit programs on the same basis as other full-time employees.

Severance and Change in Control Agreements

Each of Mr. Urso’s, Mr. Drazba’s, and Dr. Ghalie’s employment agreements provides for certain severance payments upon the applicable employee’s termination by us, other than for cause or by the applicable employee for good reason, as such terms are defined in the respective employment agreement. Upon such a termination of employment, we will: (i) make a payment to the applicable employee in lieu of notice in an amount equal to twelve months of such employee’s base salary (as in effect at the time of such employee’s termination from employment), and (ii) accelerate the vesting of the applicable employee’s options so that such employee will be vested in the same number of shares of common stock subject to the options as if such employee had continued to be employed by us for an additional twelve months. Such payment and additional option vesting will be conditional upon the execution of a customary release of claims in favor of us and our affiliates, in a form prescribed by us. The payment in lieu of notice will be paid to the applicable employee in a single lump sum payment as soon as administratively practicable after the maximum review and revocation period for the release agreement as may be required under applicable law, if any, or such earlier date as determined in our sole discretion, but in no event more than 60 days after the applicable employee’s termination of employment. If their employment had been terminated in accordance with the foregoing provisions on June 30, 2022, Mr. Urso, Mr. Drazba, and Dr. Ghalie would have been entitled to payments for 12 months salary in the amount of $614,000, $428,635, and $479,205, respectively, and payments for fiscal year 2023 bonus funded at 77.5% target of $237,925, 132,887, and $148,554, respectively. Each would be entitled to 12 months of option vesting as follows: Mr. Urso 69,194 shares, Mr. Drazba 9,989 shares, and Dr. Ghalie, 13,969 shares. The intrinsic values of the option vesting acceleration on June 30, 2023, would have been nil for all three NEOs because all options were underwater.

Dr. Gold’s employment as CEO was terminated by us without cause on June 2, 2023, when Mr. Urso became CEO. Dr. Gold’s severance was paid pursuant to his employment agreement dated April 23, 2010, with 12 months base salary and accelerated vesting of the portion of his stock options that would have vested over the next 12 months, plus his fiscal year 2023 bonus based on performance and board discretion. Further, a total of 58,053 options accelerated, reflecting the number of shares Dr. Gold that would have vested in during the next 12 months. Dr. Gold’s vested options may be exercised after separation of Board service for three years, not to exceed their original term.

In the event of a change in control of MEI Pharma, as defined in the 2008 Equity Plan, unless the Compensation Committee of the Board of Directors determines otherwise, all of the options granted to Mr. Urso, Dr. Ghalie will accelerate and become fully exercisable effective upon the date of the change in control. For each Mr. Urso, Mr. Drazba, Dr. Ghalie and former President and CEO Dr. Gold there was no intrinsic value of unvested stock options, as of June 30, 2023, which would accelerate and become fully exercisable upon a change in control.

Tax and Accounting Considerations

The tax and accounting consequences to us of certain compensation elements are important considerations for the Compensation Committee when evaluating and recommending compensation packages for our executive officers. Generally, the Compensation Committee seeks to balance its objective to create an effective compensation program that attracts, retains and rewards executives in order to maximize the return to stockholders with the need for appropriate tax and accounting consequences of such compensation.

In addition to considering the tax consequences, the Compensation Committee considers the accounting consequences of its decisions, including the impact of expenses being recognized in connection with equity-based awards, in determining the size and form of different equity-based awards.

CEO Pay Ratio

SEC rules require us to disclose the total annual compensation of our principal executive officer for fiscal 2023, who was David Urso, our President and Chief Executive Officer, the median of the total annual compensation of all employees other than our principal executive officer, as well as their ratio to each other (the “CEO Pay Ratio”). Total annual compensation for our principal executive officer and for the median of the total annual compensation of all employees is calculated in accordance with SEC rules applicable to the Summary Compensation Table. For fiscal 2023, these amounts were as follows:

Our principal executive officer’s total annual compensation: $2,101,058
Our median employee’s total annual compensation: $259,806
CEO Pay Ratio: 8.09 to 1

In determining the median compensated employee, we chose June 30, 2023 as the determination date. As of this date, we had 46 employees, excluding our principal executive officer. We annualized compensation of employees who were not employed with us for the full

11


Table of Contents

 

fiscal year. In determining our median compensated employee and calculating the CEO Pay Ratio, we did not use any of the exemptions permitted under SEC rules, nor did we rely upon any material assumptions, adjustments or estimates.

We believe that the CEO Pay Ratio set forth above is a reasonable estimate for fiscal 2023, determined in a manner consistent with SEC rules. The SEC rules for identifying the median compensated employee and calculating the CEO Pay Ratio based on that employee’s total annual compensation permit companies to adopt a variety of methodologies, to apply certain exemptions and to make certain assumptions, adjustments or estimates that reflect their compensation policies. Accordingly, the CEO Pay Ratio may not be comparable to the pay ratios reported by other companies, which may have used different methodologies, assumptions, adjustments or estimates in calculating their pay ratios.

COMPENSATION COMMITTEE REPORT

Our Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis required by Item 402(b) of Regulation S-K and contained within this Proxy Statement with management. Based on such review and discussions, our Compensation Committee recommended to our Board that the Compensation Discussion and Analysis be included in this Proxy Statement and submitted on October 1, 2023, by the members of the Compensation Committee of the Board of Directors:

Dr. Nicholas R. Glover

Ms. Tamar D. Howson

Dr. Thomas C. Reynolds

Mr. Sujay R. Kango

This Section is not “soliciting material,” is not deemed “filed” with the SEC and is not to be incorporated by reference in any filing of our under the Exchange Act or the Securities Act, other than in our Annual Report on Form 10-K where it shall be deemed to be furnished, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.

12


Table of Contents

 

EXECUTIVE COMPENSATION

Our Executive Officers

Our named executive officers for the year ended June 30, 2023, were:

David M. Urso, President and Chief Executive Officer
Richard G. Ghalie, Chief Medical Officer
Daniel P. Gold, Former President and Chief Executive Officer and Director
Brian G. Drazba, Former Chief Financial Officer

Summary Compensation Table

The table below sets forth for the fiscal years ended June 30, 2023, 2022 and 2021, the compensation of our named executive officers.

Name and Principal Position

 

Year

 

Salary ($)

 

 

Stock Awards ($)(1)

 

 

Option Awards ($) (2)

 

 

Non-Equity Incentive Plan Compensation ($) (3)(4)(5)(6)

 

 

All Other Compensation ($)

 

 

Total ($) (7)

 

David M. Urso (8)

 

2023

 

$

541,185

 

 

$

 

 

$

1,352,600

 

 

$

207,273

 

 

$

 

 

$

2,101,058

 

President and Chief Executive Officer

 

2022

 

$

516,810

 

 

$

 

 

$

1,078,500

 

 

$

148,842

 

 

$

 

 

$

1,744,152

 

 

 

2021

 

$

492,200

 

 

$

174,500

 

 

$

1,265,250

 

 

$

188,267

 

 

$

 

 

$

2,120,217

 

Richard G. Ghalie. M.D.

 

2023

 

$

479,205

 

 

$

 

 

$

218,900

 

 

$

148,554

 

 

$

 

 

$

846,659

 

Chief Medical Officer

 

2022

 

$

463,000

 

 

$

 

 

$

575,200

 

 

$

118,528

 

 

$

 

 

$

1,156,728

 

 

 

2021

 

$

432,481

 

 

$

69,800

 

 

$

522,750

 

 

$

118,065

 

 

$

 

 

$

1,143,096

 

Daniel P. Gold, Ph.D. (9)

 

2023

 

$

685,603

 

 

$

 

 

$

584,700

 

 

$

344,894

 

 

$

831,443

 

 

$

2,446,640

 

Former President and Chief

 

2022

 

$

716,625

 

 

$

 

 

$

1,536,800

 

 

$

275,184

 

 

$

 

 

$

2,528,609

 

Executive Officer and Director

 

2021

 

$

682,500

 

 

$

279,200

 

 

$

1,638,800

 

 

$

348,075

 

 

$

 

 

$

2,948,575

 

Brian G. Drazba (10)

 

2023

 

$

428,635

 

 

$

 

 

$

136,800

 

 

$

132,877

 

 

$

 

 

$

698,312

 

Former Chief Financial Officer

 

2022

 

$

414,140

 

 

$

 

 

$

359,500

 

 

$

106,020

 

 

$

 

 

$

879,660

 

 

 

2021

 

$

406,020

 

 

$

 

 

$

554,300

 

 

$

138,047

 

 

$

 

 

$

1,098,367

 

 

(1)
Represents the aggregate grant date fair value of restricted stock unit awards (RSUs) granted in accordance with Financial Accounting Standards Board, Accounting Standards Codification, Topic 718, “Stock Compensation” ("ASC Topic 718"), calculated based on the closing market price of our common stock on the date of grant. The RSUs, which were granted in July 2020, are reported as fiscal year 2021 compensation because the grant date occurred after the end of fiscal year 2020. These RSUs were viewed as separate from the regular option program in fiscal year 2021 because they were a reward for fiscal year 2020.
(2)
Represents the aggregate grant date fair value of options granted in accordance with ASC Topic 718.
(3)
Mr. Urso received a bonus of 38% of his base salary for the fiscal year ended June 30, 2023 based upon the Compensation Committee’s determination to award bonuses at 77.5% of target levels. Mr. Urso received a bonus of 29% of his base salary for the fiscal year ended June 30, 2022, based upon the Compensation Committee’s determination to award bonuses at 64% of target levels. Mr. Urso received a bonus of 38% of his base salary for the fiscal year ended June 30, 2021, based upon the Compensation Committee’s determination to award bonuses at 85% of target levels.
(4)
Dr. Ghalie received a bonus of 31% of his base salary for the fiscal year ended June 30, 2023, based on the compensation committee's determination to award bonuses at 77.5% of target levels. Dr. Ghalie received a bonus of 26% of his base salary for the fiscal year ended June 30, 3022, based on the compensation committee’s determination to award bonuses at 64% of target levels. Dr. Ghalie received a bonus of 26% of his base salary for the fiscal year ended June 30, 2021, based on the compensation committee's determination to award bonuses at 85% of target levels.
(5)
Dr. Gold received a bonus of 50% of his base salary for the fiscal year ended June 30, 2023, based upon the Compensation Committee’s determination to award bonuses at 77.5% of target levels. Dr. Gold received a bonus of 38% of his base salary for the fiscal year ended June 30, 2022, based upon the Compensation Committee’s determination to award bonuses at 64% of target levels. Dr. Gold received a bonus of 51% of his base salary for the fiscal year ended June 30, 2021, based upon the Compensation Committee’s determination to award bonuses at 85% of target levels.
(6)
Mr. Drazba received a bonus of 31% of his base salary for the fiscal year ended June 30, 2023, based upon the Compensation Committee’s determination to award bonuses at 77.5% of target levels. Mr. Drazba received a bonus of 26% of his base salary for the fiscal year ended June 30, 2022, based upon the Compensation Committee’s determination to award bonuses at 64% of target levels. Mr. Drazba received a bonus of 34% of his base salary for the fiscal year ended June 30, 2021, based upon the Compensation Committee’s determination to award bonuses at 85% of target levels.

13


Table of Contents

 

(7)
In accordance with SEC rules, the compensation described in this table does not include various health and welfare or other benefits received by our named executive officers that were generally available to all of our regular, full-time employees, as well as certain perquisites and other benefits received by our named executive officers that, in the aggregate, were less than $10,000 for any officer.
(8)
Effective June 2, 2023, Mr. Urso became our president and chief executive officer, and prior to such date, Mr. Urso, was our chief operating officer and general counsel.
(9)
Dr. Gold resigned as our president and chief executive officer effective June 2, 2023. All Other Compensation consists of $741,707 and $89,736 paid to Dr. Gold as severance and paid time off, respectively, pursuant to his termination agreement effective as of June 2, 2023, and more fully described below in “Employment Agreements.”
(10)
Mr. Drazba resigned as our chief financial officer on August 1, 2023. Justin J. File became our chief financial officer August 1, 2023.

Employment Agreements

We have entered into written employment agreements with each of the named executive officers, which set forth the terms of their respective employments.

Employment Agreement between David M. Urso and MEI Pharma

On May 31, 2023, the MEI board of directors appointed Mr. Urso as President and Chief Executive Officer of MEI, effective as of June 2, 2023. Mr. Urso was also elected as a member of the MEI board of directors, effective as of June 8, 2023. Mr. Urso will serve as a member of the class of directors whose term expires at the 2025 annual meeting of MEI’s stockholders and until his successor is duly elected and qualified or until his earlier resignation or removal. At this time, Mr. Urso is not expected to serve on any committees of the board of directors.

In connection with Mr. Urso’s appointment as President and Chief Executive Officer, Mr. Urso and MEI entered into a new employment agreement (the “CEO Employment Agreement”), effective as of June 2, 2023, that replaces the existing employment agreement dated March 6, 2014, between MEI and Mr. Urso, as amended by Amendment No. 1, dated July 12, 2018. The CEO Employment Agreement provides for an annual base salary of $614,000, with a target annual bonus opportunity of 50% of base salary. Mr. Urso will be eligible to participate in MEI’s health, retirement, expense reimbursement and other benefit plans.

The CEO Employment Agreement provides for a grant as of June 2, 2023 of an option to purchase a number of shares of MEI’s common stock, under MEI’s equity compensation plan, equal to 2.5% of MEI’s outstanding shares as of the date of grant, with vesting over a 4-year period, full vesting on a change in control, and other terms and conditions consistent with the CEO Employment Agreement and grants made to other senior executives (the “CEO Initial Grant”). The exercise price of the CEO Initial Grant will be equal to the Nasdaq closing price per share of MEI stock on the date of grant. The CEO Employment Agreement further provides for a stock option grant to be made on the closing date of the Merger, contingent on the consummation of the Merger and subject to Mr. Urso’s being employed by or providing service to MEI or an affiliate at the time of grant (i.e., the closing date of the Merger), that is equal to 2.5% of the outstanding shares of MEI on the closing date of the Merger (calculated immediately after the effective time of the Merger), less the number of MEI shares underlying the CEO Initial Grant; provided, however, that the total number of shares covered by options granted to Mr. Urso in a calendar year shall not exceed 200,000 shares pursuant to the terms of the MEI’s equity compensation plan (the “CEO Second Grant”). The exercise price of the CEO Second Grant will be equal to the Nasdaq closing price per share of MEI stock on the date of grant (the closing date of the Merger). The CEO Second Grant will have the same vesting terms as the CEO Initial Grant.

If the full number of options called for pursuant to the CEO Second Grant cannot be granted on the closing date of the Merger in 2023 because of the per person share limit under the equity compensation plan, then an option for the number of shares that could not be granted on the closing date will be granted on January 2, 2024 (the “Top Off Grant”); provided that, if on January 2, 2024, MEI’s equity compensation plan does not have sufficient shares available to make the Top Off Grant, such grant will be made on the first subsequent date on which MEI does have sufficient shares under the equity compensation plan. To receive the Top Off Grant, Mr. Urso must be employed by or providing services to MEI or an affiliate on the applicable date of grant. The exercise price of the Top Off Grant will be equal to the Nasdaq closing price per share of MEI stock on the date of grant of the Top Off Grant, and the Top Off Grant will have the same vesting terms as the CEO Initial Grant. If the Merger is not consummated, then in certain circumstances a CEO Second Grant (and a Top Off Grant, if applicable) will be made to Mr. Urso according to the terms and conditions of the CEO Employment Agreement. On May 31, 2023, the MEI board of directors approved the CEO Initial Grant, the CEO Second Grant, and the Top Off Grant, as applicable, to be effective on their respective dates of grant.

For 2024 and subsequent years, Mr. Urso will be eligible to receive equity awards on similar terms as other senior executives of MEI. MEI will pay Mr. Urso’s legal fees in connection with negotiation of the CEO Employment Agreement and ancillary agreements, up to $7,500.

Under the CEO Employment Agreement, if Mr. Urso’s employment is terminated by MEI without cause or Mr. Urso resigns for good reason, Mr. Urso will be eligible to receive the following severance benefits if he signs an effective release of claims: (i) lump sum payment equal to 12 months of his base salary, (ii) if he elects COBRA health care continuation coverage, MEI will pay the monthly COBRA premium for 12 months, (iii) payment of a pro-rata annual bonus, if any, for the year of termination, and (iv) accelerated vesting of a portion of Mr. Urso’s outstanding stock options equal to the number of options that would have vested if he had continued to be employed by MEI for 12 months following termination. The CEO Employment Agreement also provides that if, within 3 months before a change in control, MEI

14


Table of Contents

 

terminates Mr. Urso’s employment without cause at the request of the other party to the change in control transaction, or if, upon or within 2 years following a change in control, Mr. Urso’s employment is terminated by MEI without cause or Mr. Urso resigns for good reason, Mr. Urso’s outstanding stock options will fully vest and become exercisable as of his termination date, provided that he signs an effective release.

In the event that Mr. Urso’s employment is terminated due to his death or disability, vesting of a portion of Mr. Urso’s outstanding stock options will accelerate equal to the number of options that would have vested if he had continued to be employed by MEI for 12 months following termination, subject to his execution of an effective release in the event of disability.

Mr. Urso will continue to remain subject to his Employee Proprietary Information and Inventions Agreement, dated April 7, 2014.

Employment Agreement between Richard G. Ghalie and MEI Pharma

In connection with Dr. Ghalie’s appointment as Chief Medical Officer, effective May 3, 2021, we entered into an amendment to his Employment Letter, dated February 17, 2016 (as amended, the “Ghalie Employment Letter”). The Ghalie Employment Letter provides for an annual base salary of $463,000, and a stock option award to purchase 75,000 shares of our common stock. Effective July 1, 2021, pursuant to the terms of the Ghalie Employment Letter, Dr. Ghalie is eligible to earn an annual cash bonus in an amount up to a maximum of 40% of the base salary based on his achievement of milestones established by the Compensation Committee of the Board of Directors.

Dr. Ghalie may terminate his employment at any time other than for Good Reason (as defined in the Ghalie Employment Letter), upon providing one (1) month advance notice to us. Dr. Ghalie may terminate his employment with Good Reason by providing us with notice within sixty (60) days of the event giving rise to the Good Reason (and we do not cure the Good Reason event within thirty (30) days after receiving notice). We have the right to terminate the Ghalie Employment Letter with or without Cause (as defined in the Ghalie Employment Letter) at any time. If Dr. Ghalie’s employment is terminated by us without Cause or by Dr. Ghalie for Good Reason, Dr. Ghalie will be entitled to (i) a lump sum payment in an amount equal to twelve (12) months of his base salary and (ii) accelerated vesting of his options such that Dr. Ghalie will be vested in the same number of options as if he had continued to be employed by us for an additional twelve (12) months, subject to his execution and nonrevocation of a release of claims. The Ghalie Employment Letter contains confidentiality provisions.

Employment Agreement between Daniel P. Gold and MEI Pharma

In May 2023, our board of directors appointed David M. Urso to be President and Chief Executive Officer of MEI, effective as of June 2, 2023, and terminated the employment of Daniel Gold, Ph.D., the current Chief Executive Officer, effective as of June 2, 2023.

Our board of directors determined that Dr. Gold’s termination of employment is a termination without cause under the terms of Dr. Gold’s employment agreement, dated April 23, 2010, between MEI and Dr. Gold (the “Gold Employment Agreement”). Dr. Gold will receive severance pay equal to 12 months of base salary and accelerated vesting of the portion of his stock options that would have vested over the next 12 months, pursuant to the terms of the Gold Employment Agreement applicable to a termination without cause, as well as an annual bonus for the fiscal year ending June 30, 2023 based on performance and board discretion and a three-year period to exercise Dr. Gold’s vested stock options following the date on which he ceases to serve as a member of our board of directors (but no later than the expiration of the term of the option). Dr. Gold continues to be bound by restrictive covenants under his Employee Proprietary Information and Inventions Agreement, and he continues to be a member of our board of directors.

Employment Agreement between Brian G. Drazba and MEI Pharma

In connection with Mr. Drazba’s appointment as Chief Financial Officer, we entered into an Employment Letter, dated February 1, 2017, with Mr. Drazba (the “Drazba Employment Letter”). The Drazba Employment Letter provided for an annual base salary of $350,000, which has been increased periodically by the Compensation Committee. Pursuant to the terms of the Drazba Employment Letter, Mr. Drazba is eligible to earn an annual cash bonus, beginning for the fiscal year starting on July 1, 2017, in an amount up to a maximum of 40% of the base salary, based on his achievement of milestones established by the Compensation Committee of the Board of Directors.

Mr. Drazba may terminate his employment at any time other than for Good Reason (as defined in the Drazba Employment Letter), upon providing two (2) months advance notice to us. Mr. Drazba may terminate his employment with Good Reason by providing us with notice within sixty (60) days of the event giving rise to the Good Reason (and we do not cure the Good Reason event within thirty (30) days after receiving notice). We have the right to terminate the Drazba Employment Letter with or without Cause (as defined in the Drazba Employment Letter) at any time. If Mr. Drazba’s employment is terminated by us without Cause or by Mr. Drazba for Good Reason, Mr. Drazba will be entitled to (i) a lump sum payment in an amount equal to twelve (12) months of his base salary and (ii) accelerated vesting of his options such that Mr. Drazba will be vested in the same number of options as if he had continued to be employed by us for an additional twelve (12) months, subject to his execution and nonrevocation of a release of claims. The Drazba Employment Letter contains confidentiality provisions.

On June 20, 2023, Mr. Drazba and MEI signed a Separation and Release Agreement, where Mr. Drazba's employment with MEI will terminate at either the closing date of the Merger or no later than September 1, 2023. In consideration of the Separation and Release Agreement, Mr. Drazba is entitled to receive a payment of $428,635, payment of monthly COBRA premium for 12 months, payment of a

15


Table of Contents

 

pro-rata annual bonus, if any, for the year of termination, and accelerated vesting of a portion of Mr. Drazba’s outstanding stock options equal to the number of options that would have vested if he had continued to be employed by MEI for 12 months following termination. Mr. Drazba terminated employment with MEI on August 1, 2023.

Grants of Plan-Based Awards For Fiscal Year Ended June 30, 2023

 

 

 

 

Estimated Possible Payouts Under Non-Equity Incentive Plan Awards (1)

 

All Other Stock Awards Number of Shares of Stocks of Units

 

All Other Option Awards Number of Securities Underlying Options

 

 

Exercise or Base Price of Option Awards

 

 

Grant Date Fair Value of Stock and Option Awards

 

Name

 

Grant Date

 

Target

 

 

Maximum

 

 

 

 

 

 

 

 

 

 

 

David M. Urso

 

July 5, 2022

 

$

267,449

 

 

N/A

 

 

 

52,500

 

 

$

10.80

 

 

$

410,400

 

David M. Urso

 

June 2, 2023

 

N/A

 

 

N/A

 

 

 

166,571

 

 

$

7.50

 

 

$

942,200

 

Richard G. Ghalie, M.D.

 

July 5, 2022

 

$

191,682

 

 

N/A

 

 

 

28,000

 

 

$

10.80

 

 

$

218,900

 

Daniel P. Gold, Ph.D.

 

July 5, 2022

 

$

445,024

 

 

N/A

 

 

 

74,800

 

 

$

10.80

 

 

$

584,700

 

Brian G. Drazba

 

July 5, 2022

 

$

171,454

 

 

N/A

 

 

 

17,500

 

 

$

10.80

 

 

$

136,800

 

 

(1) The Board established single bonus targets and, as disclosed in the Summary Compensation Table, determined to pay out bonuses at 77.5% of the target levels.

16


Table of Contents

 

Outstanding Equity Awards at Fiscal Year-End

The following table provides information on all stock options and RSUs held by our named executive officers on June 30, 2023:

 

 

Option Awards

 

Stock Awards

 

 

 

Number of Securities Underlying Unexercised Options (Exercisable)

 

 

Number of Securities Underlying Unexercised Options (Unexercisable)

 

 

 

 

Options Exercise Price

 

 

Option Expiration

 

Number of Shares or Units of Stock That Have Not Vested

 

Market Value of Shares or Units of Stock That Have Not Vested

 

Name

 

(#)

 

 

(#)

 

 

Footnote

 

($/Share)

 

 

Date

 

(#)

 

($)

 

David M. Urso

 

 

 

 

166,571

 

 

(1)

 

$

7.50

 

 

6/2/2033

 

 

$

 

 

 

 

 

 

52,500

 

 

(2)

 

$

10.80

 

 

7/5/2032

 

 

$

 

 

 

 

14,375

 

 

 

15,625

 

 

(3)

 

$

59.00

 

 

7/1/2031

 

 

$

 

 

 

 

19,142

 

 

 

7,108

 

 

(4)

 

$

69.80

 

 

7/2/2030

 

 

$

 

 

 

 

17,136

 

 

 

364

 

 

(5)

 

$

50.40

 

 

7/1/2029

 

 

$

 

 

 

 

11,000

 

 

 

 

(6)

 

$

85.60

 

 

7/12/2028

 

 

$

 

 

 

 

6,500

 

 

 

 

(7)

 

$

86.60

 

 

6/22/2028

 

 

$

 

 

 

 

6,500

 

 

 

 

(8)

 

$

56.60

 

 

7/6/2027

 

 

$

 

 

 

 

6,500

 

 

 

 

(9)

 

$

27.20

 

 

7/28/2026

 

 

$

 

 

 

 

6,375

 

 

 

 

(11)

 

$

31.40

 

 

7/27/2025

 

 

$

 

Richard G. Ghalie, M.D.

 

 

 

 

28,000

 

 

(2)

 

$

10.80

 

 

7/5/2032

 

 

$

 

 

 

 

7,675

 

 

 

8,325

 

 

(3)

 

$

59.00

 

 

7/1/2031

 

 

$

 

 

 

 

1,956

 

 

 

1,794

 

 

(14)

 

$

71.00

 

 

5/3/2031

 

 

$

 

 

 

 

5,472

 

 

 

2,028

 

 

(4)

 

$

69.80

 

 

7/2/2030

 

 

$

 

 

 

 

7,344

 

 

 

156

 

 

(5)

 

$

50.40

 

 

7/1/2029

 

 

$

 

 

 

 

6,500

 

 

 

 

(6)

 

$

85.60

 

 

7/12/2028

 

 

$

 

 

 

 

3,250

 

 

 

 

(15)

 

$

57.60

 

 

7/7/2027

 

 

$

 

 

 

 

1,250

 

 

 

 

(13)

 

$

27.60

 

 

7/13/2026

 

 

$

 

 

 

 

6,500

 

 

 

 

(12)

 

$

24.20

 

 

3/6/2026

 

 

$

 

Daniel P. Gold, Ph.D.

 

 

35,850

 

 

 

 

(16)

 

$

10.80

 

 

7/5/2032

 

 

$

 

 

 

 

31,177

 

 

 

 

(16)

 

$

59.00

 

 

7/1/2031

 

 

$

 

 

 

 

33,292

 

 

 

 

(16)

 

$

69.80

 

 

7/2/2030

 

 

$

 

 

 

 

33,750

 

 

 

 

(16)

 

$

50.40

 

 

7/1/2029

 

 

$

 

 

 

 

15,000

 

 

 

 

(16)

 

$

85.60

 

 

7/12/2028

 

 

$

 

 

 

 

19,000

 

 

 

 

(16)

 

$

86.60

 

 

6/22/2028

 

 

$

 

 

 

 

19,000

 

 

 

 

(16)

 

$

56.60

 

 

7/6/2027

 

 

$

 

 

 

 

19,000

 

 

 

 

(16)

 

$

27.20

 

 

7/28/2026

 

 

$

 

 

 

 

13,775

 

 

 

 

(16)

 

$

31.80

 

 

7/28/2025

 

 

$

 

Brian G. Drazba

 

 

 

 

17,500

 

 

(2), (17)

 

$

10.80

 

 

7/5/2032

 

 

$

 

 

 

 

4,800

 

 

 

5,200

 

 

(3), (17)

 

$

59.00

 

 

7/1/2031

 

 

$

 

 

 

 

8,391

 

 

 

3,109

 

 

(4), (17)

 

$

69.80

 

 

7/2/2030

 

 

$

 

 

 

 

11,261

 

 

 

239

 

 

(5), (17)

 

$

50.40

 

 

7/1/2029

 

 

$

 

 

 

 

5,000

 

 

 

 

(6), (17)

 

$

85.60

 

 

7/12/2028

 

 

$

 

 

 

 

6,500

 

 

 

 

(7), (17)

 

$

86.60

 

 

6/22/2028

 

 

$

 

 

 

 

2,500

 

 

 

 

(8), (17)

 

$

56.60

 

 

7/6/2027

 

 

$

 

 

 

 

7,500

 

 

 

 

(10), (17)

 

$

31.80

 

 

4/3/2027

 

 

$

 

(1)
Twenty-five percent of the options vest on June 3, 2024; the remaining seventy-five percent of the option will vest in equal monthly installments over the following 36 months.
(2)
Twenty-five percent of the options vest on July 5, 2023; the remaining seventy-five percent of the option will vest in equal monthly installments over the following 36 months.
(3)
Twenty-five percent of the options vest on July 5, 2022; the remaining seventy-five percent of the option will vest in equal monthly installments over the following 36 months.
(4)
Twenty-five percent of the options vested on July 2, 2021; the remaining seventy-five percent of the options will vest in equal monthly installments over the following 36 months.
(5)
Twenty-five percent of the options vested on July 1, 2020; the remaining seventy-five percent of the options will vest in equal monthly installments over the following 36 months.
(6)
Twenty-five percent of the options vested on July 12, 2019; the remaining seventy-five percent of the options will vest in equal monthly installments over the following 36 months.
(7)
Twenty-five percent of the options vested on June 22, 2019; the remaining seventy-five percent of the options will vest in equal monthly installments over the following 36 months.
(8)
Twenty-five percent of the options vested on July 6, 2018; the remaining seventy-five percent of the options will vest in equal monthly installments over the following 36 months.

17


Table of Contents

 

(9)
The options vested in equal installments over 36 months from the grant date of July 29, 2016.
(10)
The options vested in equal monthly installments over 36 months from the date of grant of April 3, 2017.
(11)
The options vested in equal installments over 36 months from the grant date of July 28, 2015.
(12)
The options vested in equal installments over 36 months from the grant date of March 7, 2016.
(13)
The options vested in equal installments over 36 months from the grant date of July 14, 2016.
(14)
Twenty-five percent of the options vested on May 3, 2022; the remaining seventy-five percent of the option vest in equal monthly installments over the following 36 months.
(15)
Twenty-five percent of the options vested on July 7, 2018; the remaining seventy-five percent of the option vested in equal monthly installments over the following 36 months.
(16)
In connection with Dr. Gold's Separation and Release Agreement, all outstanding options vested and became exercisable on an accelerated basis as of the transition date for the same number of shares that would have vested had he continued to be employed by MEI through the first anniversary of the transition date (June 2, 2024).
(17)
In connection with Mr. Drazba's Separation and Release Agreement dated June 16, 2023, upon his transition date of August 1, 2023, all outstanding options vest and become exercisable on an accelerated basis as of the transition date for the same number of shares that would have vested had he continued to be employed by MEI through the first anniversary of the transition date (August 1, 2024).

Option Exercises and Stock Vested

Mr. Urso, Dr. Ghalie, Dr. Gold and Mr. Drazba did not exercise any stock options during the fiscal year ended June 30, 2023. 1,000 RSUs vested for Dr. Ghalie during the fiscal year ended June 30, 2023.

Pay Versus Performance

Provided below is our “pay versus performance” disclosure as required pursuant to Item 402(v) of Regulation S-K promulgated under the Exchange Act. As required by Item 402(v), we have included:

A description of our most important measures that our Compensation Committee used in fiscal year 2023 to link a measure of pay calculated in accordance with Item 402(v) (referred to as “compensation actually paid”, or “CAP”) to our performance;
A table that compares the total compensation of our named executive officers’ (also known as NEOs) as presented in the Summary Compensation Table (“SCT”) to CAP and that compares CAP to specified performance measures; and
Graphs that describe:
o
the relationships between CAP and our cumulative total shareholder return (“TSR”), GAAP Net Income, and our selected measure, Total Cash (defined as all cash, cash equivalents, and investment held to maturity); and
o
the relationship between our TSR and the TSR of the Nasdaq Biotechnology Index (“Peer Group TSR”).

Given our current pay program, the only difference between the SCT and CAP amounts for our NEOs is the value of equity awards, which for purposes of the SCT is based on the grant date fair value of equity awards granted during the year, and for purposes of CAP is based on the year over year change in the fair value of equity awards that are unvested as of the end of the year, or that vested, or were forfeited during the year.

Note: pursuant to Item 402(v)(8), MEI, as a smaller reporting company ("SRC"), has provided the information required by 402(v) for three years, instead of five years and is not required to provide the disclosure required by 402(v)(2)(iv) or 402(v)(5) with respect to the total shareholder return of any peer group, or our-Selected Measure disclosure required by 402 (v)(2)(vi), or the Tabular List provided pursuant to 402(v)(6).

This disclosure has been prepared in accordance with Item 402(v) and does not necessarily reflect value actually realized by the NEOs. Please refer to our Compensation Discussion and Analysis, above, for a discussion of our executive compensation program objectives and the ways in which we align executive compensation with performance.

Our Most Important Metrics Used for Linking Pay and Performance. As required by Item 402(v), below are the most important metrics linking CAP to performance for fiscal year 2023. Besides stock price, the only financial performance measure the Committee used to link executive compensation to performance in 2023 was Total Cash.

Compensation decisions are made each year taking into account a number of other factors. Target pay levels are primarily set based on clinical milestones, individual performance, scope of responsibility, and an annual assessment of pay competitiveness within the market, but

18


Table of Contents

 

aside from Total Cash and stock price, no additional financial performance measures were used by us to link compensation actually paid to our NEOs in fiscal year 2023 to our performance.

Pay Versus Performance Table. In accordance with Item 402(v) and under rules adopted by the SEC pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, we are providing the tabular disclosure for our Chief Executive Officer (our Principal Executive Officer or “PEO”) and the average of our NEOs other than the PEO for fiscal years 2021, 2022 and 2023.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Value of Initial Fixed $100 Investment Based on Total Shareholder Return

 

 

 

 

 

 

 

Year

 

Summary Compensation Table for Total Current PEO
(Urso)
(1)

 

 

Compensation Actually Paid to Current PEO
(Urso)
(2,3)

 

 

Summary Compensation Table for Total Former PEO
(Gold)
(1)

 

 

Compensation Actually Paid to Former PEO
(Gold)
(2,3)

 

 

Average Summary Compensation Table Total for Non-PEO
NEOs
(1)

 

 

Average Compensation Actually Paid to Non-PEO
NEOs
(2,3)

 

 

MEI Total Shareholder Return

 

Peer Total Shareholder
Return
(4)

 

 

MEI Net Income
($ Millions)

 

 

Company Selected Measure: Total Cash ($Millions)(5)

 

(a)

 

(b)

 

 

(c)

 

 

(b)

 

 

(c)

 

 

(d)

 

 

(e)

 

 

(f)

 

 

 

 

(h)

 

 

(i)

 

2023

 

$

2,101,058

 

 

$

1,689,893

 

 

$

2,446,640

 

 

$

1,853,678

 

 

$

772,486

 

 

$

640,229

 

 

$

8

 

$

95

 

 

$

(32

)

 

$

101

 

2022

 

$

 

 

$

 

 

$

2,528,609

 

 

$

268,643

 

 

$

1,260,180

 

 

$

250,830

 

 

$

15

 

$

87

 

 

$

(54

)

 

$

153

 

2021

 

$

 

 

$

 

 

$

2,948,575

 

 

$

1,476,023

 

 

$

1,271,435

 

 

$

607,434

 

 

$

69

 

$

120

 

 

$

(41

)

 

$

153

 

 

(1)
The PVP table reflects required disclosures for fiscal years 2021, 2022 and 2023. The Principal Executive Officer (PEO) is Daniel Gold from fiscal 2021, 2022 and 2023 but was replaced by David Urso as the PEO as of June 2, 2023. The non-PEO NEOs in fiscal year 2021 are Brian Drazba, Richard Ghalie, Robert Mass (former Chief Medical Officer) and David Urso; the non-PEO NEOs in fiscal year 2022 are Brian Drazba, Richard Ghalie, and David Urso; the non-PEO NEOs in fiscal year 2023 are Brian Drazba and Richard Ghalie.

 

 

Fiscal Year

 

PEO

 

Non-PEO NEOs

2023

 

David M. Urso (Current)
Daniel P. Gold, Ph.D. (Former)

 

Brian G. Drazba and Richard G. Ghalie, M.D.

2022

 

Daniel P. Gold, Ph.D.

 

Brian G. Drazba, Richard G. Ghalie, M.D. and David M. Urso

2021

 

Daniel P. Gold, Ph.D.

 

Brian G. Drazba, Richard G. Ghalie, M.D., Robert D. Mass (former Chief Medical Officer; retired on May 3, 2021) and David M. Urso

 

(1)
The amounts shown for CAP have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized, or received by our NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below.
(2)
"Compensation Actually Paid" (CAP) is calculated by taking Summary Compensation Table total compensation: a) less the stock award and stock option grant values; b) plus the year over year change in the fair value of stock and option awards that are unvested as of the end of the year, or that vested, or were forfeited during the year. We have not paid dividends historically and does not sponsor any pension arrangements; thus, no adjustments are made for those items. Reconciliation of the Summary Compensation Table total compensation and CAP is summarized in the following table:

19


Table of Contents

 

 

Current PEO (Urso)(i)

 

Fiscal Year

2021

 

2022

 

2023

 

SCT Total

$

2,120,217

 

$

1,744,152

 

$

2,101,058

 

 Stock and Option Award Values Reported in SCT for the Covered Year

 

(1,439,750

)

 

(1,078,500

)

 

(1,352,600

)

 Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year

 

974,099

 

 

167,280

 

 

1,064,015

 

 Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years

 

(283,889

)

 

(508,767

)

 

(70,339

)

 Fair Value of Stock and Option Awards Granted in Covered Year that Vested

 

 

 

 

 

 

 Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year

 

(146,040

)

 

(127,938

)

 

(52,241

)

 Fair Value of Stock and Option Awards Forfeited during the Covered Year

 

 

 

 

 

 

Compensation Actually Paid

$

1,224,637

 

$

196,227

 

$

1,689,893

 

 

 

 

 

 

 

 

 

Former PEO (Gold)(i)

 

Fiscal Year

2021

 

2022

 

2023

 

SCT Total

$

2,948,575

 

$

2,528,609

 

$

2,446,640

 

 Stock and Option Award Values Reported in SCT for the Covered Year

 

(1,918,000

)

 

(1,536,800

)

 

(584,700

)

 Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year

 

1,305,119

 

 

238,374

 

 

 

 Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years

 

(551,681

)

 

(747,241

)

 

 

 Fair Value of Stock and Option Awards Granted in Covered Year that Vested

 

 

 

 

 

188,782

 

 Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year

 

(307,990

)

 

(214,299

)

 

(129,123

)

 Fair Value of Stock and Option Awards Forfeited during the Covered Year

 

 

 

 

 

(67,921

)

Compensation Actually Paid

$

1,476,023

 

$

268,643

 

$

1,853,678

 

 

 

 

 

 

 

 

 

Average Non-PEO (Gold)(i)

 

Fiscal Year

2021

 

2022

 

2023

 

SCT Total

$

1,271,435

 

$

1,260,180

 

$

772,486

 

 Stock and Option Award Values Reported in SCT for the Covered Year

 

(785,225

)

 

(671,067

)

 

(177,850

)

 Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year

 

439,021

 

 

104,085

 

 

101,680

 

 Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years

 

(146,669

)

 

(349,416

)

 

(31,805

)

 Fair Value of Stock and Option Awards Granted in Covered Year that Vested

 

 

 

 

 

 

 Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year

 

(99,445

)

 

(92,952

)

 

(24,282

)

 Fair Value of Stock and Option Awards Forfeited during the Covered Year

 

(71,683

)

 

 

 

 

Compensation Actually Paid

$

607,434

 

$

250,830

 

$

640,229

 

 

 

 

 

 

 

 

(i) The fair value of options awards used to calculate CAP was determined using the Black-Scholes option pricing model, in accordance with FASB 718

 

 

(4)
The Peer Group TSR set forth in this table utilizes the Nasdaq Biotechnology Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report for the year ended June 30, 2019. The comparison assumes $100 was invested for the period starting June 30, 2020, through the end of the listed year in us and in the Nasdaq Biotechnology Index, respectively. Historical stock performance is not necessarily indicative of future stock performance.
(5)
We determined Total Cash to be the most important financial performance measure used to link our performance to CAP to our PEO and Non-PEO NEOs in 2023. Total Cash is defined as total cash, cash equivalents and short-term investments.

Relationship between CAP and TSR. The chart below reflects the relationship between the PEO and average non-PEO NEO CAP versus our TSR and the Peer Group TSR.

img104060336_12.jpg 

20


Table of Contents

 

Relationship between CAP and GAAP Net Loss. The chart below reflects the relationship between the PEO and average non-PEO NEO CAP and our GAAP Net Loss.

img104060336_13.jpg 

 

 

Relationship between CAP and Total Cash (our Selected Measure). The chart below reflects the relationship between the PEO CAP and average non-PEO NEO CAP and our Total Cash.

img104060336_14.jpg 

 

 

21


Table of Contents

 

Compensation of Directors

The following table provides details of the fees paid to our non-executive directors who served on the Board for the fiscal year ended June 30, 2023:

 

 

Fees Earned or Paid in Cash ($) (1)

 

 

Option Awards ($) (2)

 

 

Total ($)

 

Name

 

 

 

 

 

 

 

 

 

Christine A. White, M.D. (3)

 

$

42,800

 

 

$

33,600

 

 

$

76,400

 

Charles V. Baltic III (4)

 

 

85,600

 

 

 

33,600

 

 

 

119,200

 

Cheryl L. Cohen (5)

 

 

32,800

 

 

 

33,600

 

 

 

66,400

 

Frederick W. Driscoll (6)

 

 

65,600

 

 

 

33,600

 

 

 

99,200

 

Tamar D. Howson (7)

 

 

63,797

 

 

 

33,600

 

 

 

97,397

 

Nicholas R. Glover, Ph.D. (8)

 

 

77,600

 

 

 

33,600

 

 

 

111,200

 

Sujay R. Kango (9)

 

 

63,475

 

 

 

33,600

 

 

 

97,075

 

Thomas C. Reynolds, M.D., Ph.D. (10)

 

 

64,100

 

 

 

33,600

 

 

 

97,700

 

Daniel P. Gold, Ph.D. (11)

 

 

3,673

 

 

 

 

 

 

3,673

 

(1) For the fiscal year ended June 30, 2023, each of our non-executive directors received an annual cash retainer of $45,600. In addition to the annual cash retainer, the Chair received additional annual compensation of $35,000, and each Board Committee chair received additional compensation as follows: Audit Committee: $20,000; Compensation Committee: $15,000; Nominating and Governance Committee: $10,000; and Strategic Committee: $10,000. Committee members not receiving compensation as a committee chairperson received additional compensation as follows: Audit Committee: $10,000; Compensation Committee: $7,500; Nominating and Governance Committee: $5,000; and Strategic Committee: $7,000. Such amounts are pro-rated for periods of service less than the full fiscal year.

(2)
Represents the aggregate grant date fair value of options granted in accordance with FASB ASC Topic 718. All stock options granted to non-employee directors in the fiscal year ended June 30, 2023, were granted under our 2008 Equity Plan, and are ten-year options with an exercise price equal to the closing market price of our common stock on the date of grant. The stock options granted vest ratably each month over 12 months, subject to continued service on the Board of Directors. During the fiscal year ended June 30, 2023, each non-employee director, except for Dr. Gold, received an annual grant of 4,375 options at an exercise price of $10.80 per share.
(3)
Dr. White received cash compensation of $17,500 in connection with her service as Chair of the Board, and $2,500 in connection with her service on the Nominating and Governance Committee. Dr. White completed her Board service on December 31, 2022.
(4)
Mr. Baltic received cash compensation of $17,500 in connection with his service as Chair of the Board beginning in January 2023, $10,000 in connection with his service on the Audit Committee, $5,000 in connection with his service as Chair of the Nominating and Governance Committee through December 31, 2022, $2,500 in connection with his service on the Nominating and Governance Committee commencing January 1, 2023, and $5,000 in connection with his service as Chair of the Ad Hoc transactions Committee commencing January 1, 2023 through July 31, 2023.
(5)
Ms. Cohen received cash compensation of $5,000 in connection with her service on the Audit Committee and $5,000 in connection with her service on the Strategic Committee. Ms. Cohen completed her Board service on December 31, 2022.
(6)
Mr. Driscoll received cash compensation of $20,000 in connection with his service as Chair of the Audit Committee.
(7)
Ms. Howson received cash compensation of $7,500 in connection with her service on the Compensation Committee, $5,000 in connection with her service on the Nominating and Governance Committee and $5,697 in connection with her service on the Strategic Committee through March 31, 2023 and then recommencing on June 8, 2023.
(8)
Dr. Glover received cash compensation of $15,000 in connection with his service as Chair of the Compensation Committee, $10,000 in connection with his service on the Audit Committee and $7,000 in connection with his service on the Strategic Committee.
(9)
Mr. Kango received cash compensation of $7,500 in connection with his service on the Compensation Committee, $5,000 in connection with his service on the Nominating and Governance Committee and $5,375 in connection with his service on the Strategic Committee through March 31, 2023.
(10)
Dr. Reynolds received cash compensation of $7,500 in connection with his service on the Compensation Committee, $2,500 in connection with his service on the Nominating and Governance Committee through December 31, 2022, $5,000 in connection with his service as Chair of the Nominating and Governance Committee commencing January 1, 2023, and $3,500 in connection with his service on the Strategic Committee commencing January 1, 2023.
(11)
Dr. Gold, our former president and chief executive officer, received cash compensation of $3,673 in connection with his transition to a non-employee director as of June 2, 2023.

Indemnification Agreements

We have entered into an indemnification agreement with each of our directors and executive officers. Subject to certain exceptions, the indemnification agreements provide that an indemnitee will be indemnified for all expenses incurred or paid by the indemnitee in connection with a proceeding to which the indemnitee was or is a party, or is threatened to be made a party, by reason of the indemnitee’s status with or service to us or to another entity at our request. In connection with proceedings other than those by or in the right of our company and to which the indemnitee was or is a party, or is threatened to be made a party, by reason of the indemnitee’s status with or service to us or to another entity at our request, the indemnification agreements provide that an indemnitee will also be indemnified for all liabilities incurred or paid by the indemnitee. The indemnification agreements also provide for advancement of expenses incurred by an indemnitee in connection with an indemnifiable claim, subject to reimbursement in certain circumstances.

22


Table of Contents

 

The rights of each indemnitee are in addition to any other rights provided for under our amended and restated certificate of incorporation, and our amended and restated by-laws, as may be amended from time to time, and under Delaware law.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The following table sets forth information with respect to the beneficial ownership of shares of our common stock as of October 1, 2023 (except as otherwise indicated below) by (i) each person known to beneficially own more than 5% of our common stock, (ii) each of our named executive officers and directors, and (iii) our officers and directors as a group. Beneficial ownership is determined in accordance with the rules and regulations of the SEC. In computing the number of shares beneficially owned by a person and the percentage ownership of that person, shares of common stock subject to options, warrants or restricted stock units, exercisable or convertible on or within sixty (60) days of October 1, 2023, are deemed outstanding. Such shares, however, are not deemed outstanding for the purposes of computing the percentage ownership of any other person. The percentage of beneficial ownership described below is based on 6,662,857 shares of common stock outstanding, plus adjustments to the number of shares of common stock outstanding as described above, as of October 1, 2023.

Name and Address of Beneficial Owner

 

Amount & Nature of Beneficial Ownership

 

 

Percentage of Shares Beneficially Owned

 

 

Anson Fund Mgmt LP (1)

 

 

914,188

 

 

 

13.7

 

%

Cable Car Capital LLC (2)

 

 

490,840

 

 

 

7.4

 

%

The Vanguard Group, Inc. (3)

 

 

383,551

 

 

 

5.8

 

%

Tang Capital Management, LLC (4)

 

 

361,084

 

 

 

5.4

 

%

Daniel P. Gold, Ph.D. (5)

 

 

244,043

 

 

 

3.5

 

%

David M. Urso (6)

 

 

133,714

 

 

 

1.7

 

%

Brian G. Drazba (7)

 

 

63,203

 

 

*

 

 

Richard G. Ghalie, M.D. (8)

 

 

53,723

 

 

*

 

 

Charles V. Baltic III (9)

 

 

27,263

 

 

*

 

 

Frederick W. Driscoll (10)

 

 

20,249

 

 

*

 

 

Thomas C. Reynolds, M.D., Ph.D. (11)

 

 

22,208

 

 

*

 

 

Nicholas R. Glover, Ph.D. (12)

 

 

21,708

 

 

*

 

 

Tamar D. Howson (13)

 

 

15,708

 

 

*

 

 

Sujay R. Kango (14)

 

 

10,214

 

 

*

 

 

All Current Directors and Executive Officers as a Group (10 People)

 

 

592,033

 

 

 

8.2

 

%

* Represents beneficial ownership of less than 1%

(1)
Based upon information contained in Amendment No. 6 to the Statement on Schedule 13D filed by the stockholder on October 13, 2023, shares beneficially owned consists of 914,188 shares of common stock held directly. The shares are held of record by Anson Funds Management LP. The principal address is 16000 Dallas Parkway, Suite 800, Dallas, Texas 75248.
(2)
Based upon information contained in Amendment No. 6 to the Statement on Schedule 13D filed by the stockholder on October 13, 2023, shares beneficially owned consists of 490,840 shares of common stock held directly. The shares are held of record by Cable Car Capital LLC. The principal address is 601 California Street, Suite 1151, San Francisco, California 94108.
(3)
Based upon information contained in the Statement on Schedule 13G filed by the stockholder on February 9, 2023, aggregate shares beneficially owned are 383,551, including 381,749 shares where the stockholder has sole dispositive power and 1,802 shares where the stockholder has shared dispositive power. The principal address is 100 Vanguard Blvd., Malvern, Pennsylvania 19355.
(4)
Based upon information contained in the Statement on Schedule 13G filed by the stockholder on May 1, 2023, shares beneficially owned consists of 361,084 shares of common stock held directly. The shares are held of record by Tang Capital Partners, LP. The principal address is 4747 Executive Drive, Suite 210, San Diego, CA 92121.
(5)
Includes 223,177 shares issuable to Dr. Gold upon the exercise of vested stock options and 20,866 shares of common stock. Dr. Gold exercises sole voting and investment control with respect to the shares. Dr. Gold’s business address is c/o MEI Pharma, Inc., 11455 El Camino Real, Suite 250, San Diego, California, 92130.
(6)
Includes 111,250 shares issuable to Mr. Urso upon the exercise of stock options that are exercisable within 60 days of October 1, 2023 and 2,464 shares of common stock. Mr. Urso exercises sole voting and investment control with respect to the shares. Mr. Urso’s business address is c/o MEI Pharma, Inc., 11455 El Camino Real, Suite 250, San Diego, California, 92130.
(7)
Includes 61,328 shares issuable to Mr. Drazba upon the exercise of vested stock options and 1,875 shares of common stock. Mr. Drazba exercises sole voting and investment control with respect to the shares. Mr. Drazba’s business address is c/o MEI Pharma, Inc., 11455 El Camino Real, Suite 250, San Diego, California, 92130.
(8)
Includes 52,277 shares issuable to Dr. Ghalie upon the exercise of stock options that are exercisable within 60 days of October 1, 2023 and 1,446 shares of common stock. Dr. Ghalie exercises sole voting and investment control with respect to the shares. Dr. Ghalie’s business address is c/o MEI Pharma, Inc., 11455 El Camino Real, Suite 250, San Diego, California, 92130.
(9)
Includes 21,708 shares issuable to Mr. Baltic upon the exercise of stock options that are exercisable within 60 days of October 1, 2023, as well as 5,555 shares of common stock. Mr. Baltic exercises direct voting and investment control with respect to 5,288 shares of common stock and indirect voting and investment control with respect to 267 shares of common stock. Mr. Baltic’s business address is c/o MEI Pharma, Inc., 11455 El Camino Real, Suite 250, San Diego, California, 92130.

23


Table of Contents

 

(10)
Includes 18,374 shares issuable to Mr. Driscoll upon the exercise of stock options that are exercisable within 60 days of October 1, 2023 and 1,875 shares of common stock. Mr. Driscoll exercises sole voting and investment control with respect to the shares. Mr. Driscoll’s business address is c/o MEI Pharma, Inc., 11455 El Camino Real, Suite 250, San Diego, California, 92130.
(11)
Includes 21,708 shares issuable to Dr. Reynolds upon the exercise of stock options that are exercisable within 60 days of October 1, 2023 and 500 shares of common stock. Dr. Reynolds exercises sole voting and investment control with respect to the shares. Dr. Reynolds’ business address is c/o MEI Pharma, Inc., 11455 El Camino Real, Suite 250, San Diego, California, 92130.
(12)
Includes 21,708 shares issuable to Dr. Glover upon the exercise of stock options that are exercisable within 60 days of October 1, 2023. Dr. Glover’s business address is c/o MEI Pharma, Inc., 11455 El Camino Real, Suite 250, San Diego, California, 92130.
(13)
Includes 15,708 shares issuable to Ms. Howson upon exercise of stock options that are exercisable within 60 days of October 1, 2023. Ms. Howson’s business address is c/o MEI Pharma, Inc. 11455 El Camino Real, Suite 250, San Diego, California, 92130.
(14)
Includes 10,214 shares issuable to Mr. Kango upon exercise of stock options that are exercisable within 60 days of October 1, 2023. Mr. Kango's business address is c/o MEI Pharma, Inc., 11455 El Camino Real, Suite 250, San Diego, California, 92130.

Item 13. Certain Relationships and Related Transactions, and Director Independence

There were no related party transactions required to be disclosed pursuant to Item 404 of the Regulation S-K during the three years ended June 30, 2023.

Item 14. Principal Accountant Fees and Services.

The Audit Committee has selected BDO USA, P.C. (“BDO USA”) as independent registered public accounting firm to audit the financial statements of MEI for the fiscal year ending June 30, 2024. The Board of Directors is submitting the appointment of BDO USA to the stockholders for ratification as a matter of good corporate practice.

BDO USA has been engaged as our independent auditor since January 18, 2011. They have performed our annual audit of our financial statements for each fiscal year beginning with the fiscal year ended June 30, 2011.

Representatives of BDO USA are expected to attend the Annual Meeting. The BDO USA representatives will have an opportunity to make a statement at the meeting and are expected to be available to respond to appropriate questions.

Fees Paid to Independent Registered Public Accounting Firm

The following table represents aggregate fees for services provided to us in the fiscal years ended June 30, 2023 and 2022. by BDO USA, our current independent registered public accounting firm:

 

 

Fiscal Year Ended June 30,

 

 

 

2023

 

 

2022

 

Audit Fees (1)

 

$

806,100

 

 

$

469,400

 

Audit-Related Fees (2)

 

 

 

 

 

 

Tax Fees (3)

 

 

76,580

 

 

 

24,400

 

All Other Fees

 

 

 

 

 

 

Total Fees

 

$

882,680

 

 

$

493,800

 

 

(1)
"Audit Fees" relate to professional services rendered in connection with the audit of our annual consolidated financial statements, quarterly review of consolidated financial statements included in our Quarterly Reports on Form 10-Q and audit services provided in connection with other statutory and regulatory filings, including providing consents for inclusion of their opinion in registration statements filed with the Securities and Exchange Commission, and comfort letters in connection with sales of securities. During 2023, "Audit Fees" include $122,525 of fees related to the proposed Merger transaction.
(2)
BDO USA did not bill us for any "Audit-Related Fees" or "All Other Fees" during the fiscal years ended June 30, 2023 and 2022.
(3)
"Tax Fees" consist of fees for professional services related to tax compliance and advice. During 2023, "Tax Fees" include $51,200 of tax due diligence fees related to the proposed Merger transaction.

Pre-Approval Policies and Procedures

The Audit Committee has adopted a policy and procedure for pre-approving all audit and non-audit services to be performed by our independent auditors. The policy requires pre-approval of all services rendered by our independent auditors either as part of the Audit Committee’s approval of the scope of the engagement of the independent auditors or on a case-by-case basis.

24


Table of Contents

 

PART IV

Item 15. Exhibits, Financial Statement Schedules

(a)
1. Consolidated Financial Statements

The consolidated financial statements required to be filed in the Amendment are included in Part II. Item 8 in the Original 10-K

2. Financial Statement Schedules

The Financial Statement Schedules have been omitted either because they are not required or because the information has been included in the consolidated financial statements or the notes thereto included in this Annual Report on Form 10-K.

3. Exhibits

The following Exhibits are filed as part of this Amendment as required by Regulation S-K. The Exhibits designated by an asterisk (^) are management contracts and compensation plans and arrangements required to be filed as Exhibits to this Report. Certain exhibits have been previously filed with the SEC pursuant to the Securities Exchange Act of 1934 (Commission File Number 0-28191).

Exhibit Index

 

 

 

    2.1

 

Agreement and Plan of Merger by and among the Company, Merger Sub and Infinity, dated February 22, 2023 (incorporated by reference to Exhibit 2.1 to the Registrant’s Current Report on Form 8-K filed on February 23, 2023 (File No. 000-50484)).

 

 

 

    3.1

Certificate of Amendment of the Amended and Restated Certificate of Incorporation of MEI Pharma, Inc., filed with the Delaware Secretary of State on April 14, 2023 (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on February 23, 2023 (File No. 000-50484)).

 

 

 

    3.2

 

Fifth Amended and Restated Bylaws of MEI Pharma, Inc. effective as of February 23, 2023 (incorporated by reference to Exhibit 3.1 to the Registrant's Current Report on Form 8-K filed on February 23, 2023 (file No. 000-50484)).

 

 

    3.5

Certificate of Designation of Series A Convertible Preferred Stock of Marshall Edwards, Inc. (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on May 11, 2011 (File No. 000-50484))

 

 

    3.6

Certificate of Designation of Series B Preferred Stock of Marshall Edwards, Inc. (incorporated by reference to Exhibit 4 to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on March 18, 2011 (File No. 000-50484))

 

 

    3.7

Fifth Amended and Restated By-Laws of MEI Pharma, Inc., effective as of February 22, 2023, (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on February 23, 2023 (File No. 000-50484)).

 

 

    4.1

Specimen Stock Certificate (incorporated by reference to Exhibit 4.1 to Amendment No. 1 to the Registrant’s Registration Statement on Form S-1 filed on October 31, 2003 (Reg. No. 333-109129)).

 

 

    4.2

Form of Warrant (incorporated by reference to Exhibit B to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on May 16, 2018 (File No. 000-50484)).

 

 

    4.3

Description of Capital Stock of MEI Pharma, Inc. (incorporated by reference to Exhibit 4.3 to the Registrant's Annual Report on Form 10-K filed on September 9, 2020 (File No. 000-50484))

 

 

    4.4

 

Description of MEI Common Stock (incorporated by reference to Exhibit 4.4 to the Registrant's Annual Report on Form 10-K filed on September 26, 2023 (File No. 000-50484)

 

 

 

  10.1^

Employment letter dated April 23, 2010, between Marshall Edwards, Inc. and Daniel Gold (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on April 26, 2010 (File No. 000-50484)).

 

 

  10.2^

 

Employment letter dated March 6, 2014, between MEI Pharma, Inc. and David M. Urso (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on April 8, 2014 (File No. 000-50484)).

 

 

  10.3^

Amendment No. 1, dated July 12, 2018, to the Employment Letter dated March 6, 2014, between MEI Pharma, Inc. and David M. Urso. (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on July 16, 2018 (File No. 000-50484)).

 

 

  10.4^

Employment letter dated February 1, 2017, between MEI Pharma, Inc. and Brian G. Drazba (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on April 3, 2017 (File No. 000-50484)).

 

 

  10.5^

Employment letter dated February 17, 2016, between MEI Pharma, Inc. and Richard G. Ghalie (incorporated by reference to Exhibit 10.5 to the Registrant's Annual Report on Form 10-K filed on September 2, 2021 (File No. 000-50484)).

 

 

  10.6^

Amendment 2021-1 dated April 29, 2021, to the Employment letter dated February 17, 2016, between MEI Pharma, Inc. and Richard G. Ghalie (incorporated by reference to Exhibit 10.6 to the Registrant's Annual Report on Form 10-K filed on September 2, 2021 (File No. 000-50484)).

 

 

 

25


Table of Contents

 

 

  10.7

 

Form of Indemnification Agreement (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on August 29, 2011 (File No. 000-50484)).

 

  10.8**

License Agreement, dated as of September 5, 2017, by and between MEI Pharma, Inc. and Presage Biosciences, Inc. (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q filed on November 8, 2017 (File No. 000-50484)).

 

 

  10.9

At-The-Market Equity Offering Sales Agreement, dated November 10, 2020 between MEI Pharma, Inc., Credit Suisse Securities (USA) LLC, and Stifel, Nicolaus & Company, Inc. (incorporated by reference to Exhibit 1.1 to the Registrant’s Current Report on Form 8-K filed on November 10, 2020 (File No. 000-50484)).

 

 

  10.10

Securities Purchase Agreement, dated May 11, 2018, between MEI Pharma, Inc. and the purchasers identified in Exhibit A therein (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on May 16, 2018 (File No. 000-50484)).

 

 

  10.11**

License, Development and Commercialization Agreement, dated as of October 31, 2018, by and between the Company and Kyowa Hakko Kirin Co., Ltd., now known as Kyowa Kirin Company (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q filed on February 7, 2019 (File No. 000-50484)).

 

 

  10.12***

License, Development and Commercialization Agreement, dated as of April 13, 2020, by and between the Company and Kyowa Kirin Co., Ltd. (formerly known as Kyowa Hakko Kirin Co., Ltd.) (incorporated by reference to Exhibit 10.12 to the Registrant's Annual Report on Form 10-K filed on September 2, 2021 (File No. 000-50484)).

 

 

 

  10.13

 

Transition and Retirement Agreement between Brian G. Drazba and MEI Pharma, Inc., dated as of July 7, 2022 (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on December 23, 2021 (File No. 000-50484)).

 

 

 

  10.14

 

Letter Agreement between Brian G. Drazba and MEI Pharma, Inc., dated as of July 7, 2022 (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on July 7, 2022 (File No. 000-50484)).

 

 

  10.15

 

CEO Employment Agreement between MEI Pharma, Inc. and David Urso, dated June 2, 2023 (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on June 2, 2023 (File No. 000-50484))

 

 

 

  10.16

 

Employee Proprietary Information and Inventions Agreement between MEI Pharma, Inc. and Jay File, dated June 9, 2023 (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on June 13, 2023 (File No. 000-50484))

 

 

 

  10.17

 

Employment Agreement between MEI Pharma, Inc. and Jay File, dated June 9, 2023 (incorporated by reference to Exhibit 10.2 to the Registrant's Current Report on Form 8-K filed on June 13, 2023 (File No. 000-50484))

 

 

 

  10.18

 

Amended and Restated MEI Pharma, Inc. 2021 Inducement Grant Equity Compensation Plan (incorporated by reference to Exhibit 10.3 to the Registrant's Current Report on Form 8-K filed on June 13, 2023 (File No. 000-50484))

 

 

 

  10.19

 

Termination Agreement, by and between MEI Pharma, Inc. and Kyowa Kirin Co., Ltd. (formerly known as Kyowa Hakko Kirin Co., Ltd.) dated as of July 14, 2023 (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on July 19, 2023 (File No. 000-50484))

 

 

 

  10.20

 

Termination Letter from MEI Pharma, Inc. to Infinity Pharmaceuticals, Inc., dated July 23, 2023 (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on July 24, 2023 (File No. 000-50484))

 

 

 

  10.21

 

Separation and Release Agreement between MEI Pharma, Inc. and Brian Drazba, dated June 16, 2023 (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on July 27, 2023 (File No. 000-50484))

 

 

 

  10.22

 

Form of Warrant (incorporated by reference to Exhibit 10.22 to the Registrant's Annual Report on Form 10-K filed on September 26, 2023 (File No. 000-50484)

 

 

 

  23.1

Consent of Independent Registered Public Accounting Firm (incorporated by reference to Exhibit 23.1 to the Registrant's Annual Report on Form 10-K filed on September 26, 2023 (File No. 000-50484)

 

 

  31.1*

Certification of Chief Executive Officer pursuant to Rule 13a-14(A) promulgated under the Securities Exchange Act of 1934

 

 

  31.2*

Certification of Chief Financial Officer pursuant to Rule 13a-14(A) promulgated under the Securities Exchange Act of 1934

 

 

  32.1*

Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350 and Rule 13a-14(B) promulgated under the Securities Exchange Act of 1934

 

 

101.INS

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document*

 

 

101.SCH

Inline XBRL Taxonomy Extension Schema Document*

 

 

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document*

 

 

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document*

26


Table of Contents

 

 

 

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document*

 

 

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document *

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)*

(*)

Filed herewith.

(**)

Portions of this exhibit have been redacted pursuant to a confidential treatment request filed with the Securities and Exchange Commission.

(***)

Portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K.

 

27


Table of Contents

 

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Exchange Act, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized, on October 27, 2023.

 

 

 

MEI PHARMA, INC.

 

 

 

By:

/s/ David M. Urso

 

David M. Urso

 

Chief Executive Officer

 

28


EX-31.1 2 meip-ex31_1.htm EX-31.1 EX-31.1

Exhibit 31.1

CERTIFICATION

I, David M. Urso, certify that:

1.
I have reviewed this Annual Report on Form 10-K/A for the year ended June 30, 2023 of MEI Pharma, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

Date: October 27, 2023

/s/ David M. Urso

David M. Urso

Chief Executive Officer

(Principal Executive Officer)

 


EX-31.2 3 meip-ex31_2.htm EX-31.2 EX-31.2

Exhibit 31.2

CERTIFICATION

I, Justin J. File, certify that:

1.
I have reviewed this Annual Report on Form 10-K/A for the year ended June 30, 2023 of MEI Pharma, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

Date: October 27, 2023

/s/ Justin J. File

Justin J. File

Chief Financial Officer

(Principal Financial Officer)

 


EX-32.1 4 meip-ex32_1.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATION

Each of the undersigned hereby certifies, for the purposes of Section 1350 of Chapter 63 of Title 18 of the U.S. Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an officer of MEI Pharma, Inc. (“MEI Pharma”) that, to his knowledge,

(1) The Form 10-K/A fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended, and

(2) The information contained in such report fairly presents, in all material respects, the financial condition and results of operations of MEI Pharma.

Date: October 27, 2023

 

/s/ David M. Urso

/s/ Justin J. File

David M. Urso

Justin J. File

Chief Executive Officer

Chief Financial Officer

(Principal Executive Officer)

(Principal Financial Officer)

 

These certifications accompanying the report to which they relate, are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of MEI Pharma under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent MEI Pharma specifically incorporates it by reference.

A signed original of this written statement required by Section 906 has been provided to MEI Pharma and will be retained by MEI Pharma and furnished to the Securities and Exchange Commission or its staff upon request.


GRAPHIC 5 img104060336_0.jpg GRAPHIC begin 644 img104060336_0.jpg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end GRAPHIC 6 img104060336_1.jpg GRAPHIC begin 644 img104060336_1.jpg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end GRAPHIC 7 img104060336_2.jpg GRAPHIC begin 644 img104060336_2.jpg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end GRAPHIC 8 img104060336_3.jpg GRAPHIC begin 644 img104060336_3.jpg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img104060336_4.jpg GRAPHIC begin 644 img104060336_4.jpg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end GRAPHIC 10 img104060336_5.jpg GRAPHIC begin 644 img104060336_5.jpg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end GRAPHIC 11 img104060336_6.jpg GRAPHIC begin 644 img104060336_6.jpg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end GRAPHIC 12 img104060336_7.jpg GRAPHIC begin 644 img104060336_7.jpg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end GRAPHIC 13 img104060336_8.jpg GRAPHIC begin 644 img104060336_8.jpg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end GRAPHIC 14 img104060336_9.jpg GRAPHIC begin 644 img104060336_9.jpg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end GRAPHIC 15 img104060336_10.jpg GRAPHIC begin 644 img104060336_10.jpg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end GRAPHIC 16 img104060336_11.jpg GRAPHIC begin 644 img104060336_11.jpg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img104060336_12.jpg GRAPHIC begin 644 img104060336_12.jpg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end GRAPHIC 18 img104060336_13.jpg GRAPHIC begin 644 img104060336_13.jpg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Ü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end GRAPHIC 19 img104060336_14.jpg GRAPHIC begin 644 img104060336_14.jpg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�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end EX-101.LAB 20 meip-20230630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Auditor Firm ID Auditor Firm ID Document Transition Report Entity Public Float Entity Public Float ICFR Auditor Attestation Flag Entity Address, State or Province Entity Address, State or Province Trading Symbol Trading Symbol Entity Address, City or Town Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Registrant Name Entity Registrant Name Entity Current Reporting Status Entity Current Reporting Status Brian Drazba and Richard Ghalie Non PEO NEO [Member] Brian Drazba and Richard Ghalie Non PEO NEO. Current Fiscal Year End Date Current Fiscal Year End Date Auditor Name Auditor Name Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years [Member] Change in fair value of outstanding unvested stock and option awards from prior years. Entity Voluntary Filers Entity Voluntary Filers David Urso David Urso [Member] David Urso. Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year [Member] Change in fair value of stock and option awards from prior years that vested in covered year. Document Period End Date Document Period End Date Entity Address, Postal Zip Code Entity Interactive Data Current Entity Interactive Data Current Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Entity Incorporation, State or Country Code Local Phone Number Document Annual Report Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year [Member] Fair value of outstanding unvested stock and option awards granted in the covered year. Document Financial Statement Error Correction [Flag] City Area Code Document Fiscal Period Focus Document Fiscal Period Focus Daniel Gold Daniel Gold [Member] Daniel Gold. Fair Value of Stock and Option Awards Granted in Covered Year that Vested Fair Value of Stock and Option Awards Granted in Covered Year that Vested [Member] Fair value of stock and option awards granted in covered year that vested. Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Cover [Abstract] Cover [Abstract] Document Fiscal Year Focus Document Fiscal Year Focus Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Amendment Flag Amendment Flag Securities Act File Number Stock and Option Award Values Reported in SCT for the Covered Year Stock and Option Award Values Reported in SCT for the Covered Year [Member] Stock and option award values reported in SCT for the covered year. Auditor Location Auditor Location Entity Address, Address Line Two Amendment Description Entity Small Business Entity Small Business Entity Shell Company Entity Shell Company Entity Address, Address Line One Title of 12(b) Security Title of 12(b) Security Document Type Document Type Entity Filer Category Entity Filer Category Documents Incorporated by Reference [Text Block] Documents Incorporated by Reference Fair Value of Stock and Option Awards Forfeited during the Covered Year Fair Value of Stock and Option Awards Forfeited during the Covered Year [Member] Fair value of stock and option awards forfeited during the covered year. EX-101.DEF 21 meip-20230630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.SCH 22 meip-20230630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.PRE 23 meip-20230630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 24 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover Page - USD ($)
$ in Millions
12 Months Ended
Jun. 30, 2023
Sep. 15, 2023
Dec. 31, 2022
Cover [Abstract]      
Document Type 10-K/A    
Amendment Flag true    
Amendment Description Throughout this document MEI Pharma, Inc. is referred to as “MEI,” and, together with its subsidiaries, as “we,” “us,” or “our.”On September 26, 2023, MEI filed its Annual Report on Form 10-K for the fiscal year ended June 30, 2023 (the “Original Form 10-K”). Certain Part III information was omitted from the Original Form 10-K in reliance on General Instruction G(3) to Form 10-K. General Instruction G(3) to Form 10-K provides that registrants may incorporate by reference certain information from a definitive proxy statement which involves the election of directors if such definitive proxy statement is filed with the Securities and Exchange Commission (the “SEC”) within 120 days after the end of the fiscal year. We do not anticipate that MEI's definitive proxy statement involving the election of directors in connection with its MEI's fiscal year 2024 annual meeting of stockholders will be filed by October 27, 2023 (i.e., within 120 days after the end of the 2023 fiscal year). Accordingly, this Amendment No. 1 (this “Amendment”) hereby amends and restates Part III, Items 10 through 14, of the Original Form 10-K as set forth below. The information included herein as required by Part III, Items 10 through 14, of the Original Form 10-K is more limited than what is required to be included in the definitive proxy statement to be filed in connection with our 2024 annual meeting of stockholders. Accordingly, the definitive proxy statement to be filed at a later date will include additional information related to the topics herein and additional information not required by Part III, Items 10 through 14, of Form 10-K.This Amendment also restates Item 15 of Part IV of the Original Form 10-K. In addition, as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), new certifications by our principal executive officer and principal financial officer are filed as exhibits to this Amendment under Item 15 of Part IV hereof.No other amendments are being made hereby to the Original Form 10-K. Except as stated herein, this Amendment does not reflect events occurring after the filing of the Original Form 10-K with the SEC on September 26, 2023, and no attempt has been made in this Amendment to modify or update other disclosures as presented in the Original Form 10-K. Terms used but not defined herein have the meanings given to them in the Original Form 10-K.    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Jun. 30, 2023    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Securities Act File Number 001-41827    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 51-0407811    
Entity Address, Address Line One 11455 El Camino Real    
Entity Address, Address Line Two Suite 250    
Entity Address, City or Town San Diego    
Entity Address, Postal Zip Code 92130    
City Area Code 858    
Local Phone Number 369-7100    
Trading Symbol MEIP    
Entity Registrant Name MEI Pharma, Inc.    
Entity Central Index Key 0001262104    
Current Fiscal Year End Date --06-30    
Entity Filer Category Non-accelerated Filer    
Entity Current Reporting Status Yes    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Small Business true    
Title of 12(b) Security Common Stock, $0.00000002 par value    
Security Exchange Name NASDAQ    
Entity Interactive Data Current Yes    
Entity Address, State or Province CA    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
ICFR Auditor Attestation Flag false    
Entity Common Stock, Shares Outstanding   6,662,857  
Entity Public Float     $ 31.8
Auditor Firm ID 243    
Auditor Location San Diego, California    
Auditor Name BDO USA, P.C.    
Document Financial Statement Error Correction [Flag] false    
XML 25 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Pay vs Performance Disclosure - USD ($)
12 Months Ended
Jun. 02, 2023
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Pay vs Performance Disclosure        
Pay vs Performance Disclosure, Table  

Pay Versus Performance

Provided below is our “pay versus performance” disclosure as required pursuant to Item 402(v) of Regulation S-K promulgated under the Exchange Act. As required by Item 402(v), we have included:

A description of our most important measures that our Compensation Committee used in fiscal year 2023 to link a measure of pay calculated in accordance with Item 402(v) (referred to as “compensation actually paid”, or “CAP”) to our performance;
A table that compares the total compensation of our named executive officers’ (also known as NEOs) as presented in the Summary Compensation Table (“SCT”) to CAP and that compares CAP to specified performance measures; and
Graphs that describe:
o
the relationships between CAP and our cumulative total shareholder return (“TSR”), GAAP Net Income, and our selected measure, Total Cash (defined as all cash, cash equivalents, and investment held to maturity); and
o
the relationship between our TSR and the TSR of the Nasdaq Biotechnology Index (“Peer Group TSR”).

Given our current pay program, the only difference between the SCT and CAP amounts for our NEOs is the value of equity awards, which for purposes of the SCT is based on the grant date fair value of equity awards granted during the year, and for purposes of CAP is based on the year over year change in the fair value of equity awards that are unvested as of the end of the year, or that vested, or were forfeited during the year.

Note: pursuant to Item 402(v)(8), MEI, as a smaller reporting company ("SRC"), has provided the information required by 402(v) for three years, instead of five years and is not required to provide the disclosure required by 402(v)(2)(iv) or 402(v)(5) with respect to the total shareholder return of any peer group, or our-Selected Measure disclosure required by 402 (v)(2)(vi), or the Tabular List provided pursuant to 402(v)(6).

This disclosure has been prepared in accordance with Item 402(v) and does not necessarily reflect value actually realized by the NEOs. Please refer to our Compensation Discussion and Analysis, above, for a discussion of our executive compensation program objectives and the ways in which we align executive compensation with performance.

Our Most Important Metrics Used for Linking Pay and Performance. As required by Item 402(v), below are the most important metrics linking CAP to performance for fiscal year 2023. Besides stock price, the only financial performance measure the Committee used to link executive compensation to performance in 2023 was Total Cash.

Compensation decisions are made each year taking into account a number of other factors. Target pay levels are primarily set based on clinical milestones, individual performance, scope of responsibility, and an annual assessment of pay competitiveness within the market, but

aside from Total Cash and stock price, no additional financial performance measures were used by us to link compensation actually paid to our NEOs in fiscal year 2023 to our performance.

Pay Versus Performance Table. In accordance with Item 402(v) and under rules adopted by the SEC pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, we are providing the tabular disclosure for our Chief Executive Officer (our Principal Executive Officer or “PEO”) and the average of our NEOs other than the PEO for fiscal years 2021, 2022 and 2023.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Value of Initial Fixed $100 Investment Based on Total Shareholder Return

 

 

 

 

 

 

 

Year

 

Summary Compensation Table for Total Current PEO
(Urso)
(1)

 

 

Compensation Actually Paid to Current PEO
(Urso)
(2,3)

 

 

Summary Compensation Table for Total Former PEO
(Gold)
(1)

 

 

Compensation Actually Paid to Former PEO
(Gold)
(2,3)

 

 

Average Summary Compensation Table Total for Non-PEO
NEOs
(1)

 

 

Average Compensation Actually Paid to Non-PEO
NEOs
(2,3)

 

 

MEI Total Shareholder Return

 

Peer Total Shareholder
Return
(4)

 

 

MEI Net Income
($ Millions)

 

 

Company Selected Measure: Total Cash ($Millions)(5)

 

(a)

 

(b)

 

 

(c)

 

 

(b)

 

 

(c)

 

 

(d)

 

 

(e)

 

 

(f)

 

 

 

 

(h)

 

 

(i)

 

2023

 

$

2,101,058

 

 

$

1,689,893

 

 

$

2,446,640

 

 

$

1,853,678

 

 

$

772,486

 

 

$

640,229

 

 

$

8

 

$

95

 

 

$

(32

)

 

$

101

 

2022

 

$

 

 

$

 

 

$

2,528,609

 

 

$

268,643

 

 

$

1,260,180

 

 

$

250,830

 

 

$

15

 

$

87

 

 

$

(54

)

 

$

153

 

2021

 

$

 

 

$

 

 

$

2,948,575

 

 

$

1,476,023

 

 

$

1,271,435

 

 

$

607,434

 

 

$

69

 

$

120

 

 

$

(41

)

 

$

153

 

 

(1)
The PVP table reflects required disclosures for fiscal years 2021, 2022 and 2023. The Principal Executive Officer (PEO) is Daniel Gold from fiscal 2021, 2022 and 2023 but was replaced by David Urso as the PEO as of June 2, 2023. The non-PEO NEOs in fiscal year 2021 are Brian Drazba, Richard Ghalie, Robert Mass (former Chief Medical Officer) and David Urso; the non-PEO NEOs in fiscal year 2022 are Brian Drazba, Richard Ghalie, and David Urso; the non-PEO NEOs in fiscal year 2023 are Brian Drazba and Richard Ghalie.

 

 

Fiscal Year

 

PEO

 

Non-PEO NEOs

2023

 

David M. Urso (Current)
Daniel P. Gold, Ph.D. (Former)

 

Brian G. Drazba and Richard G. Ghalie, M.D.

2022

 

Daniel P. Gold, Ph.D.

 

Brian G. Drazba, Richard G. Ghalie, M.D. and David M. Urso

2021

 

Daniel P. Gold, Ph.D.

 

Brian G. Drazba, Richard G. Ghalie, M.D., Robert D. Mass (former Chief Medical Officer; retired on May 3, 2021) and David M. Urso

 

(1)
The amounts shown for CAP have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized, or received by our NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below.
(2)
"Compensation Actually Paid" (CAP) is calculated by taking Summary Compensation Table total compensation: a) less the stock award and stock option grant values; b) plus the year over year change in the fair value of stock and option awards that are unvested as of the end of the year, or that vested, or were forfeited during the year. We have not paid dividends historically and does not sponsor any pension arrangements; thus, no adjustments are made for those items. Reconciliation of the Summary Compensation Table total compensation and CAP is summarized in the following table:

 

Current PEO (Urso)(i)

 

Fiscal Year

2021

 

2022

 

2023

 

SCT Total

$

2,120,217

 

$

1,744,152

 

$

2,101,058

 

 Stock and Option Award Values Reported in SCT for the Covered Year

 

(1,439,750

)

 

(1,078,500

)

 

(1,352,600

)

 Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year

 

974,099

 

 

167,280

 

 

1,064,015

 

 Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years

 

(283,889

)

 

(508,767

)

 

(70,339

)

 Fair Value of Stock and Option Awards Granted in Covered Year that Vested

 

 

 

 

 

 

 Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year

 

(146,040

)

 

(127,938

)

 

(52,241

)

 Fair Value of Stock and Option Awards Forfeited during the Covered Year

 

 

 

 

 

 

Compensation Actually Paid

$

1,224,637

 

$

196,227

 

$

1,689,893

 

 

 

 

 

 

 

 

 

Former PEO (Gold)(i)

 

Fiscal Year

2021

 

2022

 

2023

 

SCT Total

$

2,948,575

 

$

2,528,609

 

$

2,446,640

 

 Stock and Option Award Values Reported in SCT for the Covered Year

 

(1,918,000

)

 

(1,536,800

)

 

(584,700

)

 Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year

 

1,305,119

 

 

238,374

 

 

 

 Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years

 

(551,681

)

 

(747,241

)

 

 

 Fair Value of Stock and Option Awards Granted in Covered Year that Vested

 

 

 

 

 

188,782

 

 Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year

 

(307,990

)

 

(214,299

)

 

(129,123

)

 Fair Value of Stock and Option Awards Forfeited during the Covered Year

 

 

 

 

 

(67,921

)

Compensation Actually Paid

$

1,476,023

 

$

268,643

 

$

1,853,678

 

 

 

 

 

 

 

 

 

Average Non-PEO (Gold)(i)

 

Fiscal Year

2021

 

2022

 

2023

 

SCT Total

$

1,271,435

 

$

1,260,180

 

$

772,486

 

 Stock and Option Award Values Reported in SCT for the Covered Year

 

(785,225

)

 

(671,067

)

 

(177,850

)

 Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year

 

439,021

 

 

104,085

 

 

101,680

 

 Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years

 

(146,669

)

 

(349,416

)

 

(31,805

)

 Fair Value of Stock and Option Awards Granted in Covered Year that Vested

 

 

 

 

 

 

 Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year

 

(99,445

)

 

(92,952

)

 

(24,282

)

 Fair Value of Stock and Option Awards Forfeited during the Covered Year

 

(71,683

)

 

 

 

 

Compensation Actually Paid

$

607,434

 

$

250,830

 

$

640,229

 

 

 

 

 

 

 

 

(i) The fair value of options awards used to calculate CAP was determined using the Black-Scholes option pricing model, in accordance with FASB 718

 

 

(4)
The Peer Group TSR set forth in this table utilizes the Nasdaq Biotechnology Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report for the year ended June 30, 2019. The comparison assumes $100 was invested for the period starting June 30, 2020, through the end of the listed year in us and in the Nasdaq Biotechnology Index, respectively. Historical stock performance is not necessarily indicative of future stock performance.
(5)
We determined Total Cash to be the most important financial performance measure used to link our performance to CAP to our PEO and Non-PEO NEOs in 2023. Total Cash is defined as total cash, cash equivalents and short-term investments.
   
Company Selected Measure Name   Total Cash    
Named Executive Officers, Footnote  

Fiscal Year

 

PEO

 

Non-PEO NEOs

2023

 

David M. Urso (Current)
Daniel P. Gold, Ph.D. (Former)

 

Brian G. Drazba and Richard G. Ghalie, M.D.

2022

 

Daniel P. Gold, Ph.D.

 

Brian G. Drazba, Richard G. Ghalie, M.D. and David M. Urso

2021

 

Daniel P. Gold, Ph.D.

 

Brian G. Drazba, Richard G. Ghalie, M.D., Robert D. Mass (former Chief Medical Officer; retired on May 3, 2021) and David M. Urso

   
Peer Group Issuers, Footnote  
(4)
The Peer Group TSR set forth in this table utilizes the Nasdaq Biotechnology Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report for the year ended June 30, 2019. The comparison assumes $100 was invested for the period starting June 30, 2020, through the end of the listed year in us and in the Nasdaq Biotechnology Index, respectively. Historical stock performance is not necessarily indicative of future stock performance.
   
Adjustment To PEO Compensation, Footnote  
(2)
"Compensation Actually Paid" (CAP) is calculated by taking Summary Compensation Table total compensation: a) less the stock award and stock option grant values; b) plus the year over year change in the fair value of stock and option awards that are unvested as of the end of the year, or that vested, or were forfeited during the year. We have not paid dividends historically and does not sponsor any pension arrangements; thus, no adjustments are made for those items. Reconciliation of the Summary Compensation Table total compensation and CAP is summarized in the following table:

 

Current PEO (Urso)(i)

 

Fiscal Year

2021

 

2022

 

2023

 

SCT Total

$

2,120,217

 

$

1,744,152

 

$

2,101,058

 

 Stock and Option Award Values Reported in SCT for the Covered Year

 

(1,439,750

)

 

(1,078,500

)

 

(1,352,600

)

 Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year

 

974,099

 

 

167,280

 

 

1,064,015

 

 Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years

 

(283,889

)

 

(508,767

)

 

(70,339

)

 Fair Value of Stock and Option Awards Granted in Covered Year that Vested

 

 

 

 

 

 

 Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year

 

(146,040

)

 

(127,938

)

 

(52,241

)

 Fair Value of Stock and Option Awards Forfeited during the Covered Year

 

 

 

 

 

 

Compensation Actually Paid

$

1,224,637

 

$

196,227

 

$

1,689,893

 

 

 

 

 

 

 

 

 

Former PEO (Gold)(i)

 

Fiscal Year

2021

 

2022

 

2023

 

SCT Total

$

2,948,575

 

$

2,528,609

 

$

2,446,640

 

 Stock and Option Award Values Reported in SCT for the Covered Year

 

(1,918,000

)

 

(1,536,800

)

 

(584,700

)

 Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year

 

1,305,119

 

 

238,374

 

 

 

 Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years

 

(551,681

)

 

(747,241

)

 

 

 Fair Value of Stock and Option Awards Granted in Covered Year that Vested

 

 

 

 

 

188,782

 

 Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year

 

(307,990

)

 

(214,299

)

 

(129,123

)

 Fair Value of Stock and Option Awards Forfeited during the Covered Year

 

 

 

 

 

(67,921

)

Compensation Actually Paid

$

1,476,023

 

$

268,643

 

$

1,853,678

 

 

 

 

 

 

 

 

 

Average Non-PEO (Gold)(i)

 

Fiscal Year

2021

 

2022

 

2023

 

SCT Total

$

1,271,435

 

$

1,260,180

 

$

772,486

 

 Stock and Option Award Values Reported in SCT for the Covered Year

 

(785,225

)

 

(671,067

)

 

(177,850

)

 Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year

 

439,021

 

 

104,085

 

 

101,680

 

 Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years

 

(146,669

)

 

(349,416

)

 

(31,805

)

 Fair Value of Stock and Option Awards Granted in Covered Year that Vested

 

 

 

 

 

 

 Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year

 

(99,445

)

 

(92,952

)

 

(24,282

)

 Fair Value of Stock and Option Awards Forfeited during the Covered Year

 

(71,683

)

 

 

 

 

Compensation Actually Paid

$

607,434

 

$

250,830

 

$

640,229

 

 

 

 

 

 

 

 

(i) The fair value of options awards used to calculate CAP was determined using the Black-Scholes option pricing model, in accordance with FASB 718

 

 

(4)
The Peer Group TSR set forth in this table utilizes the Nasdaq Biotechnology Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report for the year ended June 30, 2019. The comparison assumes $100 was invested for the period starting June 30, 2020, through the end of the listed year in us and in the Nasdaq Biotechnology Index, respectively. Historical stock performance is not necessarily indicative of future stock performance.
   
Non-PEO NEO Average Total Compensation Amount   $ 772,486 $ 1,260,180 $ 1,271,435
Non-PEO NEO Average Compensation Actually Paid Amount   $ 640,229 250,830 607,434
Adjustment to Non-PEO NEO Compensation Footnote  
(2)
"Compensation Actually Paid" (CAP) is calculated by taking Summary Compensation Table total compensation: a) less the stock award and stock option grant values; b) plus the year over year change in the fair value of stock and option awards that are unvested as of the end of the year, or that vested, or were forfeited during the year. We have not paid dividends historically and does not sponsor any pension arrangements; thus, no adjustments are made for those items. Reconciliation of the Summary Compensation Table total compensation and CAP is summarized in the following table:

 

Current PEO (Urso)(i)

 

Fiscal Year

2021

 

2022

 

2023

 

SCT Total

$

2,120,217

 

$

1,744,152

 

$

2,101,058

 

 Stock and Option Award Values Reported in SCT for the Covered Year

 

(1,439,750

)

 

(1,078,500

)

 

(1,352,600

)

 Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year

 

974,099

 

 

167,280

 

 

1,064,015

 

 Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years

 

(283,889

)

 

(508,767

)

 

(70,339

)

 Fair Value of Stock and Option Awards Granted in Covered Year that Vested

 

 

 

 

 

 

 Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year

 

(146,040

)

 

(127,938

)

 

(52,241

)

 Fair Value of Stock and Option Awards Forfeited during the Covered Year

 

 

 

 

 

 

Compensation Actually Paid

$

1,224,637

 

$

196,227

 

$

1,689,893

 

 

 

 

 

 

 

 

 

Former PEO (Gold)(i)

 

Fiscal Year

2021

 

2022

 

2023

 

SCT Total

$

2,948,575

 

$

2,528,609

 

$

2,446,640

 

 Stock and Option Award Values Reported in SCT for the Covered Year

 

(1,918,000

)

 

(1,536,800

)

 

(584,700

)

 Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year

 

1,305,119

 

 

238,374

 

 

 

 Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years

 

(551,681

)

 

(747,241

)

 

 

 Fair Value of Stock and Option Awards Granted in Covered Year that Vested

 

 

 

 

 

188,782

 

 Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year

 

(307,990

)

 

(214,299

)

 

(129,123

)

 Fair Value of Stock and Option Awards Forfeited during the Covered Year

 

 

 

 

 

(67,921

)

Compensation Actually Paid

$

1,476,023

 

$

268,643

 

$

1,853,678

 

 

 

 

 

 

 

 

 

Average Non-PEO (Gold)(i)

 

Fiscal Year

2021

 

2022

 

2023

 

SCT Total

$

1,271,435

 

$

1,260,180

 

$

772,486

 

 Stock and Option Award Values Reported in SCT for the Covered Year

 

(785,225

)

 

(671,067

)

 

(177,850

)

 Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year

 

439,021

 

 

104,085

 

 

101,680

 

 Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years

 

(146,669

)

 

(349,416

)

 

(31,805

)

 Fair Value of Stock and Option Awards Granted in Covered Year that Vested

 

 

 

 

 

 

 Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year

 

(99,445

)

 

(92,952

)

 

(24,282

)

 Fair Value of Stock and Option Awards Forfeited during the Covered Year

 

(71,683

)

 

 

 

 

Compensation Actually Paid

$

607,434

 

$

250,830

 

$

640,229

 

 

 

 

 

 

 

 

(i) The fair value of options awards used to calculate CAP was determined using the Black-Scholes option pricing model, in accordance with FASB 718

 

   
Compensation Actually Paid vs. Total Shareholder Return  

Relationship between CAP and TSR. The chart below reflects the relationship between the PEO and average non-PEO NEO CAP versus our TSR and the Peer Group TSR.

img104060336_12.jpg 

   
Compensation Actually Paid vs. Net Income  

Relationship between CAP and GAAP Net Loss. The chart below reflects the relationship between the PEO and average non-PEO NEO CAP and our GAAP Net Loss.

img104060336_13.jpg 

   
Compensation Actually Paid vs. Company Selected Measure  

Relationship between CAP and Total Cash (our Selected Measure). The chart below reflects the relationship between the PEO CAP and average non-PEO NEO CAP and our Total Cash.

img104060336_14.jpg 

   
Total Shareholder Return Vs Peer Group  

img104060336_12.jpg 

   
Total Shareholder Return Amount   $ 8 15 69
Peer Group Total Shareholder Return Amount   95 87 120
Net Income (Loss)   $ (32,000,000) $ (54,000,000) $ (41,000,000)
Company Selected Measure Amount   101,000,000 153,000,000 153,000,000
Additional 402(v) Disclosure  
(1)
The amounts shown for CAP have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized, or received by our NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below.
   
Measure:: 1        
Pay vs Performance Disclosure        
Non-GAAP Measure Description  
(5)
We determined Total Cash to be the most important financial performance measure used to link our performance to CAP to our PEO and Non-PEO NEOs in 2023. Total Cash is defined as total cash, cash equivalents and short-term investments.
   
Daniel Gold [Member]        
Pay vs Performance Disclosure        
PEO Total Compensation Amount   $ 2,446,640 $ 2,528,609 $ 2,948,575
PEO Actually Paid Compensation Amount   $ 1,853,678 $ 268,643 $ 1,476,023
PEO Name   Daniel Gold Daniel Gold Daniel Gold
David Urso [Member]        
Pay vs Performance Disclosure        
PEO Total Compensation Amount   $ 2,101,058 $ 1,744,152 $ 2,120,217
PEO Actually Paid Compensation Amount   1,689,893 196,227 1,224,637
PEO Name David Urso      
PEO | Daniel Gold [Member] | Stock and Option Award Values Reported in SCT for the Covered Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount   (584,700) (1,536,800) (1,918,000)
PEO | Daniel Gold [Member] | Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount     238,374 1,305,119
PEO | Daniel Gold [Member] | Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount     (747,241) (551,681)
PEO | Daniel Gold [Member] | Fair Value of Stock and Option Awards Granted in Covered Year that Vested [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount   188,782    
PEO | Daniel Gold [Member] | Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount   (129,123) (214,299) (307,990)
PEO | Daniel Gold [Member] | Fair Value of Stock and Option Awards Forfeited during the Covered Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount   (67,921)    
PEO | David Urso [Member] | Stock and Option Award Values Reported in SCT for the Covered Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount   (1,352,600) (1,078,500) (1,439,750)
PEO | David Urso [Member] | Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount   1,064,015 167,280 974,099
PEO | David Urso [Member] | Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount   (70,339) (508,767) (283,889)
PEO | David Urso [Member] | Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount   (52,241) (127,938) (146,040)
Non-PEO NEO | Stock and Option Award Values Reported in SCT for the Covered Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount   (177,850) (671,067) (785,225)
Non-PEO NEO | Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount   101,680 104,085 439,021
Non-PEO NEO | Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount   (31,805) (349,416) (146,669)
Non-PEO NEO | Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount   $ (24,282) $ (92,952) (99,445)
Non-PEO NEO | Fair Value of Stock and Option Awards Forfeited during the Covered Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount       $ (71,683)
XML 26 meip-20230630_htm.xml IDEA: XBRL DOCUMENT 0001262104 2021-07-01 2022-06-30 0001262104 meip:ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInCoveredYearMember ecd:NonPeoNeoMember 2022-07-01 2023-06-30 0001262104 2022-07-01 2023-06-30 0001262104 meip:FairValueOfOutstandingUnvestedStockAndOptionAwardsGrantedInTheCoveredYearMember ecd:NonPeoNeoMember 2022-07-01 2023-06-30 0001262104 meip:DanielGoldMember 2022-07-01 2023-06-30 0001262104 meip:StockAndOptionAwardValuesReportedInSctForTheCoveredYearMember ecd:NonPeoNeoMember 2021-07-01 2022-06-30 0001262104 meip:ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInCoveredYearMember ecd:PeoMember meip:DavidUrsoMember 2020-07-01 2021-06-30 0001262104 meip:DavidUrsoMember 2021-07-01 2022-06-30 0001262104 meip:StockAndOptionAwardValuesReportedInSctForTheCoveredYearMember ecd:PeoMember meip:DanielGoldMember 2022-07-01 2023-06-30 0001262104 2022-12-31 0001262104 meip:StockAndOptionAwardValuesReportedInSctForTheCoveredYearMember ecd:PeoMember meip:DavidUrsoMember 2020-07-01 2021-06-30 0001262104 meip:StockAndOptionAwardValuesReportedInSctForTheCoveredYearMember ecd:NonPeoNeoMember 2022-07-01 2023-06-30 0001262104 meip:ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYearsMember ecd:NonPeoNeoMember 2020-07-01 2021-06-30 0001262104 meip:ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYearsMember ecd:NonPeoNeoMember 2021-07-01 2022-06-30 0001262104 2023-09-15 0001262104 meip:ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYearsMember ecd:PeoMember meip:DanielGoldMember 2021-07-01 2022-06-30 0001262104 meip:ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInCoveredYearMember ecd:PeoMember meip:DavidUrsoMember 2022-07-01 2023-06-30 0001262104 meip:FairValueOfOutstandingUnvestedStockAndOptionAwardsGrantedInTheCoveredYearMember ecd:PeoMember meip:DavidUrsoMember 2022-07-01 2023-06-30 0001262104 meip:FairValueOfOutstandingUnvestedStockAndOptionAwardsGrantedInTheCoveredYearMember ecd:NonPeoNeoMember 2020-07-01 2021-06-30 0001262104 meip:FairValueOfStockAndOptionAwardsForfeitedDuringTheCoveredYearMember ecd:NonPeoNeoMember 2020-07-01 2021-06-30 0001262104 meip:FairValueOfOutstandingUnvestedStockAndOptionAwardsGrantedInTheCoveredYearMember ecd:PeoMember meip:DanielGoldMember 2021-07-01 2022-06-30 0001262104 meip:ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYearsMember ecd:PeoMember meip:DanielGoldMember 2020-07-01 2021-06-30 0001262104 meip:FairValueOfOutstandingUnvestedStockAndOptionAwardsGrantedInTheCoveredYearMember ecd:PeoMember meip:DavidUrsoMember 2021-07-01 2022-06-30 0001262104 meip:DavidUrsoMember 2020-07-01 2021-06-30 0001262104 meip:FairValueOfOutstandingUnvestedStockAndOptionAwardsGrantedInTheCoveredYearMember ecd:PeoMember meip:DavidUrsoMember 2020-07-01 2021-06-30 0001262104 meip:ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInCoveredYearMember ecd:PeoMember meip:DanielGoldMember 2020-07-01 2021-06-30 0001262104 meip:FairValueOfOutstandingUnvestedStockAndOptionAwardsGrantedInTheCoveredYearMember ecd:NonPeoNeoMember 2021-07-01 2022-06-30 0001262104 meip:ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYearsMember ecd:PeoMember meip:DavidUrsoMember 2021-07-01 2022-06-30 0001262104 meip:DanielGoldMember 2021-07-01 2022-06-30 0001262104 meip:ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInCoveredYearMember ecd:NonPeoNeoMember 2021-07-01 2022-06-30 0001262104 meip:DavidUrsoMember 2023-06-02 2023-06-02 0001262104 meip:ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInCoveredYearMember ecd:NonPeoNeoMember 2020-07-01 2021-06-30 0001262104 meip:StockAndOptionAwardValuesReportedInSctForTheCoveredYearMember ecd:NonPeoNeoMember 2020-07-01 2021-06-30 0001262104 meip:StockAndOptionAwardValuesReportedInSctForTheCoveredYearMember ecd:PeoMember meip:DavidUrsoMember 2022-07-01 2023-06-30 0001262104 1 2022-07-01 2023-06-30 0001262104 meip:FairValueOfOutstandingUnvestedStockAndOptionAwardsGrantedInTheCoveredYearMember ecd:PeoMember meip:DanielGoldMember 2020-07-01 2021-06-30 0001262104 meip:DavidUrsoMember 2022-07-01 2023-06-30 0001262104 meip:ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInCoveredYearMember ecd:PeoMember meip:DavidUrsoMember 2021-07-01 2022-06-30 0001262104 meip:StockAndOptionAwardValuesReportedInSctForTheCoveredYearMember ecd:PeoMember meip:DanielGoldMember 2021-07-01 2022-06-30 0001262104 meip:FairValueOfStockAndOptionAwardsGrantedInCoveredYearThatVestedMember ecd:PeoMember meip:DanielGoldMember 2022-07-01 2023-06-30 0001262104 meip:ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYearsMember ecd:PeoMember meip:DavidUrsoMember 2022-07-01 2023-06-30 0001262104 2020-07-01 2021-06-30 0001262104 meip:DanielGoldMember 2020-07-01 2021-06-30 0001262104 meip:ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInCoveredYearMember ecd:PeoMember meip:DanielGoldMember 2022-07-01 2023-06-30 0001262104 meip:StockAndOptionAwardValuesReportedInSctForTheCoveredYearMember ecd:PeoMember meip:DanielGoldMember 2020-07-01 2021-06-30 0001262104 meip:ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYearsMember ecd:NonPeoNeoMember 2022-07-01 2023-06-30 0001262104 meip:ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInCoveredYearMember ecd:PeoMember meip:DanielGoldMember 2021-07-01 2022-06-30 0001262104 meip:StockAndOptionAwardValuesReportedInSctForTheCoveredYearMember ecd:PeoMember meip:DavidUrsoMember 2021-07-01 2022-06-30 0001262104 meip:FairValueOfStockAndOptionAwardsForfeitedDuringTheCoveredYearMember ecd:PeoMember meip:DanielGoldMember 2022-07-01 2023-06-30 0001262104 meip:ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYearsMember ecd:PeoMember meip:DavidUrsoMember 2020-07-01 2021-06-30 shares iso4217:USD --06-30 0001262104 FY true 10-K/A true 2023-06-30 2023 false 001-41827 MEI Pharma, Inc. DE 51-0407811 11455 El Camino Real Suite 250 San Diego CA 92130 858 369-7100 Common Stock, $0.00000002 par value MEIP NASDAQ No No Yes Yes Non-accelerated Filer true false false false false 31800000 6662857 BDO USA, P.C. San Diego, California 243 Throughout this document MEI Pharma, Inc. is referred to as “MEI,” and, together with its subsidiaries, as “we,” “us,” or “our.”On September 26, 2023, MEI filed its Annual Report on Form 10-K for the fiscal year ended June 30, 2023 (the “Original Form 10-K”). Certain Part III information was omitted from the Original Form 10-K in reliance on General Instruction G(3) to Form 10-K. General Instruction G(3) to Form 10-K provides that registrants may incorporate by reference certain information from a definitive proxy statement which involves the election of directors if such definitive proxy statement is filed with the Securities and Exchange Commission (the “SEC”) within 120 days after the end of the fiscal year. We do not anticipate that MEI's definitive proxy statement involving the election of directors in connection with its MEI's fiscal year 2024 annual meeting of stockholders will be filed by October 27, 2023 (i.e., within 120 days after the end of the 2023 fiscal year). Accordingly, this Amendment No. 1 (this “Amendment”) hereby amends and restates Part III, Items 10 through 14, of the Original Form 10-K as set forth below. The information included herein as required by Part III, Items 10 through 14, of the Original Form 10-K is more limited than what is required to be included in the definitive proxy statement to be filed in connection with our 2024 annual meeting of stockholders. Accordingly, the definitive proxy statement to be filed at a later date will include additional information related to the topics herein and additional information not required by Part III, Items 10 through 14, of Form 10-K.This Amendment also restates Item 15 of Part IV of the Original Form 10-K. In addition, as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), new certifications by our principal executive officer and principal financial officer are filed as exhibits to this Amendment under Item 15 of Part IV hereof.No other amendments are being made hereby to the Original Form 10-K. Except as stated herein, this Amendment does not reflect events occurring after the filing of the Original Form 10-K with the SEC on September 26, 2023, and no attempt has been made in this Amendment to modify or update other disclosures as presented in the Original Form 10-K. Terms used but not defined herein have the meanings given to them in the Original Form 10-K. <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pay Versus Performance</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Provided below is our “pay versus performance” disclosure as required pursuant to Item 402(v) of Regulation S-K promulgated under the Exchange Act. As required by Item 402(v), we have included:</span></p><div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A description of our most important measures that our Compensation Committee used in fiscal year 2023 to link a measure of pay calculated in accordance with Item 402(v) (referred to as “compensation actually paid”, or “CAP”) to our performance; </span></div></div><div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A table that compares the total compensation of our named executive officers’ (also known as NEOs) as presented in the Summary Compensation Table (“SCT”) to CAP and that compares CAP to specified performance measures; and</span></div></div><div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Graphs that describe:</span></div></div><div style="margin-left:9.065%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.989278055754109%;">o</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the relationships between CAP and our cumulative total shareholder return (“TSR”), GAAP Net Income, and our selected measure, Total Cash (defined as all cash, cash equivalents, and investment held to maturity); and</span></div></div><div style="margin-left:9.065%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.989278055754109%;">o</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the relationship between our TSR and the TSR of the Nasdaq Biotechnology Index (“Peer Group TSR”).</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Given our current pay program, the only difference between the SCT and CAP amounts for our NEOs is the value of equity awards, which for purposes of the SCT is based on the grant date fair value of equity awards granted during the year, and for purposes of CAP is based on the year over year change in the fair value of equity awards that are unvested as of the end of the year, or that vested, or were forfeited during the year.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Note: pursuant to Item 402(v)(8), MEI, as a smaller reporting company ("SRC"), has provided the information required by 402(v) for three years, instead of five years and is not required to provide the disclosure required by 402(v)(2)(iv) or 402(v)(5) with respect to the total shareholder return of any peer group, or our-Selected Measure disclosure required by 402 (v)(2)(vi), or the Tabular List provided pursuant to 402(v)(6).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> This disclosure has been prepared in accordance with Item 402(v) and does not necessarily reflect value actually realized by the NEOs. Please refer to our </span><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Compensation Discussion and Analysis</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">, </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">above,</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">for a discussion of our executive compensation program objectives and the ways in which we align executive compensation with performance.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Most Important Metrics Used for Linking Pay and Performance. </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As required by Item 402(v), below are the most important metrics linking CAP to performance for fiscal year 2023. Besides stock price, the only financial performance measure the Committee used to link executive compensation to performance in 2023 was Total Cash.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Compensation decisions are made each year taking into account a number of other factors. Target pay levels are primarily set based on clinical milestones, individual performance, scope of responsibility, and an annual assessment of pay competitiveness within the market, but</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">aside from Total Cash and stock price, no additional financial performance measures were used by us to link compensation actually paid to our NEOs in fiscal year 2023 to our performance.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pay Versus Performance Table</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. In accordance with Item 402(v) and under rules adopted by the SEC pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, we are providing the tabular disclosure for our Chief Executive Officer (our Principal Executive Officer or “PEO”) and the average of our NEOs other than the PEO for fiscal years 2021, 2022 and 2023.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:91.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:4.103%;"></td> <td style="width:1.123%;"></td> <td style="width:1%;"></td> <td style="width:6.717%;"></td> <td style="width:1%;"></td> <td style="width:1.123%;"></td> <td style="width:1%;"></td> <td style="width:6.635%;"></td> <td style="width:1%;"></td> <td style="width:1.123%;"></td> <td style="width:1%;"></td> <td style="width:6.635%;"></td> <td style="width:1%;"></td> <td style="width:1.123%;"></td> <td style="width:1%;"></td> <td style="width:6.635%;"></td> <td style="width:1%;"></td> <td style="width:1.123%;"></td> <td style="width:1%;"></td> <td style="width:6.717%;"></td> <td style="width:1%;"></td> <td style="width:1.123%;"></td> <td style="width:1%;"></td> <td style="width:6.635%;"></td> <td style="width:1%;"></td> <td style="width:1.123%;"></td> <td style="width:1%;"></td> <td style="width:6.798%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:6.043%;"></td> <td style="width:1%;"></td> <td style="width:1.123%;"></td> <td style="width:1%;"></td> <td style="width:6.349%;"></td> <td style="width:1%;"></td> <td style="width:1.123%;"></td> <td style="width:1%;"></td> <td style="width:6.635%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:7pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="5" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">Value of Initial Fixed $100 Investment Based on Total Shareholder Return</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:7pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">Year</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">Summary Compensation Table for Total Current PEO<br/>(Urso)</span><span style="color:#000000;top:-3.283pt;white-space:pre-wrap;font-weight:bold;font-size:4.69pt;font-family:Times New Roman;position:relative;min-width:fit-content;">(1)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">Compensation Actually Paid to Current PEO<br/>(Urso)</span><span style="color:#000000;top:-3.283pt;white-space:pre-wrap;font-weight:bold;font-size:4.69pt;font-family:Times New Roman;position:relative;min-width:fit-content;">(2,3)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">Summary Compensation Table for Total Former PEO<br/>(Gold)</span><span style="color:#000000;top:-3.283pt;white-space:pre-wrap;font-weight:bold;font-size:4.69pt;font-family:Times New Roman;position:relative;min-width:fit-content;">(1)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">Compensation Actually Paid to Former PEO<br/>(Gold)</span><span style="color:#000000;top:-3.283pt;white-space:pre-wrap;font-weight:bold;font-size:4.69pt;font-family:Times New Roman;position:relative;min-width:fit-content;">(2,3)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">Average Summary Compensation Table Total for Non-PEO<br/>NEOs</span><span style="color:#000000;top:-3.283pt;white-space:pre-wrap;font-weight:bold;font-size:4.69pt;font-family:Times New Roman;position:relative;min-width:fit-content;">(1)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">Average Compensation Actually Paid to Non-PEO<br/>NEOs</span><span style="color:#000000;top:-3.283pt;white-space:pre-wrap;font-weight:bold;font-size:4.69pt;font-family:Times New Roman;position:relative;min-width:fit-content;">(2,3)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">MEI Total Shareholder Return</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">Peer Total Shareholder<br/>Return</span><span style="color:#000000;top:-3.283pt;white-space:pre-wrap;font-weight:bold;font-size:4.69pt;font-family:Times New Roman;position:relative;min-width:fit-content;">(4)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">MEI Net Income<br/>($ Millions)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">Company Selected Measure: Total Cash ($Millions)</span><span style="color:#000000;top:-3.283pt;white-space:pre-wrap;font-weight:bold;font-size:4.69pt;font-family:Times New Roman;position:relative;min-width:fit-content;">(5)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:7pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">(a)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">(b)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">(c)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">(b)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">(c)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">(d)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">(e)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">(f)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">(h)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">(i)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:7pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">2,101,058</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">1,689,893</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">2,446,640</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">1,853,678</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">772,486</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">640,229</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">8</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">95</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">32</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">101</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:7pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">2,528,609</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">268,643</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">1,260,180</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">250,830</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">15</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">87</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">54</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">153</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:7pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">2,948,575</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">1,476,023</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">1,271,435</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">607,434</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">69</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">120</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">41</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">153</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="margin-left:1.333%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:9pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.598295276029473%;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">The PVP table reflects required disclosures for fiscal years 2021, 2022 and 2023. The Principal Executive Officer (PEO) is </span><span style="font-size:9pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Daniel Gold</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> from fiscal 2021, 2022 and 2023 but was replaced by </span><span style="font-size:9pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">David Urso</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> as the PEO as of June 2, 2023. The non-PEO NEOs in fiscal year 2021 are Brian Drazba, Richard Ghalie, Robert Mass (former Chief Medical Officer) and David Urso; the non-PEO NEOs in fiscal year 2022 are Brian Drazba, Richard Ghalie, and David Urso; the non-PEO NEOs in fiscal year 2023 are Brian Drazba and Richard Ghalie.</span></div></div><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"> </p><div style="font-size:8pt;font-family:Times New Roman;"> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:8.84%;"></td> <td style="width:1%;"></td> <td style="width:19.54%;"></td> <td style="width:1%;"></td> <td style="width:69.62%;"></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Fiscal Year</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">PEO</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Non-PEO NEOs</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">David M. Urso (Current)<br/>Daniel P. Gold, Ph.D. (Former)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Brian G. Drazba and Richard G. Ghalie, M.D.</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Daniel P. Gold, Ph.D.</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Brian G. Drazba, Richard G. Ghalie, M.D. and David M. Urso</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Daniel P. Gold, Ph.D.</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Brian G. Drazba, Richard G. Ghalie, M.D., Robert D. Mass (former Chief Medical Officer; retired on May 3, 2021) and David M. Urso</span></p></td> </tr> </table></div><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div><div style="margin-left:1.333%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:9pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.598295276029473%;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">The amounts shown for CAP have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized, or received by our NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below.</span></div></div></div><div style="font-size:9pt;font-family:Times New Roman;"><div style="font-size:10pt;font-family:Times New Roman;"><div style="margin-left:1.333%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:9pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.598295276029473%;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">"Compensation Actually Paid" (CAP) is calculated by taking Summary Compensation Table total compensation: a) less the stock award and stock option grant values; b) plus the year over year change in the fair value of stock and option awards that are unvested as of the end of the year, or that vested, or were forfeited during the year. We have not paid dividends historically and does not sponsor any pension arrangements; thus, no adjustments are made for those items. Reconciliation of the Summary Compensation Table total compensation and CAP is summarized in the following table: </span></div></div> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:69.4%;"></td> <td style="width:1%;"></td> <td style="width:8.8%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:7.2%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:8.6%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="8" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Current PEO (Urso)(i)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Fiscal Year</span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">SCT Total</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2,120,217</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,744,152</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2,101,058</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,439,750</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,078,500</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,352,600</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">974,099</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">167,280</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,064,015</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">283,889</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">508,767</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">70,339</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">146,040</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">127,938</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">52,241</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Compensation Actually Paid</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,224,637</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">196,227</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,689,893</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="8" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Former PEO (Gold)(i)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Fiscal Year</span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">SCT Total</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2,948,575</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2,528,609</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2,446,640</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,918,000</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,536,800</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">584,700</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,305,119</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">238,374</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">551,681</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">747,241</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">188,782</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">307,990</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">214,299</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">129,123</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">67,921</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Compensation Actually Paid</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,476,023</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">268,643</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,853,678</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="8" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Average Non-PEO (Gold)(i)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Fiscal Year</span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">SCT Total</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,271,435</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,260,180</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">772,486</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">785,225</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">671,067</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">177,850</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">439,021</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">104,085</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">101,680</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">146,669</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">349,416</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">31,805</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">99,445</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">92,952</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">24,282</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">71,683</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Compensation Actually Paid</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">607,434</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">250,830</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">640,229</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td colspan="9" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(i) The fair value of options awards used to calculate CAP was determined using the Black-Scholes option pricing model, in accordance with FASB 718</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div><div style="margin-left:1.333%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:9pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.598295276029473%;">(4)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">The Peer Group TSR set forth in this table utilizes the Nasdaq Biotechnology Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report for the year ended June 30, 2019. The comparison assumes $100 was invested for the period starting June 30, 2020, through the end of the listed year in us and in the Nasdaq Biotechnology Index, respectively. Historical stock performance is not necessarily indicative of future stock performance. </span></div></div></div></div><div><div style="margin-left:1.333%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:9pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.598295276029473%;">(5)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">We determined </span><span style="font-size:9pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Total Cash</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> to be the most important financial performance measure used to link our performance to CAP to our PEO and Non-PEO NEOs in 2023. Total Cash is defined as total cash, cash equivalents and short-term investments. </span></div></div></div> 2101058 1689893 2446640 1853678 772486 640229 8 95 -32000000 101000000 2528609 268643 1260180 250830 15 87 -54000000 153000000 2948575 1476023 1271435 607434 69 120 -41000000 153000000 Daniel Gold Daniel Gold Daniel Gold David Urso <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:8.84%;"></td> <td style="width:1%;"></td> <td style="width:19.54%;"></td> <td style="width:1%;"></td> <td style="width:69.62%;"></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Fiscal Year</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">PEO</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Non-PEO NEOs</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">David M. Urso (Current)<br/>Daniel P. Gold, Ph.D. (Former)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Brian G. Drazba and Richard G. Ghalie, M.D.</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Daniel P. Gold, Ph.D.</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Brian G. Drazba, Richard G. Ghalie, M.D. and David M. Urso</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Daniel P. Gold, Ph.D.</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Brian G. Drazba, Richard G. Ghalie, M.D., Robert D. Mass (former Chief Medical Officer; retired on May 3, 2021) and David M. Urso</span></p></td> </tr> </table> <div style="margin-left:1.333%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:9pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.598295276029473%;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">The amounts shown for CAP have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized, or received by our NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below.</span></div></div> <div style="font-size:10pt;font-family:Times New Roman;"><div style="margin-left:1.333%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:9pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.598295276029473%;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">"Compensation Actually Paid" (CAP) is calculated by taking Summary Compensation Table total compensation: a) less the stock award and stock option grant values; b) plus the year over year change in the fair value of stock and option awards that are unvested as of the end of the year, or that vested, or were forfeited during the year. We have not paid dividends historically and does not sponsor any pension arrangements; thus, no adjustments are made for those items. Reconciliation of the Summary Compensation Table total compensation and CAP is summarized in the following table: </span></div></div> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:69.4%;"></td> <td style="width:1%;"></td> <td style="width:8.8%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:7.2%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:8.6%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="8" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Current PEO (Urso)(i)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Fiscal Year</span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">SCT Total</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2,120,217</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,744,152</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2,101,058</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,439,750</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,078,500</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,352,600</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">974,099</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">167,280</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,064,015</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">283,889</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">508,767</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">70,339</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">146,040</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">127,938</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">52,241</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Compensation Actually Paid</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,224,637</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">196,227</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,689,893</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="8" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Former PEO (Gold)(i)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Fiscal Year</span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">SCT Total</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2,948,575</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2,528,609</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2,446,640</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,918,000</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,536,800</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">584,700</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,305,119</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">238,374</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">551,681</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">747,241</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">188,782</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">307,990</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">214,299</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">129,123</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">67,921</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Compensation Actually Paid</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,476,023</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">268,643</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,853,678</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="8" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Average Non-PEO (Gold)(i)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Fiscal Year</span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">SCT Total</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,271,435</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,260,180</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">772,486</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">785,225</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">671,067</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">177,850</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">439,021</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">104,085</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">101,680</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">146,669</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">349,416</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">31,805</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">99,445</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">92,952</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">24,282</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">71,683</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Compensation Actually Paid</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">607,434</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">250,830</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">640,229</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td colspan="9" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(i) The fair value of options awards used to calculate CAP was determined using the Black-Scholes option pricing model, in accordance with FASB 718</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div><div style="margin-left:1.333%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:9pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.598295276029473%;">(4)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">The Peer Group TSR set forth in this table utilizes the Nasdaq Biotechnology Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report for the year ended June 30, 2019. The comparison assumes $100 was invested for the period starting June 30, 2020, through the end of the listed year in us and in the Nasdaq Biotechnology Index, respectively. Historical stock performance is not necessarily indicative of future stock performance. </span></div></div></div> <div style="margin-left:1.333%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:9pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.598295276029473%;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">"Compensation Actually Paid" (CAP) is calculated by taking Summary Compensation Table total compensation: a) less the stock award and stock option grant values; b) plus the year over year change in the fair value of stock and option awards that are unvested as of the end of the year, or that vested, or were forfeited during the year. We have not paid dividends historically and does not sponsor any pension arrangements; thus, no adjustments are made for those items. Reconciliation of the Summary Compensation Table total compensation and CAP is summarized in the following table: </span></div></div> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:69.4%;"></td> <td style="width:1%;"></td> <td style="width:8.8%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:7.2%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:8.6%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="8" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Current PEO (Urso)(i)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Fiscal Year</span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">SCT Total</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2,120,217</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,744,152</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2,101,058</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,439,750</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,078,500</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,352,600</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">974,099</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">167,280</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,064,015</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">283,889</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">508,767</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">70,339</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">146,040</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">127,938</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">52,241</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Compensation Actually Paid</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,224,637</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">196,227</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,689,893</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="8" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Former PEO (Gold)(i)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Fiscal Year</span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">SCT Total</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2,948,575</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2,528,609</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2,446,640</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,918,000</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,536,800</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">584,700</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,305,119</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">238,374</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">551,681</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">747,241</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">188,782</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">307,990</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">214,299</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">129,123</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">67,921</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Compensation Actually Paid</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,476,023</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">268,643</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,853,678</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="8" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Average Non-PEO (Gold)(i)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Fiscal Year</span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">SCT Total</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,271,435</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">1,260,180</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">772,486</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">785,225</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">671,067</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">177,850</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">439,021</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">104,085</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">101,680</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">146,669</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">349,416</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">31,805</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">99,445</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">92,952</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">24,282</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">71,683</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Compensation Actually Paid</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">607,434</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">250,830</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">640,229</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;"> <td colspan="9" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(i) The fair value of options awards used to calculate CAP was determined using the Black-Scholes option pricing model, in accordance with FASB 718</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table> 2120217 1744152 2101058 -1439750 -1078500 -1352600 974099 167280 1064015 -283889 -508767 -70339 -146040 -127938 -52241 1224637 196227 1689893 2948575 2528609 2446640 -1918000 -1536800 -584700 1305119 238374 -551681 -747241 188782 -307990 -214299 -129123 -67921 1476023 268643 1853678 1271435 1260180 772486 -785225 -671067 -177850 439021 104085 101680 -146669 -349416 -31805 -99445 -92952 -24282 -71683 607434 250830 640229 <div style="margin-left:1.333%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:9pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.598295276029473%;">(4)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">The Peer Group TSR set forth in this table utilizes the Nasdaq Biotechnology Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report for the year ended June 30, 2019. The comparison assumes $100 was invested for the period starting June 30, 2020, through the end of the listed year in us and in the Nasdaq Biotechnology Index, respectively. Historical stock performance is not necessarily indicative of future stock performance. </span></div></div> <div style="margin-left:1.333%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:9pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.598295276029473%;">(5)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">We determined </span><span style="font-size:9pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Total Cash</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> to be the most important financial performance measure used to link our performance to CAP to our PEO and Non-PEO NEOs in 2023. Total Cash is defined as total cash, cash equivalents and short-term investments. </span></div></div> Total Cash <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Relationship between CAP and TSR</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The chart below reflects the relationship between the PEO and average non-PEO NEO CAP versus our TSR and the Peer Group TSR.</span></p><div><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img alt="img104060336_12.jpg" src="img104060336_12.jpg" style="width:525px;height:285px;"/> </p></div> <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img alt="img104060336_12.jpg" src="img104060336_12.jpg" style="width:525px;height:285px;"/> </p> <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Relationship between CAP and GAAP Net Loss</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The chart below reflects the relationship between the PEO and average non-PEO NEO CAP and our GAAP Net Loss.</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img alt="img104060336_13.jpg" src="img104060336_13.jpg" style="width:526px;height:300px;"/> </p> <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Relationship between CAP and Total Cash (our Selected Measure).</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> The chart below reflects the relationship between the PEO CAP and average non-PEO NEO CAP and our Total Cash.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img alt="img104060336_14.jpg" src="img104060336_14.jpg" style="width:525px;height:285px;"/> </p> EXCEL 27 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 28 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 29 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 30 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 50 61 1 false 11 0 false 2 false false R1.htm 100000 - Document - Cover Page Sheet http://www.meipharma.com/20230630/taxonomy/role/CoverPage Cover Page Cover 1 false false R2.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 2 false false All Reports Book All Reports meip-20230630.htm meip-20230630.xsd meip-20230630_def.xml meip-20230630_lab.xml meip-20230630_pre.xml img104060336_0.jpg img104060336_1.jpg img104060336_10.jpg img104060336_11.jpg img104060336_12.jpg img104060336_13.jpg img104060336_14.jpg img104060336_2.jpg img104060336_3.jpg img104060336_4.jpg img104060336_5.jpg img104060336_6.jpg img104060336_7.jpg img104060336_8.jpg img104060336_9.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true false JSON 33 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "meip-20230630.htm": { "nsprefix": "meip", "nsuri": "http://www.meipharma.com/20230630", "dts": { "inline": { "local": [ "meip-20230630.htm" ] }, "schema": { "local": [ "meip-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd" ] }, "definitionLink": { "local": [ "meip-20230630_def.xml" ] }, "labelLink": { "local": [ "meip-20230630_lab.xml" ] }, "presentationLink": { "local": [ "meip-20230630_pre.xml" ] } }, "keyStandard": 61, "keyCustom": 0, "axisStandard": 4, "axisCustom": 0, "memberStandard": 3, "memberCustom": 8, "hidden": { "total": 4, "http://xbrl.sec.gov/dei/2023": 4 }, "contextCount": 50, "entityCount": 1, "segmentCount": 11, "elementCount": 143, "unitCount": 2, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 39, "http://fasb.org/us-gaap/2023": 3, "http://xbrl.sec.gov/ecd/2023": 94 }, "report": { "R1": { "role": "http://www.meipharma.com/20230630/taxonomy/role/CoverPage", "longName": "100000 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_0583d5aa-7c50-47f0-96b1-3e77ce8b46e1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "meip-20230630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0583d5aa-7c50-47f0-96b1-3e77ce8b46e1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "meip-20230630.htm", "first": true, "unique": true } }, "R2": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "2", "firstAnchor": { "contextRef": "C_0583d5aa-7c50-47f0-96b1-3e77ce8b46e1", "name": "ecd:PvpTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "meip-20230630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0583d5aa-7c50-47f0-96b1-3e77ce8b46e1", "name": "ecd:PvpTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "meip-20230630.htm", "first": true, "unique": true } } }, "tag": { "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r107" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r108" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "auth_ref": [ "r109" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r106" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "auth_ref": [ "r138" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r107" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "auth_ref": [ "r130" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r68", "r69", "r82" ] }, "meip_DanielGoldMember": { "xbrltype": "domainItemType", "nsuri": "http://www.meipharma.com/20230630", "localname": "DanielGoldMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Daniel Gold", "label": "Daniel Gold [Member]", "documentation": "Daniel Gold." } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r108" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r105" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r108" ] }, "meip_BrianDrazbaAndRichardGhalieNonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.meipharma.com/20230630", "localname": "BrianDrazbaAndRichardGhalieNonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Brian Drazba and Richard Ghalie Non PEO NEO [Member]", "documentation": "Brian Drazba and Richard Ghalie Non PEO NEO." } } }, "auth_ref": [] }, "meip_FairValueOfStockAndOptionAwardsGrantedInCoveredYearThatVestedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.meipharma.com/20230630", "localname": "FairValueOfStockAndOptionAwardsGrantedInCoveredYearThatVestedMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value of Stock and Option Awards Granted in Covered Year that Vested", "label": "Fair Value of Stock and Option Awards Granted in Covered Year that Vested [Member]", "documentation": "Fair value of stock and option awards granted in covered year that vested." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "auth_ref": [ "r132" ] }, "meip_StockAndOptionAwardValuesReportedInSctForTheCoveredYearMember": { "xbrltype": "domainItemType", "nsuri": "http://www.meipharma.com/20230630", "localname": "StockAndOptionAwardValuesReportedInSctForTheCoveredYearMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock and Option Award Values Reported in SCT for the Covered Year", "label": "Stock and Option Award Values Reported in SCT for the Covered Year [Member]", "documentation": "Stock and option award values reported in SCT for the covered year." } } }, "auth_ref": [] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r108" ] }, "meip_ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYearsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.meipharma.com/20230630", "localname": "ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYearsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years", "label": "Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years [Member]", "documentation": "Change in fair value of outstanding unvested stock and option awards from prior years." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r65" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "meip_FairValueOfStockAndOptionAwardsForfeitedDuringTheCoveredYearMember": { "xbrltype": "domainItemType", "nsuri": "http://www.meipharma.com/20230630", "localname": "FairValueOfStockAndOptionAwardsForfeitedDuringTheCoveredYearMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value of Stock and Option Awards Forfeited during the Covered Year", "label": "Fair Value of Stock and Option Awards Forfeited during the Covered Year [Member]", "documentation": "Fair value of stock and option awards forfeited during the covered year." } } }, "auth_ref": [] }, "meip_DavidUrsoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.meipharma.com/20230630", "localname": "DavidUrsoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "David Urso", "label": "David Urso [Member]", "documentation": "David Urso." } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "auth_ref": [ "r109" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "auth_ref": [ "r136" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r134" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "terseLabel": "Award Type", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r30", "r31", "r32", "r33", "r34", "r35", "r36", "r37", "r38", "r39", "r40", "r41", "r42", "r43", "r44", "r45", "r46", "r47", "r48", "r49", "r50", "r51", "r52", "r53", "r54", "r55" ] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r109" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r131" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r65" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "auth_ref": [ "r109" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "auth_ref": [ "r133" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r105" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r137" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Securities Act File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r105" ] }, "meip_ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInCoveredYearMember": { "xbrltype": "domainItemType", "nsuri": "http://www.meipharma.com/20230630", "localname": "ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInCoveredYearMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year", "label": "Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year [Member]", "documentation": "Change in fair value of stock and option awards from prior years that vested in covered year." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r143" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r68", "r69", "r82", "r118" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "auth_ref": [ "r138" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r106" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r109" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "auth_ref": [ "r109" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r137" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "auth_ref": [ "r117" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r129" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "auth_ref": [ "r79", "r91", "r101", "r127" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Public Float", "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r65" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "auth_ref": [ "r78", "r90", "r100", "r117", "r126" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "auth_ref": [ "r110" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r104" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r129" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "auth_ref": [ "r117" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r110" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]", "terseLabel": "Award Timing Disclosures" } } }, "auth_ref": [ "r129" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "auth_ref": [ "r110" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "auth_ref": [ "r72", "r84", "r94", "r120" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r138" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r78", "r90", "r100", "r126" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "auth_ref": [ "r139" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r130" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "auth_ref": [ "r117" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r78", "r90", "r100", "r126" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "auth_ref": [ "r110" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r110" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "auth_ref": [ "r81", "r90", "r100", "r117", "r126", "r130", "r138" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "auth_ref": [ "r140" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r79", "r91", "r101", "r127" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r110" ] }, "meip_FairValueOfOutstandingUnvestedStockAndOptionAwardsGrantedInTheCoveredYearMember": { "xbrltype": "domainItemType", "nsuri": "http://www.meipharma.com/20230630", "localname": "FairValueOfOutstandingUnvestedStockAndOptionAwardsGrantedInTheCoveredYearMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year", "label": "Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year [Member]", "documentation": "Fair value of outstanding unvested stock and option awards granted in the covered year." } } }, "auth_ref": [] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "auth_ref": [ "r81", "r90", "r100", "r117", "r126", "r130", "r138" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r129" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r78", "r90", "r100", "r126" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r78", "r90", "r100", "r126" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r110" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]", "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure" } } }, "auth_ref": [ "r71", "r83", "r93", "r119" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "auth_ref": [ "r141" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r111" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r78", "r90", "r100", "r126" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]", "terseLabel": "Insider Trading Policies and Procedures:" } } }, "auth_ref": [ "r70", "r142" ] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Well-known Seasoned Issuer", "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r144" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Voluntary Filers", "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r113" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]", "terseLabel": "Insider Trading Arrangements:" } } }, "auth_ref": [ "r136" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r112" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "auth_ref": [ "r73", "r85", "r95", "r121" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "auth_ref": [ "r136" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "auth_ref": [ "r80", "r92", "r102", "r128" ] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "auth_ref": [ "r116" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r114" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "auth_ref": [ "r71", "r83", "r93", "r119" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r70", "r142" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r115" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r64" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r115" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r65" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r70", "r142" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "auth_ref": [ "r129" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss)", "terseLabel": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r5", "r6", "r7", "r8", "r9", "r10", "r11", "r12", "r13", "r14", "r15", "r16", "r17", "r18", "r19", "r20", "r21", "r22", "r23", "r24", "r25", "r26", "r27", "r28", "r29", "r56", "r57", "r58", "r59", "r60", "r61", "r62", "r63", "r145" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r77", "r89", "r99", "r125" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r74", "r86", "r96", "r122" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r137" ] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r66" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r65" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Auditor Location", "label": "Auditor Location" } } }, "auth_ref": [ "r68", "r69", "r82" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Auditor Name", "label": "Auditor Name" } } }, "auth_ref": [ "r68", "r69", "r82" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r68", "r69", "r82" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r74", "r86", "r96", "r122" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r129" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r65" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "All Award Types", "terseLabel": "All Award Types", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r30", "r31", "r32", "r33", "r34", "r35", "r36", "r37", "r38", "r39", "r40", "r41", "r42", "r43", "r44", "r45", "r46", "r47", "r48", "r49", "r50", "r51", "r52", "r53", "r54", "r55" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r75", "r87", "r97", "r123" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r135" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r67" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Auditor Firm ID", "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r68", "r69", "r82" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "auth_ref": [ "r129" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r65" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "auth_ref": [ "r117" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r76", "r88", "r98", "r124" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "auth_ref": [ "r139" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.meipharma.com/20230630/taxonomy/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r103" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r137" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r137" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r4": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r5": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r6": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r7": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r8": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r9": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r10": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r11": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r12": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r13": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r14": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r15": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r16": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r17": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r18": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r19": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r20": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r21": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r22": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r23": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r24": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r25": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r26": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r27": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r28": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r29": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r30": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r31": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r32": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r33": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r34": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r35": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r36": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r37": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r38": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r39": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r40": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r41": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r42": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r43": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r44": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r45": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r46": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r47": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r48": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r49": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r50": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r51": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r52": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r53": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r54": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r55": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r62": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r63": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r64": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r65": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r66": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r67": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r68": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r69": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r70": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r71": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r72": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r73": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r74": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r75": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r76": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r77": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r78": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r79": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r80": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r81": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r82": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r83": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r84": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r85": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r86": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r87": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r88": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r89": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r90": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r91": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r92": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r93": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r94": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r95": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r96": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r97": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r98": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r99": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r100": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r101": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r102": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r103": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r104": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r105": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r106": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r107": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r108": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r109": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r110": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r111": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r112": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r113": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r114": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r115": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r116": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r117": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r118": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r119": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r120": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r121": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r122": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r123": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r124": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r125": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r126": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r127": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r128": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r129": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r130": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r131": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r132": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r133": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r134": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r135": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r136": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r137": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r138": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r139": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r140": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r141": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r142": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r143": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r144": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r145": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" } } } ZIP 34 0000950170-23-055978-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-23-055978-xbrl.zip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�GA430JP< M,R-.J2:R!.X_C3&X]H<$F) MJ^E\@+TJZFFE2^$4M8X_=MM[U:E0.*K15LTN:@62)G85'6JNJTB+2$SZ=/72 M05R_^[C&,7!Q'Y-9!2[2$GXR@.)WS PW'S,B.=$-1%"K)-C.D2+;6QA-< RK M?S@7;W5H@A; [:A"&=WKZ-.;LO?R8C50Y[]^DI/'4/>3RJ\XRB![H1+=L#=M M%\S,X<=%2LUP(5O!PB^V=_N3 @LX^-J;7>)>P-TGKBS;Y"0R !D[4RIH@ &4 MC4);%2SQ1YIPC^+,':YV\R)BR%W'_'?2N:.B-((@-+T*8X?4]:D/A[&)$?W# M8A*=X/G#_IX^V-B-^V.-QR9N3YQ/[N&;/*,?5U\#!4VZTF+\M0$A OR_OT^MO2UEUIG4 _@J^L!@:6[[$ V>$073O:_4DTN6G,L@I]%V,S^+) MAGL[JY%;Q6#RMGD%R8."BD &5YD3GP^=.NT"/O"*I:5%G#+(P9%&V!2T5V<] M-!;O:=K OB)!9@ ^M!F,TWBYA,MD^]%+%V**])JX8T9$/#EJ;%_6%H4\G7/( M]$^V3L[!3H2Z%*U,B$=[B/2IS,F8YX8K/@QX.5_W('BO-0]*"1)D^0$7)1UF M .&;"[6XV7 'N+38Z;Q>UGEQXI7TPKH9,9_$#B(#0.@CD?2XEEC\6='F15&[ M\^+^?PV$PK94X*BQ]\P &OY$,R%N._B%2A[#O6DM/<__KM$F/E:?VV-@6W*' M9=)'K,W!-NPQF !]KCP);]V;P,'' ?:OM^$'8U$OF,6W=)-PT;_:"WL3,C(M^S;B6 M2O+<69C80F(QU4P8,EQ%5T!U?0#O!T'ISW=8%I-BXW306?8ZTJ4G#GP\I$SG M>I,":0=)B?%&M?>=7_!KS/TX7OU,3Z;Z_EZ2? 'L%VQM!!IB/Z&#GC/T%GQCYS?+1 M6V?3QI"+=RT3B=OM5I0G1RI+)SL.MW+QW;&[&3+XBAV $[6*YYI>5AV]].F2 M6]DDO_\KMQ/73ZL=!\;J[Q98DN[H\@]EWG@W\R--5B=(2STAB8#VPG@'@FSWV M@G9[=K4J:?QN%H(.5^!Z>)\^*-'PSNK*G&G$GIMM&Z*(= MZ(6>X[JOM41.;3TDB*P\C;5G0Q&@M!;4>A,=5WR1N$F+NF"U[\ODP>D'MYNB M5GIXGA=Y*]]^II.[YSENCY$97*=IY&3A.YYK><7)9]28?-'CCGZLL9L.AI$K M67T^#HV%JSFZ::>NCE:([> \HI)_O>@YH'!<,HN;0+&*=?)V(*2]3!BZ%1X_ M_N;9K>/_*9Y3_P@85' MTPN,5!/N7D-%PC=9%U[#2-S9%,G08'G-.X.J:-"*L)5ZC.C[M+Y(PZG/4Z&2 M1FSX8$U4M$OKF.'%/>,OIE_9L=NJ$^0+YZ):\'HYRLYQ3?QG4>9.B>08Y'[# M;++"@R'CT]:/F^=?3OO28F>ZONIPDD(5YJ XK27$B/,#SRJC%*F>,3LN0GZG M=A[;!W)H%/29I_+XG-DSG8S1SXV\=1"P[?'^D=HNRAM;HE#7:A#LJZKM89/, MF1:1VK-Y"3Y=;1]3"&S1&VQQ'7Z0MD I$_E6Y?(V_NF::NE!7E9T%QMY$&0# M9WGJF3\1H/\U=X@0;[S04+TU>KZ^U:T7W!."48$S +AN':C]][JFL%('&!%M M=#BJIH[GZ)JA\B3Z&JH,"XEQ69$\19RR%"C'5T23UHYGQGK&I2#2@7AWN#LQ MXH3.B7I/4+=PJ'J.<1%,$KRJR^]C33<6_L ;-51% &+-'Y/L0;;#F&,6,4# MOCNJX;KDNR"+.O]#)H?-^ M8.X6A/-T5I3A5R41WM>]>>\WR\73:,P*PTE79I9SF#$#*"JFA7GI,!EJ',R0 MN;Y;#.#MTQD1U#PDFP&,6='UZB""//UO$I5" M/ HE5(U^FA@4/CPE;;\0$[6(FU\<(YYCJA%OG^R:-%S^I,)GYW&%&'! M/- O7[6+#&GQHLM7UHVH6B>'2SZ-\3K/W1=\.^+88EY1%!5Z#1EV)^O"@3TK MM5*7E'.$PV]/W0*_>;J%NH">4RNPKSTQFB9#RB+U/SK8RW$C3Q3R$I8-&,V! M0:M!1TD&/5EQJ2?VCL] ^Z08 )NS1,M/[,V[:=$*.0WD0NWL^ARYQTFHL!7IDG/5&Z-X'&8+$>>Q-C#QZ!#9?A64&AC)J M*2N=PV>SN=;[Q3ECITDNJ,(B9Q:_LF8IU\#U"T$52YA#M?X,@'TYOK=CO*TD M8K/\[>+6)]M()F&"YNX'0K< MZ9_CU"OT,'@9W(C8)4I#?K+AL>B 2N_G"Z(7X%7_E.F__S)S5\59J>B*'?W[ M3;*%Q]_ENOY/ZE]RCG=,PDN0\[;X+%+LY8V#:0\T(&'WL,35M@A9=V?YX"#" MM?%]^8+,[%8ER^B%J_S>\35"%>7"7LOLY4:"LLIY(8!%N9F%P^?_4I3J]"EK MMB6^<>)UA.!M[;8R;M4W20>Y]D[TS^UO#M==^'T_KB1,/CC0P5\XW#^:^#'C M6H8WR&Q0J(O& %(]RV^ 4NU1!PO7/#DW?FIN5G*^?!B&P&?%)D= I?&U,WQD MEYYV/')"<4_N9JW?/8!L5H5+;"&.KAAGPY6+"-K M9=Y#5CP8XBG@MOZ/N=B#'NO"6,/A_K3I' ?+W$+)I\ M:4,QFSY$M<)$5F]Y.;= J5AMIP]?/:@VEJU.\N.AE5O19U^CG^YH%%C< "5, M!4APS"<[(YXVBH:GB%TH&^QT#^(VO#U3*'+$8+C8H5&*UXO>] M9O1H /M^\??JBH%U)?D>G\GN+?7'=K HUU7TU;6E=-9J!B 4H/V9=**[P0C? MOQ,L:6"R,NM7=$7G5U%K)+"U"@OY4E8 7Z%^![T)%Q>&; I@YYV&GSQQ+I\4 M>;(NQ6?=6F<&NF\IF\ZCTBK)R@!"K6XF;5.-U^$/3RI@+O<&-"]JHK,]*)7) M'"79=Y?WI,]<#S/:R"V1G)VE"[E% H3ZX[.^-#G_<]T%^SFBKYU:G7'>"]UOU#O?95(0.(C;,IC@I09P!]-9#N4TR7]IPQ;EQ:"5.X5YM MW".,[%M)@Z5V[L>D=,YS"DI4@4L5N(!-S;7EJM[)*F^9G6ZL[9V% !/B,)C7 MZ:RC\@H$X6#A&S&/Y&Z+F?%!1%MY&P!/,?)$<8Q<4U5J!;*LXX">ZDOKS4B&2FZ9:,EAL3EE9*'9!:&9^>7))I[J[>P>6[?T[ M[@A*' R@U7I7:8+O!G@.FOX!G M,Q.U491H]W[.==.YT2E7#.[[-,6/9=P2%55_"!KY4];%^B_JN1O8D@?"5&K\ M=6^>>J]UF[?,?H 7ZXP4YU,<)^A&:@,B0B^^;QZZ\KU!3=ZRFGHNSOB'3".< MYGI1I&L5&S0R:*8K0I<17P>7.0TS#P&3B%#^BM5A$9"I@EGP/*.@5S=,/1VT>NY MG[%-NZ/6W8(LF"7@]CI?:08[$M8><# !:.'6UK1"%^H6)770+8C.;%U M5U*VY)9BFTS)?-O9P*7NU9\@-JG*I72P0A59J\#KKO#A4HE/^PLNR0=J#Q$I):LF[Q@U?+#8B+:A= MWQH)^.I;.F ^M\S%VTI/.\5W!BI@759S+:J)2KA UP;9>A#DQ'2K]?HEX-6PCK7ITG+-F&"+"^^#_ P M(\_L0PQLW=:NO> D U!"Z5X^$[=ZH\512V+V]G%U2>_QPOG[BGW)$:?;HE/< M=%=MA.[[5!G4DCA"*.W4(OX> \ ,,8 9O> 3F9G4:Y!M/(RZ9+;[#K98 MCMH;3.>RSVO$@6B[:#I%,# '_&L=LK\CRWKGE%)Y"P/09K+)QC"(0PC=_PH# M"#P()$1&K2NC!NP9P&;&E3_0?Z#_0/^!_@/]!_H/]!_H/]#_0NB:I*6@__Q< M:. &:W=[$E"=)[1T2*@/0: M.@B$:H"0G+Q[]OZ^?Y\Y>^:4O?_SEW=E[IEG9JW> Q0$A ":X20@&@XF("&^14)*2$!.3T%'<@5 RT4.9 MF>@9&>^R\W/=9>5E8V3D%KO'^T#PX<.'4*Y'TN)"4OS"#X7^4H)'1$1$0DQ" M2TI**\3"R"+T__C =@+DA/@$8 @(CQ6X08X'(L?#]@)0W#QOXOW+ ?SK@7<# MA'^3 $Q(=(L8=T'=;> &'@AT Q]T\R8^/NZL/^X\@$]^DX)%4([@CK89F-6% M4B@H(8^03;ZZBTKG)Y)=^/7;8*);U#2T=/0Z+_3T#0S-+2S?6%G;V+JZN7MX>GG[A+P+#0M_'Q&9F/0A.27U8UIZ M?D%A47%)Z:?/-5]KZ^H;&IN:NWMZ^_H'O@U^'Y^8_#4U/3,[MXI86]_8W-K> MV3TZ/CD]._^#NKC\RRX\ (3W;\?_I5WD.+MNX..#\,%_V85WP_.O"\CQ;[(( M$E#(:8/-7.ZP"@414LHGY%5W$;$)ZR"I7K_]>8N:_>$JQ]%?IOV+9?_W# O^ M?V79/PS[IUUS D(#^<\$#D \ZC),4/\FW8K19;&.F_7B>#_ZRC!U#:1?"! M,G@[/+YL$D_IZC[D$UN1AT MSD+V=L!X62($A!79D*79,CW:7#W/6[Y]ICW>L M_>I8AGW3W06X\R/_EO])A>K,Z<_H,95/Z3]] M#E!J*_PM_Y_D^1F3D>8XBX$[<6/%SWG;-#(A_](;&Y3?BF*]=*R-+2(52&)+ M6(+6;]N< MH*E/_=Y<6;*BS "U\Q':_=^Q\D[1OAD?3KZ:;AB>.+W]7]^HA! MWZ(A&2??H/+6>.E;?7Q<3QM]?;E-M9+)Z!*Z%2&Y]HP8$/-9G--1E%"0:\%K MFHDJ*=I)U70P=_QSS-(CT:A\\GOF$;I:EFF#:E/4 ME/:5=[)3;6JDD'?BO88$+(!W%RYQ:@S3JOO%^[JU)NU-0[RE,7R4()#WYTOC MK5XU-0&J+ HC,5V#%,XF&UG=D4=L3 3^=@*ZJ"8K!X_7$[7G+1$:)*-<*0S; M#S01+J>Y$.7\QGTVA&)4Z4XJC2>O?6&#UKC\ELO=T]FXME$F'@+3:*VH?-:? MBQ57PAI4H^T/E%;3@=-+'C'Y:?O6Q\4<9TD4[_;=S<(4F9YC7G^14EI#24E7 M#A2KF+'W)>M_8[]%L+83:PVJSF\D]4449Q4O2M?GV#LMDM'+<7[K.A>7[$AM M,T1V]/I";YOP19_O6[IA@=TN_^VM,482J+T6V$Y!R, \F"9=[WD,Y=<6QIN@ M3YRM>\]1+99.SDXRH;(0<$1 /3E'@[E'J@/+]G$W62M?4=]7;@ M .K'G*=<"ROF%[[3YF6V]PIW: Q#^BV,O'Z$4J[42VK=G.-Y]P555/32ID'/ MT^/8Z"'OY_APLO%$R.+.!.-6K(*ETE$DF_.39N%RNM449R.H>FY +=XNI:ZZ ML$[=KU.44WGAR=T/ED:TYW?CM.Q2CP1Z'<1Z_L194D)\/7+VJ&COYYWRC<+D M9)FRJ#;3G?IF^/G7PDY4O;07!-(8YX^2%F[#LCR;VRML\G9JEIT0G M:@)X>[(TI54"S:@^VO@H::99X1YU<1TX #FI<"+S4_\R5?6ZNKG.ER="8V;D M>GM@0AS_SBG:&M3TYE;1QT!@D*O.<@:5JC!YT%>14N0DM4Y!SI 4VWA6WL'@ M]5F 9%8^SO:D;B6!QFY_/O#1#F:LB@%9W]C.-)TWF0T2C]&W)VUXA.^.4[=M M-Q]B8^;Z]HYW&&>\P)\O1'W>#>_:66TOER/V:Z]:?)_A7X4?Q =_U)E=SU'= MDQ)&;/NI%9N8\!5T\GT,D^^J$]3QD?ZODR,WJ_Z4Y_*5'G MX @ELXLL<[B"SB]W.[X[FK[S%^^T2NAV]<\!3Y&M5%/: @/EVI^S:^"P%/_" MN%PP- OP":7J]?)%O$FM,"XJ^B%@[L)"3.NY%*OI,$,+TS9^45%:G%2X: MA M4*X_2KMUKTM\7Y;&NI*B!Y&2[%*\:+PX/V@_5O-9GE%251GF6?+4-?L153*T MGSNFBV)[Y(M5F$&7O;]HT.48N%1;]^&PZK3>Q&I[3=*/8.UD>_.98&FY,C= MUT'QDD]8HZD]$[-+.*;S=5LLRF9K-RK7D MRT=]DR/1$$L,9-0.D[R[3%+GM \E4G+<3[//[':==M*%)0RLRC(E4PX6Q1*: MV!CKB$_^2QXDJGLO%1UY=!-E2\,T4G;D.A-5I+[X=W:)7R("I9F_GO&YJOW\ M8:[='K8PF!4TRL5DEXG+,C4H^7)%R)R*CU."H% M1-2>9^2O%:-7.R7.\P;'+% M-LT>49Q9;,EF=!]581%QX@,=%1[,?$>M,I2-]4&_339*Y"\,;@3B#>3EDE5& MYN7O1E18GS='N]3:23@2#K"[QNV\;'B/83="^;Y,?>HO8?!#3DV9G7@2U/G7 M%Q"1%:YP)ZL2%;@SQKC5Y2*VUXUVV'OC3S_Q\_B*V&3>H=G-#US;>!@WO)UD MJLD8JL)QKB7EV?#)6RL/G:)$Q1I4G$IG1;*/*55KG&0UJX"@BVEO_Y&LMTKH M8Z=U:]"0%-$:D^^+(PM1S^E-.V_M(988,(L*;2>BKIW3*U5O[*"<9<)QN/E[ M[&@=9:(<[7K(2Z<>V 6S VPO,^<2KV(T&G9\>QP+["5A 4%9YJ!54OFMY\B* MT/WU;,O>4K7V,:''Y&,N<_5[P3_/CE8[0N?>Y$]5O2U8OQ_30.>QGJ-Y5)%# MY-4_WY?P\N/^W)+1VY8"*])XUV#(BC6H,+^Z51/!+258R'"!L%%QH5>L"/[A MCPE,#^D.N*=)9:#IRI29TDTGU9$60B ^"D:?Y9(%5_MI(\2E! JC=O*\&Y19 ME2?7>.6D?9U)'?1 1YX8!3732XSF]0U58!0+A/8Y80%9&SCR+OQ(I*00_?QG MU9:^(R*][^.*U#NA '8W=+4^%B"N]1=^]K-J[DJSKLDR\Z;-ZQ=W'1AO*"J8 MH=60^[&AG^>&2OI9(G=H/P:M&BB/2.-]RX4XOM#3^O[X'AT^8_ ]NP24J]\? M9G"];P01]<;:TD#^IS4D**Z[NDX@JMF/HL;FTF]:UF53&6.8X_Q 0Z8Q%Z*4 MWSJJB>IPX%T5(15+><\9N$FZ%]O2QABN:1$/NCH%3#/R> M3O'[/2--,ISW3S?*@Z20-X3R-53Z8*AVS[9$383'-H\29P=6OYDW^R81MA)F M_+%BB*.[MFN9/.-19]-,N3S79B0GJ3[P!Y@&& M]^B@7$B!6\R+:F5JAZ$"?3P>01I&X-0B-P+O]?0M1Q9U*N@_<2:]H M^[V[SDXKB5=-W[7F-@J[:);^F]Y\&5QXO]XK2I.//]66V M^]=J2T73A#$HJL;[T /&2KT^,DG.?(=GM'<_5J[$+JQ-U18D<$:PQ_SZV6EI M^0B?^9W>**YZW?#*,,*,J7DT,.L,?&D_2-L29Z[;#J!$Q=SN1PS'T:2#_VML5U O8 W2*<0U*6V"?U M-'WI^!SIU.Y1@)_%:HKCN^S+,E50!2&<:&R6:(+H]_R^?H>DXGLM+&V-^6(! MB36:-=H3C/_M]VT*(T980"X7HI/_R48BDWXDV:G4"$RNT?)!O(OI/>Q]62U> M5I5M]78ZTV8!)R2)[C[D2'!5":%<)86R]*ZPHU_<6#PH\10I%UPM2-3Y;AS' MR$P 2$M__M.W+Y?W\[<]Y=H^11K#PMV=BR_HSUB@NX6C'NG5.##L+MDDT[,! MP@),L"S W;"RPCQ_IFXS3Z+G5J;%L?XEWL)TC-=)OT?[/2-E^_W-2!Z/-WS\ M>*^=P4"F&RS+%OTJV_SSSM1Z#LLK?@(O7B/P*>BD8C1\3B"L"BU($C8R?G"R M22/S%NQNG^GL0V).FTMLVS@F5^X3,Y=TIB>C!0]MO$6>D+5_K2$>Q] M+K(_Z?P"X>VIS*8\N?+UMJ;) DC+$"7PN'IJY5=YA7I=K^27ZOK;!SHE/*=< MQ3Q@Q"$Z,J7C#)USB?\![\4\XCHZE3N5_N58[P IZW>H4_L#89/HV!K6Y@>6 M9O%*\CQ;G.-17O)\QC0'R]*MX?.OA;# [^4L7VA/ENF57K?H]GY:!61V>5OF M$",ABR8%W*8]M69FA]V=KUA"26*7 DG23U)1?;9,[WRD?J2MU'92R'P4@2,J MJ\\%R 9*^F=2SI S&,1*SK0U>F](A(E]QEI"?3Y:Q7=S$ L -^6QP#/4&'A, M0O03=5W!O.V# G;7XI6*2==@F*#),TL$DVD/_+;AT+/)@P,^ZI4>UE&>!S/+ M[D@-,#XSSY@?'BY915.QP,MY+/#8]F0TZ@4KA,)HL;2SJ8&A;58%.N0 ^$I3 M):WZR]5IDMA,Q[X]EFT9+2.#[)+::>$I4/[7BT%Z![H:"P3!52?*ATTQN.[6 MV5$$J/WCV>(O)55<67J!!?RP (M>*?!7??ROEBIV5+?1U6,U\,&%9ERE(KS( M9]$92E5K(W J+D*H]=5 D!_8&K*WP.!#I@)YT3RZS*0W?3+2B/V],!\KYUJ? MK2Y'5Z"EV<_IHX1F-;JF9(78_%XE2JQ$!^CNZ#$_0OYJ:TJK\V(T9S'G^(@! MI0-Q W,?FDU#JMX$G:O?U==M$V.$3HAL+1.W2EJ6+9N8F'8F#=A2Z3PB>/[5 M*E&"$6]YJAE&;EOM-;K:7^!KZ72_HG8EU,^1135Q 5[3BZ$:0?,=D:8D>_M: M^DO(IK(8/F)W^$SG&J^R8@$=#Y30?+]$/0%;I<_0J?L:O+0Y6>88>L-)1S[> M9;H2?FL8!8.S8,8G9@=C/)Y&;7N37J [DFW02D2%4+A,%,/H\Y AZLDLD^[W[I /UM-^Q +40D;(JXZJ(L E6U13>, G$10S M$9132K5KASR4"^DYUK].L,@9>M1L=C6,NNH\WVI0/<8"M%A@4+X#"U0E8]1, M+@0N<>'J-@8>R:8>9YMN5;,L'F93HOS1-^NS^KP:M!>M5X@ZZ:;G2PW9;*ZN MCEVRDP\UEOC"2QDF?;F5HXJ0881_NRJ&SYM>4Y[M=MS& NM/)K' 8AP64.0# MWIJ".?WG6O$3/T9T_H;\@)RBRR"($G2L$J:M %-7C?3$R)PY76[1G-@.H#YA M 38[Y# M*2I9/-X;X&N7@B2H6_4G^^Y=IPB=HU"63\+SKUXQ!S-:;)U6IB**T]B\#$?T MM6H,OH-6_'_Q1&->0?J_R# KK=I=T96?1?D^]JNA5LS<7WI'AC>JY3K0!KQ& MG6B-N:OK$ _? 9K)Q,:)=X&,X#-HSS.S82HO>Q#Q[C'>AV!OYMRX MJ:^8V_!O7?Y8P*3C2F+ZV9$IYLDI[K$H,Z]SQCD7#9,'E8PAD0\K[Z+N;NNYXN$8V33PZ_]XJ[Q]1Z_];NW M1IA-5UC;[!6A8611'>\]H B"!>7>:O9H6(72$JX\F,\(?,Q+0QX:3S[ZW1=# MT'!6P3E@.,%>._D\PS[\-=11<,35A!S1=G^B9XG-SH'_=)C^9L++!WQWK X2 M):-!J&GO(YIG;3($XR :Q=;CN35&B]\C$Z@3E!9!R?ERSS6I>OF;G@U:5AY7 M_H!RO%&$W7<_)=<26$0E?^U3CC1WK^ \V1*0.%.[_;0-$M=9,8R3I_<$SAXD MC=0\;OTL^/3E-@Z@N$HC@GU:8/;]YO_HW>Z5\S Q7Z8@U:,D]2V+@ MV?C"TMQC6"J#A/=[!IOY2;U(/UA-W:24F9V#-[YK]R"+X+&*"2,W-I3II)OZ %_XN65L:N%BGYD- M::T#PU=>9]DAZ,^)-,/_J1AO4>$EIDTY-;"P853)46[*37SB@]]J0 M<9&G&:.D!A%.^[F-#:&O4QY9$LII$7A+X^ 5. W]9&R_%GKG9K7F?>+W[[Y' M_213ONOKDM/?QGQYJ:ZV*M606+]C.7&\OSO3!?LHL@6[??912@Z13._K??28 MOC,Z,X*!/=/GV.4P\C1&L>NT(]350!E(9(+9!WK8^RU76H-^H/%6YTW)]T:I M=LR=\$WL%$N8K>[B9?>D[P9P>IFJ3M2J^GEZ MF6@H%HCGS,-=PX9#=%3;DX!>* IS7;?,*%+(+RH[9$/'!?((> U?>1+7W99J M.)FD_--)!-Q_]WTCN,4#&M%918#<"G>2,B[3)'$M=[P]S%YS0U'E_$ E%V)X M1!J;ZKIB<^KKVV*^;A0$G.AQQ-^0/!,?6'L)Z6XS^BW#9<=EK^!+]]1CJ;5J MIS% !(ZAQ.!F(F?D='7^:\"66B^ X@B6.$*/&'F>P.0CI@C>D64N.C+521GM M<9Z3[PN8%ITE/ BTB!NE2D"V]$BX'V2X?%XV['/ERGP=8:GU/1=0Z5I[!"MZ MB!S/OY8PV.?S,$#HIZ/(O /K^+;Q2\V6K<"PF =%38Y9+6\:G:*U MO[2,6V"H52C]Y4R/0Q:G^_!FV?_0%-FMEZQ]G,F)N-,5%0X^I M)^![(?!MW7$4I-?PB6."@#POD3[5T@% ="@U(_UJ: M5*21NG5Y;*(H$1T[%9,FN,X[)\K]O?OA'1-;T>U!DE!Y@EWYTI<8\6' ]_?4 M UL?EIHFG3%-0B5@927.<"/ESRH6"%.:#=$GH@E^(2RYM1C(67*TL=&7&LAA M]\;"AEI\=G+EBL',RS6L:669-Y"A&*4/S Q?M[$"Z580/7CP\\2A)-O88?)??YX M8Z^T\%Y"^I8OJ/C@>Q>P4R*>]LI_SR6ZO30'A% OOB/F)/$;3PI/Q!Z&NO0+ MCOWRE[\R.L(TATF^/@8HQ//!%FK9A=G9Z].6R +-FI:?A]F;XTM61H%4A=&" M4.Z=!),T1NWN#-88;7ASP8U X8=,MYAH>K[8/#JATHHP*CZ>Y84_0^E)L2%I MWJF$/;/X&G)"1SG*+8/"K]HQ!DX;VE_\FU];7XJD&GM6K.GN:(O\Y)6[BY9PTT6P3!& M!ZF@I#]EXQ@FU7$4C0;_6[T?VJ>XB)! 15FN+DH@1J:?*.NX+SGB:Q@QB0:K ML$E[5/ ,/;9"^*!: Q;XDH,9L2M#]5A5 M]+XI25^IZ>QC=^E9\ZMU$G*YNP!$(VVTS05Z6PIFLWIXNUQ4\MV=7D[]41D3 M%5IP(Z(E)[R=;]PZ;T_3HKRC%T<>/9F\.#67/L&U ,V";W* RE$J1 M]V7?4O'>L9'21AYLV7%M&\??VLO8!L8TS=;F,S)*_;ZMNZ4_6-M( $!0#4&4 M7@E::KRC!@VU:7+AFW*$8F[^@1^-U3F>;_5(H"=VQ&KF7JJ#J+PL)0V,VL>= MX52Y),8"?3+D1T^)S%P=\(7$;_$=F -6/XU*)O(JI[@3"75H/_"ZE.IJSY ! M581'6^&U'9!=9Z5BXXM/0BE>:F&";@-LU?LYJF>:)+O#-#U[ZIHZGC+J7Z6B M%?4_)^+]8<>391*A^H;R1%!G(/CTKF08[#YR6O+1Q9.(/F(+P<& 6WNE.+TH M*QRT'BZY=L4EO:S(P=DJ]-\#!]:C^@BN4/1SB]I%1HJ&.3YCKQG73,@?S9W( MF:.#VNR[R*KP,_Q.3QMJ76CW"K?9=< [/=^U#@B\6VYU4(=]T=,I+;=S/?Z1 M:6] 8Q6!F+!_TN_0N$3VDQO9P]%W+LR/*?$.X) B?1FF&1RQ=*=^ Y-C2S^6 M9L5\_]/WJ105,33?&L.[?,]A #\H:%Y\;;S-KM/9OV2U+I-N((-Q)Z<\EF=0 M2J;>T"DR/\2TGF"6*;]1!;P@%9V3UP=XRO -^'E[R!4R#[L-#IFU;@W'BB5BI .+-!:/U.T\WE(A.4ZZJ#,(:\U)VG19R?WS'J@4V\3!]^((&/V^@: MCN%3OS8JK?4WG'U7/\YV-]D;+&Z)[C_\7M_.B,I1=R+I*7FY)'=S^)/E/,^[ MA<)$PE&31C0WZ".J8'6>C_5\Y+@;/U@R]_N1XH.\5,:@,0OFI>1):XHENPZB M-\&B-ORAK?5[NS,C-)B+SDI31.I[WCJ[/1Y)NG&W.K)Q%09+-5%Q<%XG4YM= M(]+-!67727VRJ_1[EZKD8[S&V$!TT(A+0R2 HZ0WO8*'>GQ:QW=?<%HD^+5U MR7G%^H(NIZNV)U!V+YN,]=2,#/@+=(I^BBH'GIMUH7&A/?K+#[8J0#5?=YAE MSVZ6Y.ETOPS>V0+M?=/:TOU6I1AU.<)S#SUYI9>PR:7"QH5_+3@,V*,-OS;% M]<8;-U6^ KA9-'V M-V@2_]5EIJ910^!RS=GQ@7@W/N M4CP5-A>J#4] M_*RH=T:+MI-B3V7XH8MOTRX=+SF^8Q2P+6&HNEK. P3Q.3] M)W*?$SD0Z\@\]C'R![_##%E@5@\2S(;,)6X7;DGM8X9=D7YU?)Y@CS@="3#' M OYW4+B?X:6@8.M^,',K]=@$X7 M+W6Q0+3IT9]"W%0?P=/'P#8KD ORVH[+S>5+!CV.H]@'KW^N'Y ,X8R%A[JW M SC*P:"&JZ4.6""OSJ6#=HO @17O3[*E*VH?=$$/[+33?C/MHAZZ'K0P17OE M[!F'OLTAXYN#@/0/:(5HDIC[1F!/]?1D;U)J_]?+&ULL<#R N7G-H_%5!'Z! M^V%N8#[@\2=C >8*S 5&ODJ7B0#NTL.F.FK',"*^LD/ZCA9?9A9>;C?OFJS(9OFXG.W^<7C,DT:1N MWI59"+[I0T6)MRD*!:^H])CN5O'BT$Y9&-\[#'O.ADF,I:5#B8&"E* M?5RRZN+*<\B4#%U?F5>LL?YN',7078^H;Z3?!A07]W>,YTF_/S]E^VNV1*O+ M8=4HN&GX<_H"S?6#>?(0IR6=UJR!Z?'F++BRL>_CY@EF<\),O,V;(PL/I&&W MQO,#'VF"O>[YJ"#KIW4G?CO9"Z@7J#LQ##)PGO$^MXB5 M@ZHN(:MZ6J!DBWRG$W4;B+B$R'W]DP62;/]A=P_JY=<3%0YJ3@]Z$P[ZA0,) MX*K5LN0OYWL\'3C:>NW8A3XI*6YWGE%MT<=U$]M8"938.N%;8('/*=*H2U&E MO8OI8FU99C,KI ]5/,.B\:+P'[-W]]AV53"ZRZ;;R"54@#&3<7[HRC%5X*!V M-*3"^J;;IJ?KM7#+/;F8JTUOZFO8"I#_3-1\TQ;T1[Q=,0N]]_-5.(>?I MR]$76SS&&ZO?QVO4.2IU6XEJYZ$6.'L[YY;]PZO:IDD!>E3_8UYYZ8B$ZP.- MU0L]LTIK#Y.[XTO=9T0Q[RTM5Q/"Y2$5-C@[C'"MP]D;EP8,,IHEL^U.)4L# M:Y>Z>X?OTMVPP!OJU'$C7IMZ]9^'0IE)C9G1S/Z"?3X(;'_0 HNL.A$JK5:P[@[M.SA/LZEC-P=95T(TI";'/9L/M2Q2D1=GMYO$TC$D"@Q9#+3\+34; M<@.5DGU+0'B?V)%)Q5%M&MOQ_!^C'D"%:4!JVEP!,+=A9@[71/[P85K(<0S5 M3HB.J'W GFG.13M:X9(>_EG[YQ4PX^"U2OV'_?!%'TQ0 EP!JE+OEZOSZ M)$=SXL$1'J''[R??NM:XN/!C.T(=4*D]+P*X)A2*)J3L8]KO/:-3[(>1[_*\ MB01.I&&KM+63>8T9^B>LD0K^44ZU]60N60/0"@_,7>1U:L3#_II6$D!R+0'R M(V87)I-4NJHTC!E M\(HK-''9E?LR#,#(_U7#3EIR<*&70HTT6E:AW.X=DE1J':F[3.O%X6? 5][A)%IUHP:7PTNTC+YQJGO!AO=7V;B4LD3O_2ICZY&@]_*4#]$P MP(].LXKG%Q-\Q 4M634\!5[01$D]S+XWKM-7F3Y3V&WIG'$!1),G7!\:+N)* MXC*AEZ[?/3/I+RUB? ^SS5R9?[A$FW-=3"LH4 *#>;$(FC +O4B%^]L]+$$K M(29V_LB );7$N691*"2E'Q=2E9KUPV-4S MI7@ O$&4G7FY%;F'?I1?%5XKZ2_()?R^ ?J@I.Y/VJ+WC[$7?]O ISV@(\V<>?$IA4B!5YHE6:>Q/TI1+2"R=Q.*O0 M\)>?UO*U*7889QMH4SG$=8(*STDMD#JSHYQ'Z46WDNQL'9&I=5%=Q&1R27GH&!%,^))\Z2D[/9@7!4#*D'Z M*#VS3[9)2[@XMN9\O7\[^@&)SUI"T+[Q-25>5NX.N;4$1WT:20RK+&1D4857 M/^='>M<1K&=1K->3SZNF+6O-^9CU0.\/SX#,2N3>=B[DGF9(XB'SF]H@W_T& M=BRPK;O@9=1=GTWU-87!QC)M\]6X"NC9?+89LYVS[,]Q;1G,$A6=");N,\H/E*IQ M"BG\X1=C1\Z*2/03OR2XL"I]J]QYEP M9W3));3[DQ_KY),YD8/LX9/Y'^S:F"'(T;.+Z=R7\WV>=GRUN\SWM H^'1!V M50IW9P,YW9=KR_REG*$%UC],7A#?D*-[M!\D2Q_ @91)1MBD(-:'2<MR<](V+Z]-:.E"VB@4(;9CI=>SSWF2%T7MK;+%-2 .7>"J(95*! MR-H/U78%]CIF0HWJZ$!%PF^8/Q5.VK*T,A3(<92>BB]5LQC'IC#-O:^)E.9T ML,7/,@^04LP\*4OP>@:#59V,7M\>?M=@(0G7Y3;W#UH$T% _87!H;?'72'/) MUC 5#LLY_16RK+";6D=QP:E],=98P$FTPI$6_J^E=7?[7TOKD[]**W>0ZB%/ MS+^4UH%VMB69JK6PV@9FLR"=62K?ZO6X2B-HJ&^RLR%73]A$JZI(QKZ*$Y-Q M$?'Z_H]P5!Q7L>M9+MG0TVIU,=7::HT72QS1T)(?/O_O0TO_EO]=Z/[_%G(_]FO9G+6A>G^1S\:K($]&=_,QO .-FX!) M?BOU(6*J O9^_TR9+_I%? '7#/K/[%WI>49JNKU8\:I7R(8(!RG=_.("VV+A MQL)JP<&8 >W#R=O^I("#MD$ R]1^JV3>PJX>[XW>DM=)(6PX*AOWU@Z\>A@M M(&5JYNOB[83/A_\YDF6$D$UJ/1WX79I?XZ>$X!$@L3ZV%>N+O' M<=0G7C[UV'O@NDD415ZGYM9YF@M1RX\\<7!%N-6;B(7+353L;[[39+SSX^+; MV\X'+YEG!R;I@=-T'G"_!+J=#CEY6?B ??0.Z[NWLI(?R98-H[J8V3/Z3*"8 M\>PE<>B(]3D+NTNL]^486$G!>SI&AEL@7,1]XN&>?A67W-7Q#UE%:4KS3V=H MGJ]CE>X\P\S$62^F)(T^*:[A6V0%GH*EK^'W@?'_['?7_OD2G383=$D$,H;^B/RT):A1SU;8Z6*0]L.]**/2&7/>KF.YP\S--KN>;.H) M*3X'7OK7JF4\!*[LH1%L';EHGOY6/>1.+0[ZS^\84B9J3#^0[G51[13:'WDN M%I!I136+9CD2.:@P]R[:O2,U;K!O71B_4<\84_BGB^G:OQ3T\4@C&0&GLC7< M/SL9I$XHK.L*;-Y7)$_IE$,_64NY]KFUC&+! G<=]##M=[" 7.56/^R8PPY^ MMB:&";0+^W?G\VRC@2>*R_NK,_?T2U4[=E2B.E M+A.3+U=B>+MFE^'70J ++>BN5=,">$N6-GWZ/5H0UDW[<)NSP:[J:V^$?<&6 MBAS#Q]A%VJUV_[TRE*ZEJ_F*FIE;#%V*4C)5/Z&\%RQ6=8XJ^GZ&!M#J? MZ> \YU;X$6]_(;_&#LK.#?"JDD5Y(R3CJ%&J%FWQUS4$HL>JN3V9M*U*=A#L\3L])&:2 MX2D-0*H]B=3OHOTM'#+!%CDX+@-!!73;9)\53^HVQG!PW/"Y'A>RBZBN9R9& M#9/E6+)%&7 IRW(]BM5Z4#*-'W>U3@^<:3*BTOP$5C\=_ J?6[_^59-]X'L- M-NU9:J48T&CY)W@:MY0@^B/^.B:L5+DV36LUY2BH&&*/Z8^ MHOC[3U'M#.]G)\ZY.6EAPMLW=8_BWM?&:"*8TS[-O(S@O7L;'/_D.XU=8H . MWHK/+>"T(PIZK%D%WRLTO:2MA/8L"<5UYQ +@GAL]<2$*IK=YR?X_<.=GJ&F M]8Z(]:JG9:@737XQZ1:L]?KFX MC6"R'&HE1^Z,$F_*CP?I>5XT>*18ZK=AH#]?EM6W/LJ__'AB.;M'9M2$ YG4 M*V0CL3@0=C@8P^6Z@4/L^$-=IKV08:4*7X>_*<'_$H+ <-O0-)>\,SX]$9CC ML[AC_SZS^548+9//%@9D7$2)=Q*;MK87Q:>DU)X]J2F::L51#I<1"R;4"4@; M:.?I0,'R%[L<2NT:JC\.7^'=MNRRQ$]$JBZW(Q7:1F/+10J_3O1]T!9O MC"A@*(S?LC-W)*)C3,KF^0( "VH#GCM-8!Y4N&$:7V#!<9(G9?Q8>NDG[' M=#=\6V17J(_QIY1._B!#<'FL$"USKV=IA;W];]V4D7%B=_.4V_VW[QQ& H@ M%M0Q%NCZX_%@=F[^*3_;&W/1@P>R:_@^4U9]U]1[NF-N^R9+K%C @G3K\PUE MI5N>_GC0"GL_N?MG+@ B[HHNPU1ZU4B$2H_Y":KSF8*^UC@['%6[=6V# MG!)OM3FU#]Z 8JF%?VE>5@,:4AQZWBR\BI=8CUW\:NS9HTFZ-(.B^*TZ;KAH M:Y3-]KW65L]6K%0:"]S?F^ZAO[$85?33[4C\$06Q&UBF3>)JJ@[PT@Q#^W_V M$GXQ:2^EG-I0KD] H6JPYKX6/)#,=DF?VDUNC-I"N&6SIA-$3BW)"9O'%\F2 M%_MFXZ%)?!5.29?\Z-=;->/JEJW^A#Z3B41+ Z\EWY6180*%KCC]79:1QX_NH53#DT!:865GK/6\9?O.^63 M&\\_=J&5#!ZB=894DE+7OT@1K#$T['&,?ON"MON&OUI?& N[9^,26N=KY[=B0ISH4 M1A>"3<]'E,$EN56R57=J47"'JD6[J3FW" >.9%0LC0=O^PLRI:85QNDBXQV? M5A-\A_OC&YR34S.R7U.X(:]=!\&.<'JW^[HN?KN;WI5W0/1?]&W>-EA,[+B5 M8P$FU>D.Z->3^]EO( MQ6F5P+@,]9SW1_HY2EUU9F+KA6(KH-_,$ M)4OS>/@#\(9JEFWKK@CUYL?6KZ SP^0O20X3-I)S(Y"\E57 G=*%LW:S A%R.2;@+?34E$%LK"<='96@T_LQ6#M(68A-\'5NQ-PV. M;3\3[M6-V7)RE_3.,#OVNVGR4JATT4;QSPL7S88S+ "<#3OU>3!#)^UY#PL: M31M$9S9UG]%G!IU0O)6([6_@"4-]*HYYW*7I=ONB_BU[SR3H^ L6&/B*>M$1 M=.9:X273O3-3^SW[>>$9;ZO%M3-DS9B\]+HLY$PI08\(4OJ82M.W<6C:#;.6 MGQ_)8_[C[P60_Q&$*@0Q2F6 4E.Y0^>VMH^ O=R$))GAT!)L116#"E^7?B^RA+8OKB\)(T"G;$&2ACR0+OGYKVB>CQ\OG;>M0OL M[6=P?BEHTA%JKX6G\!J5TWL)#W7[ZNOW0XVI6C['1_$4.GE>>:-GS;UU>H_I M/';JO'Q&:$#F7&Y7SWIT%<9*/2GI;8+=,2&48GOGZ!XYS7D?12@LY>[-E:H'=%5QPJ#;!$C&44IVR M,&L:REN=NE"#-VW3N>X#/]MU8D8M:1)PA"B]3C6U%0(URV=X[)_#EG+)^B.+ M"DVS-)]\F:3#?[,[]^@[*+[E@^A?D'T72JV/BM^18$X4X?W&&BLGNBQXM18R MT%'OHP4N_JG=:2EZE/:+^G6!3][WD 70PO,/_S&Y4O=4'FOY\EP[\8?S3==I MP_V^T\U1A???L$#?(T:!QM&3AWB?/MF>I[_TSCIA@?+:#4&1Y1_7CYB+TE:L MR_-@+NP@=I_C0ERS;2I&^? 8R$QX;.[^SDP-D)69Q;A_E67\,X/6QA$;'M.K M=?@1I7]<'_24H@X+M"MA 7)C4DI@IN?]I+*<,P%",MV=4@LJ +=\^U#EJ[ )HCD9U?\N@:TWK*I/6;3+H?1 :];=S6(2:^& MJRYSS&-+WF>[8[Z-)T;:7NO67^QZ;\95[6$()AWS8F2?9PPUA2F01 _-.V^[ M9(>U'3[^M3KM9F2LL4 5NRKFP,6A*0^[05C%T'Y$D" 3A3@[>1)7NE28$A'2 M&#.[N!^$H9K:%J,O"9>!*,&M;DF/\VBPI:E!^ KW I6069-?OJX[F!Q]#4A/ MW_IH&5%R*Y8Q^64!P_ZP5PE*6JK<$)60ZQ5N$KLDS3+_N[IWT^O)E=1$0E!# M@=OAWO, "CMZUQG- B5KARK$]>]R(T['WBOSH#A,FQ%RH'=1]% ^T>'M,8/O MMAJ-;*'3RPT/,M,NX@NKX\];415T M7TGZG64J:[$07?/QD45U8>8 $D#Q8PAAC_M64):B\=/T/;*1_B* >%ZG>,,P?WRP_3D6,-TKZ#!#E+Y8ZS;L?2J<\4CY,I0] M(+]Q-$2,Y)(@SU%SB.F;RWX3+I[N&*=&5%+#P+L389VB0LDR&V2PCY7"*S]( MFLD*G)6&.+[)^GN48@%$F3<6:%5<3-M<[5A7-\VX*' R19F/XQ#+KM3?BT#_ M PC>6@=#BIQOO@IK2CWQW/+D/?%T1M'579(:'O+8_$WNT?5CH[/O_X MYNXK80%X[VTX?0]J$(?!Y>'3Z_!+8BV"JAZ!"RX?S:L:^/9 97V30)CIL<9I MSA\++/ SSM@!\ KOO3 U1,45;Y=OF&G>9[0J4.[A.N:YT-,NL\& CEX;6K]( M3\ZJ/3_&HYF5#S,+OD7 1IK==D'5Y:=2G[*'2.ZKM;(;&6.%OHV$9=FC95&> MQ5YV/*C M:^Y7 VN@+^C/!^&K#JQ[J[PN@S9XB;ZB627<8A&$[*('KOMG4I_76KI:LYEJ< MG\[6++$%)E LI1T9GW>B>XLG&Q5.8>YQ:\<8W=05ZU='2GU&5_,S4VZF$CO: M_1M777HA,P2TE[]>!VR):1*6/'Y#;\4!.=6"/#"^+J=9"F M1"];A<*A@F6F:ZF769#K'2R0J'53D\IK_DJLTX<_J$0M:O!T'E[;G/TZNK]# MX%='ZE2=#"W*5W.LO+^J]'O.G![Q5=W='$YA+/"5&;/@,YT]AX(^;T4Z+$

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end